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A b s t r a c t
Applicability o f adsorbent resins for the recovery o f geldanamycin 
from  S trep tom yces h yg ro sco p icu s  var. ge ldanus fermentation broths
Adsorbent resins are gaining increased application in recovery 
bioprocesses, thus it was decided to assess the ir applicability for the 
recovery o f geldanamycin, an antibiotic produced Streptomyces 
hygroscopicus var. geldanus, in both a Downstream Processing (DSP) 
and In-Situ Product Recovery (ISPR) context.
Antibiotic production was initially assessed using the conventional disk 
diffusion assay. This was inefficient for large sample sets, therefore a 
microtiter plate-based bioassay was developed. This assay was an 
improvement on the disk diffusion assay, it was high throughput, allowed 
quantitative assessment of sample bioactivity, but quantification of 
geldanamycin in fermentation samples, was not possible. To achieve this, 
a High Performance Liquid Chromatography (HPLC) method was 
developed. During method development, significant difficulties, including 
column fouling, low sample throughput and poor geldanamycin solubility 
and had to be addressed. Once these issues were resolved, the HPLC 
method could be used to treat large sample sets, with minimal column 
damage, and was therefore employed for analysis o f all geldanamycin 
containing samples.
Product recovery is key in bioprocesses, and it was found that the resins 
assessed had capacity and affinity for geldanamycin adsorption when 
applied in a DSP context. They were robust to temperature and pH 
changes and facilitated the generation of product streams of high product 
purity and concentration. Addition of solvent increase the selectivity of 
adsorption from fermentation broths, by approximately 5-fold. Two resins, 
Amberlite XAD-1600 and Diaion HP-20 were selected for further 
examination in an ISPR context based on their performance in DSP 
studies.
Applied in an ISPR context, it was found that the resins were capable of 
adsorbing compounds other than geldanamycin and their inclusion 
impacted on the growth rate o f the organism. An approximate 3-fold 
increase in production could be achieved depending on resin 
concentration and addition time. In summary adsorbent resins are suitable 
for recovery o f geldanamycin from fermentation broth and their correct 
application can increase product yields.
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C h a p t e r  1 .  I n t r o d u c t i o n
1 .1  B i o t e c h n o l o g y  a n d  B i o p r o c e s s i n g
The European Federation of Biotechnology proposed a definition of 
biotechnology in 1981 as T h e  integrated use o f biochemistry, 
m icrobiology and engineering sciences in order to achieve technological 
(industrial) application of the abilities of microorganisms, cultured tissues 
and parts thereof (Lilly, 1997). From this, it is clear to see that 
biotechnology encompasses an array of methodologies and techniques 
which can be considered bioprocesses. The two terms ‘biotechnology’ and 
‘bioprocessing’ are interlinked, and should be considered as involving a 
w ide variety of distinct subject areas (Trevan et al., 1987, Rehm and 
Reed, 1985), and for the remainder of this document, the use o f either 
term can be considered as meaning the other.
Biotechnology and bioprocessing can be considered disciplines o f great 
antiquity, with such examples as silage production, traditional foods, 
wastewater treatment and alcohol production through brewing, spanning 
centuries (Smith, 1981, Brown et al., 1987, Scragg, 1991). Traditional, and 
modern, biotechnological processes have contributed greatly to the 
quantity and quality of our food, medicines, environment and our personal 
health and vitality (Bailey, 1995). The spectrum of bioprocesses, by 
extension, incorporates the production of fermented foods and chemicals 
such as antibiotics, enzymes, ethanol, vinegar, citric acid and vitamin B12, 
cell cultivation, wastewater treatment and a number activities, such as 
energy production, oil recovery, and nitrogen fixation (Rehm and Reed, 
1985).
Even though there are a vast range of compounds which fall under the 
classification of bioproducts, one can argue that there are three major 
techniques, or process disciplines, which can be routinely and repeatedly
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employed in biotechnological methodologies. These include enzyme 
catalysis, cell-based systems, and tissue or whole-organism systems.
In general, enzymes are considered as proteins which catalyse reactions 
in a very specific manner. These biocatalysis reactions (meaning 
catalysed by biological material), use the enzyme to perform actions which 
would usually be associated with chemical processes. The specificity o f 
the reactions means the application of enzymes in biological processes is 
limited to single enzymes for single, or closely related, processes. There is 
a great deal of interest in extending enzyme use in food processing, 
chemical production, analytical and diagnostic systems and in the 
treatment of diseases. Over 2000 enzymes have been identified, and a 
few hundred have commercial applications, such as those used for genetic 
manipulations, like restriction endonucleases, ligases and editing enzymes 
(Towalski and Rothman, 1995).
W here enzymes function through catalysis o f specific reactions, the 
microbial cell performs a series o f such reactions. They can, by virtue of 
this, become the basis of more complex bioprocesses than enzymatic 
processes. The cell can essentially act as a complete biomanufacturing 
plant. The umbrella of microbial cell bioprocesses incorporates scientific 
activities ranging from relatively modern applications for the production of 
recombinant human hormones and microbial insecticides, to the more 
traditional mineral leaching and to bioremediation o f toxic wastes (Glazer 
and Nikaido, 1995).
The use of microbial cells for waste water treatm ent include so-called 
‘green’, or environmentally friendly bioprocesses, such as bioremediation 
and biodégradation. Many human activities have resulted in negative 
impacts on the environment, especially the contamination of water, the 
atmosphere and soil (Zhong, 2004). Bioremediation and biodégradation 
involve the application of microorganisms to remove toxins from the 
environment and are steadily becoming the technologies o f choice for the 
remediation of many contaminated environments (Crawford and Crawford, 
1996), and their application has expanded enormously (Alexander, 1994).
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Microbial cells are, however, more frequently applied in production 
fermentations. These types o f processes involve the controlled culturing o f 
specific cells, in specially designed media, for the production of desirable 
products. The major products produced from such microbial cell systems 
include fermented juices and liquors, cheese, cell biomass, enzymes, 
vitamins, vaccines and antibiotics. During the last two decades there has 
been a large increase in the range o f commercial products, especially 
secondary metabolites and recombinant proteins, and an associated 
increase in fermenter and facility design to improve performance 
(Buckland and Lilly, 1993), with antibiotic production being one of the most 
significant microbial cell-based processes.
Of the many thousands of microbial species relatively few are exploited in 
production processes. The principal m icroorganisms involved are all 
chemo— organotrophs, and derive their carbon and energy supply from 
the metabolism of organic compounds. Of the Gram-positive organisms, 
aerobic, endospore-forming bacteria o f the genus Bacillus, some 
coryneform bacteria and the filamentous bacteria, particularly of the genus 
Streptomyces, are well represented. The Gram-negative organisms 
include acetic acid bacteria and xanthomonads, with various yeast and 
fungi also prevalent, and the relevant characteristics of all microorganisms 
involved in these processes are that they should be non-pathogenic, easy 
to maintain and cheap to culture (Brown et a l, 1987).
Microbial cells are not the only cell type utilised in fermentation processes. 
Animal and plant culturing is also employed for the production of beneficial 
compounds. Animal cell bioprocesses involve an interplay between 
medicine, biology and engineering. Modern industrial animal cell culture 
began in the 1950’s, with the use of animal cells for the development of 
vaccines (Schugerl, 2000a). An important example of the types of cells 
used in animal cell culture are the hybridomas, which have infinite life 
spans and are the most frequently employed cell type in animal cell culture 
(Kelley et al., 1993). An excellent description o f these cells, and their use 
for the production of monoclonal antibodies is detailed by Primrose (1987),
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who described how hybridomas are created from the fusing of myeloma (a 
type o f tumour) cells with antibody producing spleen lymphocytes, and can 
be grown indefinitely while continuing to secrete antibody. All the 
antibodies produced by culture of any particular hybridoma will be identical 
and are termed monoclonal, i.e. they are all derived from a single clone of 
lymphocytes. These monoclonal antibodies can be purified easily and find 
application in many different areas, from diagnostic kits to cancer therapy 
and protein purification.
Plant cell-based bioprocessing and culture dates back to the beginning of 
the last century, and since the 1930’s a great deal o f progress has been 
achieved. The concept of culturing plant cells includes the culture of plant 
organs, tissue, cells, protoplasts, embryos and plantlets, the main aspects 
of which are the production of secondary metabolites, microproagation 
and the study of plant cell genetics, physiology, biochemistry and 
pathology (Zhong, 2001). Plants are valuable sources of numerous 
metabolites, including pharmaceuticals, agrochemicals, flavours, colours, 
biopesticides, food additives and biologically active compounds, with more 
than 100,000 plant secondary metabolites having been identified (Zhong 
and Yue, 2005, Zhong, 2002).
Although bioprocesses have existed for millennia, since the 1970’s, there 
has been somewhat o f a biological revolution (Trevan et a!., 1987). The 
breakthrough into what is termed ‘new biotechnology’ came about with the 
advances in the knowledge of the genetic make-up o f organisms, and was 
based on a combination of cell culture and recombinant DNA technology, 
(Vasil, 1990). True gene technology succeeded after the first gene transfer 
into Escherichia coli in 1973, and since then, gene transfer in microbial, 
animal and plant cells has become a well established technology (Fiecher,
2000). The ability to manipulate the genetic makeup o f living organisms 
has made it possible to enhance the ability o f an organism to produce a 
particular chemical product, to prevent it from producing a product and to 
enable an organism to produce an entirely new product (Me Gloughlin and 
Burke, 2000). Genetic manipulation of microbial cells is most prevalent in 
bioprocessing, however, it is foreseen that the genetic modification of
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animals could be of significant benefit in future bioprocessing applications 
(Me Gloughlin and Burke, 2000, Stranzinger and Went, 1996).
It is one thing for the laboratory scientist to clone a novel gene, discover a 
new antibiotic or invent an enzyme catalysed process, but it is quite 
another to transfer that knowledge to the scale o f operation required to 
make useful products in significant quantities (Trevan et al., 1987). The 
two key aspects of any bioprocess can be summarised as compound 
production and recovery of the product o f interest. Brauer, (1985) wrote 
the following with respect to production and product recovery, with focus 
on a successful bioprocess.
T h e  problems addressed are not only related to microbial mass 
conversion in bioreactors, but also to upstream and downstream
processes............ microbial mass conversion in bioreactors is a
function o f the laws describing the transport momentum, heat and
mass as well as bioreaction kinetics............ in upstream and
downstream processes, transport phenomena play the decisive 
role. Especially in downstream processes, designed for separation 
of desired products of microbial mass conversion from undesired 
ones, transport phenomena occur, in many cases, under extreme 
conditions and this is primarily due to the small concentration of 
these products in the fluid and the low density difference between 
the microorganism and the flu id ’.
Biotechnological and bioprocess applications encompass a range of 
technologies and an even more diverse range of products. These 
techniques employed can be traditional or at the cutting edge of scientific 
research, but either way, the benefits which they afford mankind are 
unmistakable. It is important to note however, that even though 
bioprocessing techniques and their products are encountered on a daily 
basis, there is considerable effort required to establish a suitable process 
for production o f a desired compound. The work performed in this pursuit 
centres on development of appropriate production and recovery 
methodologies.
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1.1 .1  F e r m e n t a t io n
The process of fermentation is one of the most important facets o f cell- 
based culture systems. In its strictest sense, fermentation refers to the 
metabolic breakdown of nutrient molecules, such as glucose, and 
historically, refers to the anaerobic consumption of sugars, by yeast, for 
the production o f alcohol. In modern bioprocesses however, this definition 
is incomplete, and more accurately, may be considered to refer to the bulk 
growth o f microorganisms on a growth medium with no distinction being 
made between aerobic and anaerobic metabolism. The cells involved in 
fermentation processes vary from animal and plant cells to microbial cells, 
and the nutrients consumed and products produced are similarly diverse. 
The core elements o f importance in any fermentation include the 
fermentation reactor design and the mode of fermentation employed.
Bioprocess technology encompasses all the basic and applied sciences as 
well as the engineering required to fully exploit living systems and bring 
their products to market and typically, in commercial production, this 
begins at the fermentation reactor (Asenjo and Merchuk, 1995). The 
fermentation reactor, fermenter, or bioreactor, is the vessel in which the 
fermentation is carried out. In the fermenter, an organism is cultivated in a 
controlled manner to produce more of the organism or a product, or in 
some specialised cases, to carry out specific reactions (Scragg, 1991), 
and is an enclosed system, comprising of the vessel and its seal, the 
head-plate, which allows sterile conditions to be maintained. In liquid 
cultures, these are frequently cylindrical vessels, fabricated from glass, up 
to a volume of three to five litres, and fabricated from stainless steel above 
this volume. Commonly, the fermentation process incorporates additional 
devices to confer control upon the system and includes methods which 
allow control of the significant fermentation parameters, such as bulk liquid 
motion, mass transfer, aeration, temperature, pH and fermentation 
volume.
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Adequate bulk liquid mixing is important in fermentation processes to 
ensure adequate agitation and mixing o f the fermentation system, which 
facilitates dispersion of biomass, nutrients and oxygen. A suitably agitated 
system is characterised by a high homogeneity and potential for heat and 
mass transfer (Solomons, 1980). In order to achieve these goals, agitators 
are employed. These are located internally and may comprise of a 
stainless steel shaft running down, from the head-plate, into the 
fermentation liquid. Attached along this shaft, or at its end, are impellers. 
Impellers are stainless steel implements which come in a variety o f forms, 
including disc, vaned disc, open disc, variable pitch, paddle, anchor, gate 
anchor, marine propeller and helical crew (Solomons, 1980, Doran, 1995). 
The impeller-type employed is dependent on, among other things, the 
fermentation process being performed, the organism involved and the 
viscosity o f the system (Doran, 1995).
In order to increase turbulence, baffles can be included in the system. 
These are vertical strips of stainless steel, mounted against the walls of 
the fermenter, protruding into the culture liquid. Baffles are placed 
equidistant from each other in the fermenter and serve to reduce vortexing 
and swirling o f the culture fluid, which would otherwise prevent sufficient 
bulk liquid motion (Doran, 1995).
In fermentations where oxygen is required, air is usually introduced into 
the system via a sparger. A ir enters into the system, after being filter 
sterilised, in the form o f bubbles. The sparger is usually located beneath 
the impeller, to facilitate bubble break-up and increase the potential for 
gas dispersion and mass transfer. Airlift bioreactors can also be used. 
These are fermentation vessels which do not employ mechanical agitation, 
instead, the introduction o f air bubbles, through sparging devices, acts as 
an aeration aid and to provide bulk liquid flow to the fermentation system 
(Doran, 1995).
Temperature maintenance is important in fermentation systems because 
the producing cells may have an optimum temperature at which they 
proliferate and produce. The product of the fermentation may also exhibit
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sensitivity to temperature extremes, and therefore without proper 
temperature control and regulation, both the producing cells and the 
product may be adversely affected. In circumstances where the optimum 
temperature fo r cell growth and viability is not the same for product 
stability, a trade-off in the temperature at which the fermentation is 
performed may be required. For temperature control, the fermenter can be 
jacketed, whereby an external space or jacket is fabricated into the design 
of the vessel walls or incorporated as a coil internally. Such devices allow 
the introduction o f heated steam or cooling water to maintain or alter the 
fermentation temperature.
Feed and bleed lines may also be included as part o f the fermenter. These 
lines allow the addition of feed streams into the system and removal of 
culture fluid out of the system. Feed lines are most frequently employed 
for addition o f nutrients or pH regulators. In fermentation processes, the 
organism metabolises nutrient sources to product. If a nutrient becomes 
limited it may impact on the health of the organism or may induce a shift in 
the organisms’ metabolism. These events can be prevented, or 
encouraged in the case of nutrient limited cultures, for antibiotic 
production, through the addition of substrates into the fermentation 
system.
pH control is another important consideration in fermentation processes. 
Frequently the organisms employed in the fermentation will have a pH 
range over which they can survive, and an optimal pH at which their 
growth will be encouraged. The organism may be capable o f the 
production o f acids, or other metabolic products, which change the 
fermentation broth pH and impact on the organism. Addition o f liquids to 
alter pH is therefore necessary to maintain the fermentation under optimal 
conditions.
Wang et al., (2005) highlighted the importance of selecting and applying 
the appropriate fermentation system, and the potential benefits of 
employing batch, fed-batch or continuous fermentations for specific 
production purposes. Although these are the most commonly employed
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fermentation configurations, there are a number o f others in existence, 
and the selection of the appropriate one is dependent on the product being 
produced and the organism used.
A batch fermentation is a system whereby apart from oxygen in aerobic 
processes, all the required constituents from the initiation of the 
fermentation and product recovery takes place when the process is 
complete (Doran, 1995). In batch fermentation systems, the organism 
proliferates and produces metabolites until one or more factors exert an 
influence on the system. The main influencing factors include substrate 
limitation and end product inhibition (Crueger and Crueger, 1982). 
Substrate limitation involves either one or more substrates being 
exhausted and thus preventing further growth or production (Doran, 1995). 
End product inhibition involves the build up of product or toxic by-product 
in the system (Glazer and Nikaido, 1995). The batch fermentation is a 
simple process, but the use of methods which allow feeding o f compounds 
into the fermentation system may lead to higher yield and to greater 
process control and reproducibility (Kuenzi, 1978).
Fed-batch processes are applied to overcome some of the problems 
associated with batch fermentation including catabolite repression of 
secondary metabolite production (Crueger and Crueger, 1982). Fed-batch 
systems essentially comprise of two 'separate’ operations; batch and 
feeding. The batch operation favours biomass growth and the feeding 
operation is ideal for controlled production. The feeding of the substrate 
involves continuous or intermittent addition o f nutrients w ithout the 
removal of culture fluid (Doran, 1995), thus there is an increase in 
fermentation volume and addition of nutrients will ultimately be limited by 
the volumetric confines o f the vessel.
A milestone in the development of bioprocessing was reached with the 
perfection of the continuous fermentation process. These were first used 
for the production of food and feed from yeast and bacteria (single cell 
protein) (Crueger and Crueger, 1982). Continuous fermentations are open 
systems and are aimed at prolonging growth and increasing product yield
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via the maintenance of substrate and product concentrations at optimum 
levels. High productivity is achieved by feeding continuously and removing 
product (Schugerl, 2000b). In this manner, substrate inhibition is reduced 
and the fermentation working volume is maintained. Ideally in continuous 
fermentations the rate o f conversion of substrate to biomass and products 
should balance the output rate, maintaining steady state in the 
fermentation (Smith, 1981).
The fermentation processes and the conditions employed are dictated by 
the producing organism and the product generated. Frequently 
considerable effort may be exerted in order to develop an optimised 
fermentation processes. Once this is achieved however, the onus for a 
successful bioprocess is transferred to the recovery o f the product.
1.1.2 D o w n s tre a m  P ro c e s s in g  (D S P ) o f  F e rm e n ta tio n  P ro d u c ts
The yield o f a bioprocess is not only dictated by the production process 
employed, but also the recovery methods. Fermentations are 
characterised by relatively low product concentrations and by the complex 
nature o f the fermentation medium utilised. Separation and purification of 
the products generated from fermentation processes can have a great 
impact on the complexity of the overall production process, are laborious, 
and dominate overall process economics (Wang and Sobnosky, 1985, 
Gordon et al., 1990).
Downstream  Processing (DSP) is a name given to any treatment of the 
fermentation broth post-fermentation to recover or purify the product 
(Doran, 1995). Downstream processing operations have long been seen 
as the bottleneck for many production processes (DePalma, 2005b). 
However, downstream operations also represent some of the greatest 
opportunities for creating value during biomanufacturing through their 
optim isation (DePalma, 2005a). Downstream Process operations follow a 
flow, from treatment of a crude broth to recovery of a purified product, and 
commonly involve three main processes; primary separation, secondary
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separation, and product polishing.
Primary separations involve a stream separation o f the fermentation broth, 
employing techniques to separate the biomass (solid stream) from the 
fermentation liquor (liquid phase). In DSP operations solid-liquid 
separation techniques, such as centrifugation, filtration and sedimentation 
are commonly the first major operation in the recovery o f bioproducts 
(Krijgsman et al., 1993). Once this is achieved removal o f non-desired 
compounds, or isolation of the desired product, is performed (van Erkel et 
al., 2004). Even though these processes fulfil a relatively simple role in the 
overall recovery process, the loss of product associated with them can be 
significant.
An important consideration, when examining the recovery of any 
compound o f interest, is its location. When the fermentation is completed 
the product may be found in the cytosol, in the periplasmic space or in the 
extracellular medium, depending on the secreting ability o f the organism 
(Hedman, 1984). If the product is secreted into the production 
environment, the liquid phase is o f predominant importance and the 
biomass may be discarded. If the product is associated with the biomass, 
being either intracellular or intraorganelle associated, discarding the solid 
stream would mean discarding the product (Zhukovsk et al., 1973).
In some cases, the product may be present in both the liquid and solid 
phases of the fermentation broth. In this scenario, one must establish the 
benefits o f treating both phases as a source o f product, with relation to the 
contribution of each, on the total amount o f product recovered. The 
separation method or technique employed in the primary separation may 
also be a source of product loss.
Secondary separation techniques are those which facilitate concentration 
and recovery o f maximal amounts of the product of interest in as pure a 
form as possible. In liquid cultures, concentration o f the product often 
entails removing or reducing aqueous volume of the fermentation feed.
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The methods employed included membrane separation techniques, 
volatilisation, extraction and chromatography.
When membrane techniques are used to concentrate the product feed, 
techniques such as microfiltration, ultrafiltration or nanofiltration are the 
most common. These techniques have become firm ly established as 
technologies which ensure purity, safety and efficacy o f modern 
biopharmaceuticals (Christy and Vermant, 2002). Li et al., (2004) and 
Tessier et al., (2005) outlined the use o f such techniques to improve 
separation, purification and extraction o f bioproducts. These techniques 
separate fermentation broth feeds via the use of membranes and 
maintenance of a transmembrane pressure as the driving force for 
separation. The pore size of the membranes dictates the retention 
capacities o f the filtration process, and such techniques have wide 
application in clarification of fermentation broths, biomass recovery and in 
particular protein recovery.
If the product is volatile, it may be recovered via evaporation. Once the 
product has a lower boiling temperature than the water which is the prime 
constituent o f the fermentation broth, then evaporation and subsequent 
distillation can be used for product recovery. In some cases, the product 
may be removed via sparging (Pankow et al., 1993). In this process the 
compound o f interest is evaporated from the liquid culture using airflow. 
The volatile products are then recovered, in a concentrated form, through 
processes such as distillation and condensation.
Extracting the compound of interest is another means o f concentrating the 
product. Techniques including liquid-mediated extractions, using 
appropriate solvents (Brunner, 1985, Roffler et al., 1987, Bruce and 
Daugulis, 1991, Daugulis et al., 1991) and solid-mediated extractions 
using chromatographic materials are commonly employed (Crueger and 
Crueger, 1982, Stoffels et al., 1993, Brocklebank and Kalyanpur, 1993, 
Ramos et al., 2004).
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Solvent extraction involves contacting the fermentation liquor with a 
suitable solvent for which the target molecule has an affinity. These 
solvents are generally immiscible with the fermentation liquor in order to 
facilitate subsequent separation, and back extraction of the product of 
interest into a new aqueous phase, if required. There are a number of 
problems associated with solvent extraction, including the generation of 
solvent waste which requires either costly disposal, or development of 
processes to facilitate recycling. Solvents may form emulsions which are 
difficult to treat, and from which, recovery o f product is difficult, and 
recovery efficiencies are therefore reduced (Doig et al., 1999, Doig et al., 
1998).
Chromatography is a process of selective adsorption of the target 
molecule from a solvent onto an adsorbent (Strube et al., 2002). 
Chromatography-mediated recovery processes are o f major significance in 
industrial production processes. Two commonly applied methodologies 
are hydrophobic interaction-mediated recovery and ion exchange- 
mediated recovery. The development o f adsorbent resins, chemically 
synthesised or conferred with desired properties like a biospecificity or 
affinity (Wang and Schultz, 1981), hydrophobic interaction capabilities 
(Kwon et al., 1998) or ion-exchange capabilities (Bartels et al., 1958) has 
facilitated the development of a number o f novel recovery strategies.
Hydrophobic interaction chromatography is based on hydrophobic 
attraction and is a technique for the purification and separation of 
biomolecules based on differences in their surface hydrophobicity, 
particularly applied to protein recovery (Bywater and Marsden, 1983). 
Molecules exposing hydrophobic areas on their surface may be separated 
due to their interaction with a non-polar ligand (Sofer and Hagel, 1997). 
The materials employed in such separations usually contain-polar 
functional groups (such as butyl, octyl or phenyl) attached to a 
hydrophobic polymer matrix.
Where hydrophobic interaction chromatography relies on the hydrophobic 
properties of the compounds being targeted, ion-exchange
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chromatography relies on the charge o f the compound. If the compound to 
be recovered is a positively charged compound, cationic chromatographic 
materials are used, and if the compound is negatively charged, anionic 
chromatographic materials are used. Thus recovery processes employing 
ion-exchange chromatography techniques rely on the interactions of 
charged functional groups with ionic functional groups o f opposite charge 
on the adsorbent surface (Ghosh et al., 1997).
Biospecific adsorbents use very complex, characteristic attributes to bring 
about adsorption. This can take the form of antibody or enzymatic-like 
complexes, and are thus among the most specific adsorption processes. 
Pyrzynska and Wierzbicki, (2005) detailed the use of modified selective 
adsorbent resins for the recovery o f vanadium. The resins were 
functionalised with porphyrin ligands to increase pre-concentration of the 
vanadium species.
Advances in genetic modification techniques mean it is now possible to 
genetically engineer an organism to produce a product with a specific 
recognition site to aid its subsequent recovery. Common examples of this 
include incorporation o f a poly amino acid tag, such as repeated units of 
histidine or arginine, onto the product. These can then be recognised and 
adsorbed by the chromatography material used, which makes subsequent 
recovery o f the product easier (Levin et al., 2005, Sontag and Cattini,
2003).
It is important to note however, that irrespective o f the mode of separation 
employed (affinity, hydrophobic or ionic-based) such events are often very 
complex, and the recovery or adsorption o f a product may be attributable 
to a combination of such interactions, despite one being dominant.
Product polishing is the final purification stage o f the DSP process. The 
bioprocessing techniques involved in final product polishing are primarily 
focused on obtaining the product in an appropriate form for its subsequent 
use, and in pharmaceutical biotechnology it is considered the most 
laborious and exacting part of the whole downstream process (Jungbaur
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and Janson, 1993). The most commonly applied techniques include high 
selectivity chromatography (Jungbaur and Janson, 1993), drying 
(Tijsterman, 1993) and crystallisation (Schügerl, 2000b). Some 
bioproducts are more stable in solid form, thus as a result, if they can be 
recovered in crystalline form, their longevity and storage potential will be 
increased. In order to bring about crystallisation there must be a high 
concentration o f pure product in the recovered stream. Strube et al.,
(2002) outlined the considerations one must take into account when 
selecting the optimal refining strategy for a product and also suggested 
that a combination of unit operations may be advantageous.
In summary, with respect to the general procedures involved in DSP 
recovery o f biocompounds, the ideal recovery process should facilitate the 
removal o f maximal amounts of product in as short a time as possible 
since bioproducts can exhibit sensitivities to the production environment 
and other external factors including temperature, light, pH, etc (Wang and 
Sobnosky, 1985). In DownStream Processing, a number of unit operations 
may be required to return the product in a suitable form (Strube et al.,
2002). The greater the number o f processes or unit operations involved in 
the recovery of product, the greater the potential for product loss, and this 
is one of the reasons In-Situ Product Recovery processes were 
developed.
1.1.3 In te g ra t io n  o f  D o w n S tre a m  P ro c e s s in g  in to  F e rm e n ta tio n  -  
U se  o f  In -S itu  P ro d u c t R e c o v e ry  (ISPR )
As previously mentioned, the downstream recovery o f products from a 
fermentation feed usually involves numerous clarification steps including 
centrifugation, filtration, extraction etc. Xu et al., (2005) suggested that 
there is significant potential for product losses and contamination during 
such steps and suggested that a process which could combine separation 
functions with recovery and purification of the product would be extremely 
beneficial. Such processes are known as integrated processes and can be 
applied for the recovery o f a range of bioproducts including alcohols,
15
organic acids, antibiotics and proteins.
In-Situ Product Recovery (ISPR), often referred to as extractive or 
integrated fermentation, involves actions taken for the immediate 
separation o f product from its producing cell (Freeman et al., 1993) or the 
production environment. Continuous recovery o f product may improve 
productivity by limiting the exposure o f the product to a potentially 
destructive environment (Schugerl, 2000b). ISPR is implemented to 
improve yield and productivity via minimisation o f product inhibition, 
product losses due to degradation or evaporation, and reduction o f the 
number of subsequent Downstream Processing steps (Dukler and 
Freeman, 1998, Freeman etal., 1993).
For a successful ISPR protocol to be established, the integrated 
bioprocess set-up should consist of a bioreactor and a downstream unit, 
coupled with a means that guarantees the fast removal o f the products 
(Bluemke and Schrade, 2001). The most applicable technique is dictated 
by the process conditions and limitations, thus a particular ISPR method 
may not be suitable for the recovery o f a wide range o f bioproducts. There 
are five main techniques which can be employed in ISPR methodologies 
for the recovery o f product from its production environment, and they are: 
1) Evaporation, 2) Extraction, 3) Permeation, 4) Immobilization and 5) 
Precipitation (Stark and von Stockar, 2003).
1) Evaporation is used for the recovery o f volatile compounds such as 
alcohols and some of the techniques employed include vacuum 
fermentation, flash fermentation, gas stripping and pervaporation (Roffler 
etal., 1984, Freeman etal., 1993).
Vacuum evaporation involves maintaining the ferm enter under vacuum so 
that the product evaporates at the normal temperature at which the 
fermentation is run. In flash evaporation procedures, the fermenter is kept 
at atmospheric pressures, and the broth is removed to an evaporation 
chamber where the product can be boiled off (Roffler et al., 1984). 
Daugulis et al., (1991) explained how this flash evaporation method could
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be adapted, whereby the product could be extracted Into a solvent, which 
in turn underwent the flash evaporation process with associated 
condensing and recycling o f the extracting solvent. Gas stripping uses a 
sparger to sparge gas bubbles into a fermenter, which removes the 
volatile compounds from the medium upon rupturing (Ezeji et a i, 2005). 
Finally, pervaporation is essentially an integrated system involving 
permeation and evaporation of the product. Pervaporation distinguishes 
itself from other membrane process, since on the feed side there are liquid 
mixtures, but on the permeate side the product is removed as a vapour. 
The driving force for the permeation is the high pressure difference across 
the membrane (Huang et a/., 2006).
2) Extraction is primarily used for the recovery o f compounds from liquid 
cultures, where they are in solution and present in low concentration. 
Extraction methodologies essentially involve removing product from one 
stream to another. The techniques generally employed are liquid-liquid 
extraction, aqueous two phase systems and solid-liquid extractions, 
although the latter can be included as an immobilisation technique and will 
be covered as such in later sections.
Liquid-liquid extraction involves removal of the product from the production 
medium into an appropriate organic solvent. The use of organic solvents 
to extract products continuously from fermentation broths is a mature 
technology, and can be used for a variety o f biocompounds (Brocklebank 
and Kalyanpur, 1993). The general technique of liquid-liquid extraction 
involves contacting the broth with the solvent, either in the fermenting 
vessel or in an external extracting vessel, at which point the products 
dissolve into the solvent and can be recovered later through processes 
such as back-extraction or distillation (Roffler eta l., 1984).
Extraction with organic solvents is a major technique in bioprocessing, 
however organic solvents may be unsuitable fo r recovery o f sensitive 
biomolecules (Doran, 1995), or the solvent itself may be toxic to the 
producing cell or environment (Stark and von Stockar, 2003). In such 
cases aqueous two phase systems gain significance. Aqueous two phase
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systems (ATPS) are employed to overcome the problems associated with 
organic liquid use in extractive fermentations. These systems generally 
employ polymers (e.g. polyethylene glycol) to establish a second liquid 
phase in the fermentation, which allows the product to distribute between 
the two phases (Roffler et a i, 1984). In ATPS the cells may be considered 
to be immobilised ‘on’ one of the phases and the required product is made 
partition into the other phase by proper manipulation o f the system (Banik 
et a i, 2003). This manipulation o f the system can include alteration of 
parameters such as polymer concentration, salt concentration, system pH 
and phase volume ratio (Benavides and Rito-Palomares, 2004).
Frequently, a combination of extraction and evaporation can be used to 
increase product yields and recoveries. Roffler et a i,  (1988) detailed the 
In-Situ extractive fermentation of acetone and butanol using oleyl alcohol 
as the extractant and employed a steam stripper and condenser to recover 
product and recycle the extractant.
3) Permeation brings about separation of the compound o f interest from 
the production environment through the use o f permeable or semi­
permeable barriers or membranes. In membrane fermentations, a feed 
composed o f two or more components is separated using a semi­
permeable barrier, the membrane, into a permeate (the fraction of the feed 
that passes through the membrane) and a reteníate (the fraction o f the 
feed retained by the membrane). This barrier can be made of a solid 
material or a fluid (gas or liquid) (Fernandes et al., 2003) and the product 
can be recovered into the extractant on the other side of the membrane.
Fernandes et a i, (2003) suggested that mass transfer in the porous 
supports generally used in membrane bioreactors is a diffusion-controlled 
process, often becoming the rate-limiting step, however, this can be 
overcome or reduced by the use of membrane modules. Where 
membrane modules are used it is essential to maintain a concentration 
driving force by continually removing product on the downstream side, via 
use of an appropriate extractant (Freeman et al., 1993).
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Membrane bioreactors can serve as a complete fermentation and recovery 
device. The unique character of membrane bioreactors, compared with 
other simultaneous bioreaction and bioproduct separation processes, is 
that neither extractant nor the membrane, as a kind o f mass separation 
agent, will mix with the product stream, thus simplifying the further 
separation and purification process (Cen and Tsao, 1993). Xu et al., 
(2005) used a novel integrated membrane chromatography device to 
improve protein separation. The unit consisted o f a hollow fibre filtration 
unit, with packing of chromatographic resin beads on the shell side o f the 
unit. It combined filtration and chromatography and reduced the process 
steps involved in protein recovery, limiting the potential fo r degradation of 
product between steps.
Dialysis membranes have also been employed in ISPR, in the form of 
electrodialysis. Electrodialysis is applied predominantly for the recovery o f 
acids, van Erkel et al., (2004) noted that electrodialysis was applicable for 
recovery of dissociated acids, for separation o f amino acids and for 
conversion o f dissociated acid into the corresponding acid. Zelic et al., 
(2004) used an novel electrodialysis ISPR process to prevent product 
inhibition during the production of pyruvate. The technique involved 
applying a charge across an ion permeable membrane, allowing the 
passage of ions from one solution to another. The entire ISPR approach 
comprised of a fermentation with protein separation and cell retention and 
recycling by ultrafiltration, product recovery by electrodialysis, sterilisation 
by m icrofiltration and subsequent recycling o f pyruvate-reduced 
fermentation permeate. This approach allowed additional product 
concentration in a separate liquid phase and reduced water handling over 
the continuous and repeated fed-batch systems which were also 
examined.
A novel variation o f this technique was detailed by Stark et al., (2003) for 
the extraction of 2-Phenylethanol from fermentations o f Saccharomyces 
cerevisiae, where a solvent, dibutylsebacate, was required for the 
extraction process. The yeast used in the production process could not 
tolerate the extracting solvent, thus a novel method was developed to
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allow ISPR o f the 2-Phenylethanol. This took the form of microcapsules 
comprised o f an outer layer o f alginate acting as the permeable barrier, 
which prevented contact between the inner core extraction liquid and the 
producing organism but allowed permeation and extraction of the product 
across the barrier and into the dibutylsebacate. A sim ilar method was 
detailed by Serp et al., (2002). Wyss et al., (2004) also used a similar 
methodology fo r herbicide and pesticide extraction from water. These 
types o f extraction processes were termed perstraction, elucidating to the 
fact that they involved an agglomeration o f permeation and extraction 
techniques.
4) Immobilisation involves removal o f the product from the production 
liquid onto a solid phase. Product removal by immobilisation has been 
demonstrated fo r a large variety of products (Freeman et al., 1993), and 
can serve to address some of the lim itations associated with solvent- 
based In-Situ extractions for product recovery such as solvent toxicity.
There are a multitude of adsorbents in existence which have a huge 
variety o f applications. Adsorbents commonly applied range from activated 
carbon, sand, charcoal and alumina (Dutta et al., 1999, Muhammad et al., 
1998, Goyne et al., 2005, Arias et al., 1979) to adsorbent resins and 
biomass (Grezegorczyk and Carta, 1996, Lee et al., 2003, Veit et al., 
2002, Aksu and Tung, 2005). The application o f adsorbents is not confined 
to ISPR application or for recovery of specific compounds. They have 
been used in many applications ranging from the adsorption o f coloured 
compounds (Kim et al., 1999, Gokmen and Serpen, 2002), proteins 
(Hamilton et al., 2000), pesticides (Kyriakopoulos et al., 2005), acids 
(Otero et al., 2004), phenols (Ku and Lee, 2000) mutagenic organics 
(Daignault et al., 1988), pollutants (Pyrzynska and Wierzbicki, 2005) and 
have even been applied to induce gene expression (Ermolaeva et al.,
2004).
5) Precipitation is perhaps the least frequently employed technique in 
ISPR processes, since only certain cases exist in which it can be 
achieved. Precipitation may involve product crystallisation and
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precipitation events to occur, where a charged product can be precipitated 
by a counter-ion during fermentation (Stark and von Stockar, 2003). van 
Erkel et al., (2004) described the benefits o f In-Situ crystallisation of 
carboxylic acid, whereby changing pH to bring about crystallisation not 
only enhanced productivity, but also resulted in the production of a raw 
product which required less subsequent purification treatments.
A novel variation o f this idea was detailed as a method o f ISPR, 
demonstrated by Wei et al., (2003) and Yang et al., (2004). In their 
process, the ISPR of Cefaclor was mediated by the formation of insoluble 
complexes o f product and extractant and recovery and product yield was 
facilitated and increased in this manner.
It is clear from discussing the use of general ISPR techniques, that an 
efficient ISPR process may take advantage o f more than one of these 
techniques to bring about product recovery. It should be emphasised that 
while ISPR is considered mostly for the improvement o f existing 
processes, in some cases, where product-cell interference is intensive, 
ISPR may be found to be essential in carrying out the process (Freeman 
et al., 1993). In the case where the producing organism has a minimum 
inhibitory concentration for its own product, Gastaldo et al., (1996) found 
that inclusion of adsorbent resins in fermentations o f Actinoplanes sp. 
A8924, resulted in the removal of the product, kirromycin, which inhibited 
Actinoplanes growth.
Alternatively, the product could be susceptible to further treatments or 
degradation in the production environment e.g. hydrolysis. Ahmed et al., 
(2001) applied ISPR techniques to increase the yield o f kinetically- 
controlled biocatalytic reactions in which competing reactions lead to 
product degradation. The product could also impart detrimental effects on 
the production environment as a whole. If the product increases the 
viscosity o f the environment, this may lower oxygen transfer and reduce 
production or growth potential of the organism (Solomons, 1980). These 
are just some of the reasons why ISPR has gained significance, and how 
the correctly selected methodology can benefit fermentation success.
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1 .2  A n t i b i o t i c s
The term ‘natural product’ is commonly reserved fo r those organic 
compounds o f natural origin that are unique to one organism, or common 
to a small number o f closely related organisms (Mann, 1987). Antibiotics 
are important examples of natural products which exhibit an ability to stop 
microbial growth (bacteriostatic activity) or to kill m icrobes completely 
(bactericidal activity), through interruption and interaction with specific 
cellular components and disordering cell metabolism (Hammond and 
Lambert, 1978). Zahner (1978) suggested that antibiotics could also be 
defined as products of secondary metabolism with an incidental action in 
minimal concentration on growth processes.
Louis Pasteur made the first recorded observation o f antibiotics, the 
inhibition o f one organism by the products o f another, when in 1877, he 
and Joubert demonstrated that anthrax bacilli were killed when the culture 
became contaminated by certain other bacteria (Hammond and Lambert, 
1978). The discovery in 1929, by the Scottish biologist Alexander Fleming 
that Penicillium notatum, a common mould, could produce a compound 
able to selectively inactivate a wide range o f bacteria w ithout unduly 
influencing the host (Smith, 1981) gave an indication that antibiotics 
derived from natural sources could be exploited fo r the benefit of mankind.
During World W ar II, the demand for chemotherapeutic agents to treat 
wound infections lead to the development o f a production process for 
penicillin and the beginning of the era o f antibiotic research (Crueger and 
Crueger, 1982). Some time later, Professor L. P. Garrod, a leading 
bacteriologist, reflected back on Flemings discovery and commented that 
no other such casual observation has had such momentous 
consequences (Calam, 1987). Antibiotic production continues to be one of 
the most important areas of microbiology today. Intensive screening 
programs in all countries continue to increase the number of described 
antibiotics; 513 were known in 1963, 4076 in 1974, and it is estimated that
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up until 1982, between 100 and 200 new compounds were discovered 
annually, with screening procedures continuing to occur to this day 
(Crueger and Crueger, 1982, W atve et al., 2001). Since the discovery o f 
the first antibiotics and penicillin, more than 6000 natural microbial 
compounds have been described, all o f which display antibiotic activity 
(VanDamme, 1983).
Before the discovery o f antibiotics Staphylococcus aureus was fatal in 80 
percent o f infected wounds, however, after the first prescriptions of 
antibiotics in the 1930’s, bacterial infection as a cause o f death plummeted 
and between 1944 and 1972 life expectancy increased by eight years, 
largely attributed to the impact of antibiotics (Walsh and McManus, 1999).
Antibiotics have not only been employed in medicine, but also in a huge 
range o f industries from food to agriculture. The successful use of 
antibiotics has greatly expanded the fermentation industry, and has 
resulted in the research, development and production of antibiotics now 
representing a multibillion dollar industry worldwide (Omura, 1986). In 
terms o f monetary value, apart from the traditional products of cheese and 
alcoholic beverages, antibiotics are currently the most important products 
o f microbial biotechnology, with the worldwide antibiotic production 
estimated at a value o f $16 billion in 1995 (Glazer and Nikaido, 1995), and 
continuing to the present day.
There is, however, a note of caution. The widespread misuse of antibiotics 
is believed to pose a significant danger to the future health of the modern 
world. The increase in emergence of antibiotic resistant strains in a 
number o f microorganism species (Crueger and Crueger, 1982, Smith, 
1981, Russell and Chopra, 1990, Walsh, 2003), has meant that antibiotic 
use must now be tightly regulated and controlled, and there is therefore, a 
continued need for research and development into new antibiotics.
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1 .2 .1  C la s s i f i c a t i o n  o f  A n t ib io t ic s
Antibiotics currently available can be classified in four major ways. 
Classification can be based upon the microbial origin o f the antibiotic, its 
mode o f action, its target organisms or its chemical structure.
Antibiotics are predominantly produced by microorganisms, thus 
classification o f antibiotics on the basis of the ir origin usually means 
identifying the microorganism which produced them as either bacterial, 
fungi or actinomycete. These are the major microbial classes o f antibiotic 
producers, with the latter two being the most prevalent (Hammond and 
Lambert, 1978). By extension, the physiological diversity among these 
microorganisms can be illustrated by the variety o f the antibiotics they 
produce (Ensign, 1981).
Classification o f antibiotics based on their mode of action is more complex. 
There are four main modes o f action of antibiotics which can be used for 
their classification. Antibiotics can exert their influence via prevention of 
cell wall synthesis, DNA replication and repair, protein biosynthesis and 
nucleic acid synthesis (Hammond and Lambert, 1978, Walsh, 2003).
Antibiotics which act through prevention of cell wall biosynthesis include 
the /M actam s and glycopeptides. In general these types of antibiotics 
exert their effect during one of the steps in bacterial cell wall assembly, 
and usually inhibit enzymes or sequester substrates involved in 
peptidoglycan (the major unit of the cell wall structure) assembly and 
cross-linking. Antibiotics which block DNA replication and repair include 
the fluoroquinolones. These antibiotics act by inhibition o f enzymes 
essential in processes of DNA replication and repair. They interact with 
and inhibit enzymes such as topoisomerases and gyrases which are 
essential for cell viability and result in increased cleavage of DNA (Walsh,
2003).
Antibiotics that block bacterial protein biosynthesis include the 
aminoglycosides, tetracyclines and the macrolides. These antibiotics exert
their actions by blockade of one or more of the protein biosynthetic steps 
that occur on the 30s and 50s subunits of the bacterial ribsome. The final 
major mode o f antibiotic activity used for classification is prevention of 
nucleic acid synthesis and is displayed by antibiotics including the 
sulphonamides and trimethoprim (Walsh, 2003). The growth and division 
of cells depends upon, amongst other factors, DNA and RNA synthesis. 
Antibiotics classified as nucleic acid synthesis inhibitors do so by either 
interruption of nucleotide metabolism, interruption of DNA template 
formation or direct inhibition of enzymatic processes essential to nucleic 
acid synthesis (Russell and Chopra, 1990).
Classification may also be based on the range of target organisms against 
which the antibiotic is efficacious. Three classes exist: broad spectrum, 
meaning the antibiotic has activity against a large group o f organisms, 
medium spectrum, meaning the antibiotic has activity against a medium 
sized group o f organisms, or narrow spectrum, meaning the antibiotic is 
relatively specific, and exerts its activity on only a small group of 
organisms.
Classification of antibiotics can be aided by the fact that they show wide 
varieties o f chemical structures encompassing aminoglycosides, 
anthracyclines, glycopeptides, /Mactams, macrolides, nucleosides, 
peptides, polyenes, polyethers, and tetracyclines. Although antibiotic 
chemical structures may be varied, the pool of primary metabolites from 
which they are derived is small, thus their chemical diversity is a result of 
variations in metabolic pathways and processes (Turner, 1973, Okami and 
Hotta, 1988).
1.2 .2 S o u rc e s  o f  A n t ib io t ic s
Antibiotics belong to a group o f substances referred to as secondary 
metabolites (Calam, 1987). Secondary metabolism is non-essential for 
growth and reproduction o f the producing organism and the secondary 
metabolites are formed by a limited number of organisms, and encoded by
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dispensable genes, which are highly regulated and usually organised into 
clusters (Martin et a/., 2005). Secondary metabolism is a characteristic of 
lower forms of life, such as microorganisms, and secondary metabolites 
can accumulate in substantial quantities and be excreted into the 
environment in which the producing organism is growing (Hammond and 
Lambert, 1978).
The taxonomic distribution of antibiotic-producing organisms is restricted 
to relatively few groups. All antibiotics o f bacterial origin used in medicine 
are produced by the genus Bacillus. The Fungi are a more important 
group, with antibiotics of chemotherapeutic use being derived from the 
genera Aspergillus and Penicillum (a group o f filamentous, spore-forming 
moulds), including penicillins, cephalosporins and fusidic acid. The 
actinomycetes, and in particular the genera Streptomyces, are easily the 
most important antibiotic producing group, synthesising a wide range of 
antibiotics, from chloramphenicol to streptomycin (Hammond and Lambert, 
1978).
1.2.2.1 F u n g i
The fungi comprise of a polyphyletic group of eukaryotic organisms which 
are united by a number o f common characteristics of nutrition and 
morphology. Currently, some 65,000 species o f fungi are accepted and 
new species are being described at a rate of 1500 per year, however only 
a few of these have been exploited for industrial use (Williams and Kirk, 
1988). The determination of the number o f individual fungi is impossible, 
given that in a gram of soil, one could expect to find in excess of 100,000 
fungal spores (Cooke, 1980). Fungi are typically filamentous 
microorganisms, capable o f spore forming, whose growth patterns involve 
production o f hyphae (the individual filaments), which grow from their tips 
and branch out to form a hyphal mass known as a mycelium (Deacon, 
1984).
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Fungi can cause immense economic losses. Their harmful activities as 
saprotrophs include damage to timber, fuel, food and manufacturing 
goods. As parasites they cause heavy crop losses and diseases of man 
and domestic animals. However, the beneficial activities of fungi are also 
of great significance. They have long been exploited as food, in food 
processing, in brewing, and in modern fermentation processes and 
contribute to the production of valuable products such as vitamins, 
enzymes and most importantly, antibiotics (Carlile and W atkinson, 1994). 
Cultivation of fungi can be achieved in surface, shaken, stirred aerated 
and continuous culture, and the method employed and materials utilised 
are dependent on the product being produced and the producing fungi 
(Turner, 1971).
Two o f the most important types of antibiotics are however produced by 
fungi, the penicillins and the cephalosporins (Carlile and Watkinson,
1994). Penicillins and cephalosporins belong chemically to a group of 
antibiotics known as /Mactams. Industrial production of penicillin and 
cephalosporin was achieved using Pénicillium chrysogenum and 
Acremonium chrysogenum respectively, and importantly from a synthesis 
and production point of view, all naturally occurring penicillins and 
cephalosporins are synthesised from the same three amino acid 
precursors, L-a-aminoadipic acid (L-a-AAA), L-cysteine and L-valine 
(Brakhage et al., 2005).
Penicillins are the most important compounds to have been isolated from 
fungi, and even to this day, penicillin represents one o f the worlds major 
biotechnology products (Turner, 1971, Li et al., 2005). Penicillin was first 
produced for clinical use at Oxford, in 1940, by a surface culture of the 
fungi Pénicillium notatum (Carlile and Watkinson, 1994). Now however, 
Pénicillium chrysogenum is the most commonly employed organism for 
the production of penicillin (El-Sabbagh et al., 2005).
The continued successful application of penicillins can be attributed to 
structural alterations of the penicillin molecule 6-amino penicillanic acid (6- 
APA) for the generation o f semi-synthetic antibiotics. This molecule
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consists o f two amino acids, cysteine and valine, to which various acyl 
side-chains may be attached and therefore form ing ‘new’ penicillins, with 
altered antibiotic activity (Deacon, 1984).
In 1945 Cephalosporium acremonium was shown to inhibit bacterial 
growth, and after detailed studies were carried out, the antibiotic 
cephalosporin was isolated (Carlile and Watkinson, 1994). One o f the 
cephalosporin antibiotics, cephalosporin C, is produced industrially and is 
sim ilar to 6-APA in that it can be altered, to yield a range o f new, semi­
synthetic antibiotics of industrial and medical significance, via the addition 
of different sub-chains (Carlile and W atkinson, 1994, Schmidt, 2002, 
Araujo et al., 1996).
1 .2 .2 .2  A c t in o m y c e te s
A classification of any microbial order is a temporary and man-made 
arrangement in which sim ilar individuals, sharing certain common 
features, are grouped together as taxonomic units at different levels in the 
taxonomic hierarchy (Cross and Goodfellow, 1973). Traditionally there had 
been much confusion about the taxonomic classification of Actinomycetes, 
with bacteriologists considering them bacteria and mycologists considering 
them fungi. The general consensus is now that Actinomycetes are more 
accurately classified as bacteria (Gottleib, 1973).
Actinomycetes are Gram positive, soil dwelling bacteria, ubiquitous in 
nature. Reproduction is usually asexual, though sexual processes have 
been shown to occur by genetic analysis. In the nonhyphal forms, asexual 
reproduction is by fragmentation or perhaps even by the usual fission of 
single cells. W here stable hyphae are produced, vegetative reproduction is 
by well formed spores resembling fungal arthropores, bourne either free or 
in sporangia. The free spores are usually in the form of sporophores and 
may consist of one, two or many spore chains arising from primary 
hyphae, which may either be straight, looped or spiral (Gottleib, 1973).
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Actinomycetes play both detrimental and beneficial roles in nature. They 
are opportunistic pathogens, can cause diseases o f animals and humans 
and plants. They can and cause problems in sewage treatment plants, and 
have been known to cause spoilage o f plant and hydrocarbon-based 
products such as hay, straw, cereal grains, seeds, rubber and plastic. 
However, far outweighing any negative attributes the actinomycetes may 
have, is their beneficial activities in biodégradation and above all, antibiotic 
production (Piret and Demain, 1988). Although the first useful antibiotic, 
penicillin, came from a fungus, Pénicillium notatum, most of the antibiotics 
in clinical use come form the Actinomycetes, especially Streptomyces 
(Carlile and W atkinson, 1994). Today, 60% o f the known antibiotics are 
produced by actinomycetes (Omura, 1986) and include almost all known 
structural classes of commercially important antibiotics (Omura, 1986).
Streptomyces are the source genus for the majority o f the secondary 
metabolites produced by the actinomycetes (Bushell, 1988). Of the 
antibiotics produced by actinomycetes, 90% originate from Streptomyces 
(Omura, 1986), and as a result it is the species which exhibits the greatest 
variety o f antibiotic production (Crueger and Crueger, 1982). Since the 
potential o f Streptomyces as source organisms fo r efficacious 
biocompounds was first identified over fifty years ago, they have been the 
subject o f intensive investigation (Dietz, 1986) and the majority of 
antibiotics discovered have been isolated from them (Thompson et al.,
2002). Crandall and Hamill, (1986) have catalogued ten major structural 
types o f antibiotics produced by the genus.
The number o f antimicrobial compounds reported from the species 
increased almost exponentially fo r about two decades until the 1970s, at 
which point there has been a decline until the present day (Watve et al.,
2001). W ithin the antibiotic industry, there are thousands o f scientists 
whose careers are dedicated to developing a better understanding of the 
growth and secondary metabolism of Streptomyces on a large scale. With 
the exception o f yeast fermentations for food and beverages, there is more 
fermentation tank capacity dedicated to Streptomyces fermentations than 
any other class o f microorganism (Bader, 1986).
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Identification o f microorganisms capable o f producing antibiotics is 
achieved through screening programmes. These programmes involve 
taking samples from the environment, such as soil samples, plating them 
and recovering sample colonies. These colonies are then grown further on 
slopes and examined for antibiotic production (Calam, 1987, Hammond 
and Lambert, 1978). Figure 1.1 outlines the typical Streptomyces life cycle 
on solid culture, which is similar to the growth and differentiation of fungi 
(Omura, 1986).
F igure  1.1: Schematic of the Streptomyces life-cycle (van Wezel, 2002) 
1.2.3 P ro d u c t io n  o f  A n t ib io t ic s
It is generally agreed, that the production o f antibiotics by microorganisms, 
is done so to gain some growth advantage in their natural environment 
(Gottleib, 1973, Turner, 1971). Competition among microorganisms for 
limited nutrients is commonplace, and it is as a result of these stresses, or 
during certain stages of growth of the microorganism, that antibiotic 
production occurs (Mann, 1987). When m icroorganisms enter the 
stationary phase o f growth and face competition for space and nutrients
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the genes responsible fo r the tinning and level o f antibiotic production are 
expressed and the antibiotics formed are used to regulate the growth of, or 
perhaps more accurately wage ‘chemical w ar’ on, their neighbours (Walsh,
2003). Antibiotic production therefore provides the organism with a 
survival advantage from an evolutionary point o f view (Bader, 1986, 
Demain and Fang, 2000).
In nature, the generation of antibiotics is tightly regulated. Since antibiotics 
are frequently associated with limitation o f nutrient supply (Roubos et a/.,
2002), and are believed to be non-essential to the producing organism, 
antibiotic production represents a drain of resources, to produce a product 
which is frequently inhibitory to future cellular growth (Mann, 1987). 
Metabolic control systems are in place to ensure easily metabolised 
nutrients are used first and that growth has priority over less urgent 
activities such as secondary metabolite production (Vining and Chatterjee, 
1982).
These control systems therefore, need an external ‘triggering force’, in 
order to initiate production. In the natural environment, this is supplied by 
the previously mentioned conditions of nutrient limitation, environmental 
stress, and competition for growth. In antibiotic fermentation processes, it 
is necessary to simulate this competition (through environmental control) 
in order to facilitate over-production of the antibiotic.
Initial investigations into antibiotic production took place in solid cultures, 
termed surface or static cultures (Kristiansen and Bu'Lock, 1980). Static 
cultures were then employed to produce the first microbial-derived 
compounds and antibiotics, since this static culture was suitable for growth 
of the most prolific producers of antibiotics, fungi and actinomycetes, 
which exhibit minimal nutrient requirements (Glazer and Nikaido, 1995). 
However, advances in bioprocessing procedures and a lack of 
reproducibility of product formation on static cultures (Bushell, 1988), 
resulted in movement of antibiotic fermentations from solid culture to liquid 
culture, termed submerged culture.
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Submerged cultures take place in suitable fermentation vessels, which 
serve to provide the culture organism with its physical environment 
(Solomons, 1980), and take advantage o f the wide variety of 
instrumentation available in the bioprocessing industries to provide tight 
control over the fermentation process. As a result of this, antibiotic 
fermentation now predominantly takes place in liquid cultures and under 
conditions of aeration and agitation (Kuenzi, 1978). The media used for 
the liquid culture of antibiotics can be comprised of ill-defined, cost 
effective, complex materials and the fermentations can take place at the 
preferred temperatures o f 24 - 28°C, and at a pH in range o f 5.6 - 7.0 (but 
can be performed in some cases, as low as pH 5), which suit the 
producing organism (Calam, 1987).
An important point of note regarding the production of antibiotics is that 
static cultures are characterised by low product yields. The most 
significant difference between static and liquid cultures is that in static 
cultures, all the different stages o f differentiation of the organism under 
investigation are present in the colony at any particular time. Where 
sequential formation of different products occurs within liquid cultures 
during the culturing processes, one could reasonably expect, in solid 
cultures, that all of those products would be present, somewhere in the 
colony, with their spatial distribution reflecting their temporal separation, in 
the equivalent liquid culture (Bushell, 1988). This variability in existence in 
the production profile in solid culture contributes to the limited application 
of solid cultures for large scale antibiotic fermentations.
1.2.3.1 F e rm e n ta tio n
Almost all antibiotics of commercial importance are manufactured by large 
scale aerobic fermentation, involving stirred tank reactors (Gupta et al., 
1997, Carlile and Watkinson, 1994). Antibiotic production has historically 
been a batch process-based industry, where cells, having been developed 
through successive rounds o f inoculum development, are inoculated into 
the medium. The organism continues to grow and consumes nutrients until
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depletion o f some nutrient causes a reduction in cell growth and an 
associated production of antibiotic (Bader, 1986). Feed-type fermentations 
are also significant in antibiotic production processes, with their main 
advantage being that many antibiotic producing organisms are less 
productive in the presence of excess carbon source. This is especially the 
case if the compounds are rapidly degradable carbon sources such as 
glucose (G lazerand Nikaldo, 1995).
Limiting nutrient supply, or supplying nutrients which can only be 
metabolised at a slow rate, mimics the natural growth environment o f the 
antibiotic producing organism, and results in a successful antibiotic 
fermentation. Improvements in fermentation yields o f antibiotics are often 
brought about by running the process in two stages. The first is 
submerged culture o f the organism with sufficient aeration and generous 
nutrient supply to attain near-maximal cell density in a short period of time. 
In the second stage, when the culture reaches the stationary phase or 
stops growing, and antibiotic production begins, the concentration of key 
nutrients, such as carbon, nitrogen and phosphate, must be controlled 
carefully (G lazer and Nikaido, 1995). This is best achieved in sequential 
batch fermentations or using feed-type fermentations.
It is important to recognise that the development of antibiotic fermentation 
processes requires a triangular interaction between organism 
improvement, development of media and optimisation o f process 
conditions (Bader, 1986). Antibiotic synthesis often requires dozens of 
enzymes and complex metabolic pathways. It may therefore, be important 
to understand the physiology o f the producing organism in order to 
maximise the fermentative production o f antibiotic (Glazer and Nikaido,
1995).
Antibiotic fermentations differ from fermentations used fo r the production 
of biomass, primary metabolites or other products in four main aspects, 
which are important from a process engineering perspective, and must be 
considered when developing an antibiotic fermentation process. These
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are: (i) growth and production, (ii) morphological change and impacts, (iii) 
growth rates, (iv) production media (Kuenzi, 1978):
(i) In antibiotic fermentations the organism generally must grow to a 
sufficient state before production occurs. Dykstra and Wang, (1990) 
detailed this phenomenon in their assessment o f the production of the 
antibiotic cyclochexamide. They found that in batch fermentations, the 
onset o f the stationary phase was marked by the beginning of significant 
antibiotic production and a substantial downturn in the rate of protein 
synthesis, while the end of the production phase was marked by the 
depletion o f glucose in the fermentation medium.
From a processing point of view, this may be regulated by the use o f either 
feeding mechanisms, such as fed-batch systems, or by having single unit 
operations, whereby a single fermentation serves to deliver maximum 
growth o f cells utilising the optimal growth media and conditions. Once this 
is achieved, the medium is drained and replaced by fresh medium, 
designed for optimal production, or the cells are harvested and re­
inoculated into fresh medium. However, there is considerable 
contamination risk from the second scenario, thus fed-batch systems 
would generally be favoured. An important point o f note with regards to 
growth and production in antibiotic fermentations is that optimal nutrition 
for growth is not necessarily the same for production (Schrader and 
Blevins, 2001, Glazebrook etal., 1992, Kojima etal., 1995).
(ii) Understanding the impacts o f morphology on antibiotic fermentations 
provides a better understanding o f the complexities that exist over those 
fermentations not involved in antibiotic production. The most frequently 
applied organisms for antibiotic production are filamentous 
microorganisms such as Streptomyces and fungi, both o f which are known 
to undergo pronounced morphological changes during culture (Kuenzi, 
1978). This can impact on the production and bioprocessing parameters 
employed, and greatly influence culture development in such systems 
(Papagianni, 2004, Prosser and Tough, 1991).
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Submerged growth o f filamentous organisms in liquid culture results in 
free movement o f the microbial particles in the liquid medium, due to 
agitation, and maximises the potential o f branched growth, by enabling the 
organism to develop in three dimensions (O'Cleirigh, 2005). Two of the 
distinct morphological states which can exist in antibiotic fermentations 
involving filamentous organisms are dispersed filamentous and pelleted 
growth, and the occurrence o f these can be influenced by both the 
organisms and the fermentation conditions.
Dispersed filamentous growth is essentially the simplest morphological 
form, comprising o f relatively uniform, short, branched hyphae, and is the 
closest approximation to unicellular behaviour possible fo r filamentous 
organisms. Dispersed filamentous growth is usually brought about in 
environments o f high shear, since this confers a high level of disruption 
and dispersion of biomass in the system. The benefit of dispersed 
filamentous growth is that there is a greater proximity between organism 
and liquid medium, thus mass transfer can be maximised (Prosser and 
Tough, 1991), however such systems frequently suffer from high 
viscosities.
The filamentous nature of Streptomyces growth tends to be the primary 
contributing factor to the creation of these highly viscous, non-Newtonian, 
fermentation broths, which are characterised by a sensitivity to shear 
(Bader, 1986). However, the problems associated with this may be 
compounded, if the organism can also produce compounds capable of 
affecting the production environment rheology.
Pellet formation, agglomeration o f mycelial masses, can occur in agitated 
systems due to collision of the biomass particles and resultant adhesion 
and intertwining of growth (Lu et a/., 1998). The pellets can range in form, 
from loosely packed ‘fluffy’ pellets to tightly packed, compact pellets 
(Papagianni, 2004), and the form which is produced, can influence the 
production o f the system through mass transfer and viscosity effects. The 
growth o f filamentous organisms in pellets is preferable to that of 
dispersed mycelia, from a bioprocessing point of view, as it reduces the
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tendency of the microorganism to grow on ferm enter walls, around 
impellers, and to foul gas distribution apparatus. This therefore improves 
operating conditions (Papagianni, 2004), and also reduces broth viscosity 
(Sinha et a i, 2001), which insures more efficient power consumption for 
mass transfer processes within the system (O'Cleirigh, 2005).
To summarise the morphological characteristics o f filamentous organisms 
in submerged culture one should note that three major characteristics can 
be observed; complex morphology, by growing in different forms; complex 
rheology, producing non-viscous Newtonian cultures or viscous non- 
Newtonian cultures depending on morphology medium; and growth on 
surfaces, as a compact mass in the fermenter, below the liquid line, 
adhered to baffles, probes etc, or as surface growth, on fermenter head- 
plate and walls above the liquid level (Solomons, 1980).
(iii) Growth rates o f the filamentous organisms used in antibiotic 
fermentations can have a number of influences on the success of the 
fermentation process. Firstly, a slow growth rate means that there is an 
increased potential for the growth environment to become contaminated 
by microorganisms with faster doubling times and growth rates. Also, 
these slower growth rates result in longer fermentation times, thus any 
errors incurred early in the fermentation process may only become visible 
or exert their effects, late on in the fermentation (Kuenzi, 1978). The net 
result o f this is that antibiotic fermentations generally take longer than 
other types o f fermentations, and require careful monitoring and control to 
prevent costly losses of fermentation viability.
(iv) The medium employed in any fermentation process is a primary 
influencing factor on the success of the process and provides energy and 
essential nutrient sources for the organism to metabolise (Corbett, 1980). 
The basic requirements of filamentous microorganisms for antibiotic 
production in submerged culture include water, molecular oxygen, an 
energy source, organic carbon, nitrogen other than in a molecular form 
and a variety of other elements (O'Cleirigh, 2005). There are 
approximately thirteen elements essential to growth, five required in large
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quantities (macronutrients: including carbon, hydrogen and oxygen), the 
remaining eight required in small amounts (micronutrients: including 
potassium, iron and zinc) (O'Cleirigh, 2005, Papagianni, 2004). 
Filamentous organisms depend heavily on the presence o f the requisite 
nutritional compounds at optimal concentrations to ensure maximal growth 
and product formation (O'Cleirigh, 2005).
The nutrient requirements of antibiotic producing organisms such as 
Streptomyces are generally less chemically defined than those of other 
microorganisms (Glazer and Nikaido, 1995). It is common practice, with 
antibiotic fermentations, to use complex materials as nutrient sources, and 
two commonly employed products are corn-steep liquor and cotton seed 
oil. These materials are at least partially soluble and can be broken down 
by enzymes, produced by the cells, at a slow and steady rate which 
matches the slow growth of the organisms associated with antibiotic 
production (Calam, 1987). Although the most common substrates for 
antibiotic fermentations are starch, oils and various types of simple or cost 
effective sugar sources such as beet molasses, many fermentation media 
contain small amounts of glucose, which provide the culture with a rapidly 
utilisable carbon source (Bader, 1986).
The above considerations highlight the differences between antibiotic 
fermentation processes and those aimed at the production of other 
bioproducts. The primary goal o f antibiotic fermentations is production of 
maximal amounts of product, but achieving this is not always a simple 
process. A better insight into the manipulation and regulation of secondary 
metabolite fermentations has generated new ideas on how to force 
cultures into over-production (Stephanopoulos et al., 1998). Even so, there 
is considerable potential for reduction of product yields as a result of 
fermentation processes.
In antibiotic fermentations, the production and accumulation of the product 
can inhibit further production and cell growth. Three main means by which 
antibiotic yields may be diminished during the fermentation process are 
product feedback inhibition, product utilisation and degradation and
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environmental impacting factors.
Product feedback inhibition is a common event in antibiotic fermentations 
(Wang e t  a l . ,  1989) and can reduce antibiotic yields. Feedback inhibition 
occurs when a product of a pathway controls the rate o f its own synthesis 
through inhibition o f an earlier step in the pathway (Horton e t  a l . ,  2006). 
These feedback mechanisms are in place to control reaction rates to 
production, via the use of enzymatic conversions (Calam, 1987). In the 
natural environment, once sufficient amounts o f antibiotic have been 
produced and excreted into the surroundings o f the producing organism to 
confer a growth advantage, production is ceased, and wastage of 
valuable, limited nutrients, is prevented.
In industrial antibiotic production processes, this natural ‘safety 
mechanism ’ can limit product yield once a threshold level (set by the 
nature o f the organism) is met. If yields are to be increased past this level, 
it is necessary to prevent this threshold from being reached, by removing 
the product as it is formed, or to change the threshold level, by genetically 
modifying the producing organism to facilitate over production. Tone et al., 
(1968) found during their studies of salicylic acid fermentations, that the 
fermentation was limited by product inhibition and that if the inhibitory 
product was removed from the culture, the fermentation could proceed 
further.
In some antibiotic fermentations, the product may be degraded or utilised 
by the mechanisms o f the organism or by catabolic processes in the 
production system. Dykstra and Wang (1990) noted that cycloheximide, 
produced in S t r e p t o m y c e s  g r is e u s  fermentations, was degraded during the 
fermentation process, and that there was evidence that both chemical and 
enzymatic mechanisms were responsible. They also suggested that 
maintenance of low broth concentrations of cyclohexim ide could alleviate 
this degradation. Product utilisation occurs when the organism degrades 
its own product, and usually as a result of a primary nutrient becoming 
limited, and is therefore performed to maintain cellular viability or 
metabolic processes (Roubos e t  a l . , 2002, Junker e t  a l . ,  2001, Turner,
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1971).
The production environment itself can also influence growth and 
production in antibiotic fermentations. This can occur not only by exposure 
to detrimental elements associated with the production process, such as 
shear forces (Tamura e t  a l . ,  1997) and temperature (Wei e t  a l . ,  2003), but 
can also be as a result of the product or producing organism imparting 
some negative influence.
The productivity of mycelial fermentations may be governed by the 
limitation o f the mass transfer of oxygen or other compounds (Garcia- 
Ochoa and Gomez, 1998, Garcia-Ochoa e t  a l . ,  2000). This is due to the 
high non-Newtonian viscosities associated with the filamentous structure 
of mycelial cells (Gbewonyo and Wang, 1981) and the general 
fermentation of filamentous antibiotic producing organisms (Aiba and 
Okabe, 1976). The reduction in the overall product yields which results,, is 
attributed to limitation of the growth and production capabilities of the 
organism, under such fermentation conditions.
1.2.4 D o w n s tre a m  P ro c e s s in g  o f  A n t ib io t ic s
In antibiotic fermentations, recovery o f the product has a critical bearing on 
the success of the process. Since the product is frequently in a low 
concentration in the fermentation broth, its recovery can require extensive 
purification procedures (Crueger and Crueger, 1982). Antibiotics are 
characterised by structural duversity and frequently display sensitivities to 
environment or fermentation treatments such as temperature, pH and 
further processing or degradation (Aksu and Tung, 2005, Bersanetti e t  a l . ,  
2005, Wang and Sobnosky, 1985, Roubos e t  a l . ,  2002). As a result, the 
successful Downstream recovery process should be expected to recover 
maximal amounts o f product in an efficient time interval and take 
advantage o f the structural properties of the antibiotics o f interest.
Antibiotic fermentation media provide the necessary nutrients for suitable
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growth and product formation, but can often cause bioprocessing 
problems such as increased viscosity, as a result of the complex 
substrates from which they are frequently comprised. On completion of the 
antibiotic fermentation, the culture is passed fo r filtration, at which point 
filter aid or coagulating materials may be added to aid the filtration 
process. Filtration is usually achieved by rotary vacuum filtration, which 
may employ filter-aid to limit clogging. The antibiotic is recovered post 
filtration by extraction with suitable materials. The ease and efficiency of 
the filtration and recovery process therefore depends on the quality of the 
fermentation (Calam, 1987), which is, in turn, affected by the raw materials 
employed. It is therefore clear that, if crude raw materials are employed in 
the antibiotic fermentation, the filtration process may become less efficient.
In general, the recovery of antibiotics requires the same generic 
Downstream Processing unit operations as the recovery o f the majority of 
bioproducts, such as stream harvesting and undissolved nutrient removal. 
Although there are a variety o f means by which antibiotics can be 
recovered from fermentation broths, including membrane techniques 
(Alves e t  a l . ,  2002), among the most significant and frequently applied 
methodologies are liquid extraction and adsorption (Soto e t  a l . , 2005).
Liquid extraction for the recovery of antibiotics generally involves the use 
of a suitable solvent into which the antibiotic will be preferentially 
recovered. The extraction process serves to enrich the product in the 
solvent stream, which is then back extracted into an aqueous phase for 
further treatment. The performance of a solvent is sometimes described in 
terms of its distribution co-efficient, which is a measure o f the solvent’s 
capacity fo r the product, and is defined as the ratio of the product 
concentration in the solvent to that in the aqueous culture medium, at 
equilibrium (Bruce and Daugulis, 1991). The advantage of solvent 
extraction is that it can be accomplished quickly. Penicillin for example, is 
subjected to two steps o f solvent extraction and is transferred back to the 
aqueous phase in a 90 second period, and such rapid extraction 
procedures are especially desired if the antibiotic is potentially unstable 
(C ruegerand Crueger, 1982).
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The apparatus / techniques commonly employed in solvent extractions of 
antibiotics include centrifugal mixer / settler countercurrent contactors and 
disc stack extractors. Recovery yields o f in excess o f 95% are reported to 
have been achieved in one to four contacting steps (Brocklebank and 
Kalyanpur, 1993). Brunner (1985) described the development of a new 
extractor, which used two counter-current extracting decanters to extract 
penicillin and erythromycin, with the added benefit of being able to deal 
with whole cell broth. This resulted in significant increases in product 
recovery yields, since antibiotic associated with the biomass was also 
recovered.
There are considerable problems associated with the safe handling and 
use o f solvents in antibiotic recovery applications, which relate to their 
toxic and flammable nature and phase separation limitations (Hollmann e t  
a i ,  1995). As a result, alternate means o f antibiotic recovery have been 
investigated and employed (Cull e t  a i ,  2000). There has been 
considerable interest shown in the development and application of 
recovery strategies involving the use o f aqueous two phase systems and 
liquid membrane techniques.
Bora e t  a i ,  (2005) examined the downstream processing and separation 
of cephalosporin antibiotics, and determined that aqueous two-phase 
systems showed good prospects as separation techniques. Aqueous two- 
phase systems provide an alternative, and efficient approach, by 
facilitating partitioning between two liquid phases (Banik e t  a i ,  2003), with 
a reduction in the hazards associated with organic solvent use. Soto e t  a i ,
(2005) substituted the use of organic solvents in a solvent extraction 
process with room temperature ionic liquids in an aqueous two phase 
extraction in their processes fo r antibiotic recovery. They found that the 
aqueous two phase process performed suitably and was a desirable 
substitute for the use of organic solvent extractions. Yang e t  a i ,  (1994) 
detailed how an aqueous two-phase system could not only be applied for 
the extraction o f cephalosporin C from whole broth, but that the difficult 
separation of cephalosporin C and disacetyl cephalosporin C could also
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possibly be achieved via this system.
Preferential transport in adsorptive membranes can be used to selectively 
remove biochemicals directly from fermentation broth (Agrawal and Burns, 
1997). In antibiotic recovery processes, these membranes need not 
necessarily be comprised o f the porous supports commonly employed in 
membrane separations, they can also be in the form of liquid membranes. 
Extraction using liquid membranes has been studied since the 1980’s and 
is one of the most advantageous techniques o f separation at present 
(Cascaval e t  a l . ,  2001). Extraction by liquid membranes is a separation 
method for recovery and concentration o f antibiotics from their dilute 
aqueous solutions (Boyadzhiev e t  a l . , 2003).
In liquid membrane separations, an intermediate, immiscible liquid, plays 
the role o f a membrane, separating the feed and stripping solutions of the 
antibiotic (Kawasaki e t  a l . ,  1996). These liquid membranes may be 
unsupported, whereby the solvent or carrier layer is achieved via 
émulsification, or supported, whereby the solvent is included in a 
hydrophobic porous polymer matrix (Cascaval e t  a l . ,  2001, Sahoo and 
Dutta, 2002). Lee e t  a l . , (1994) found that the use of a supported liquid 
membrane system, employing Amberlite LA-2 dissolved in 1-decanol, 
showed promising results for the selective separation and recovery of 
Penicillin G.
The main advantages of using liquid membranes, over conventional liquid- 
liquid extraction methods is that the quantity o f solvent used is reduced 
because it is continually regenerated. In liquid membrane systems, there 
is potential for partitioning of product, against its concentration gradient, as 
long as the pH gradient is maintained (Cascaval e t  a l . ,  2001). A novel 
downstream application of liquid membranes was detailed by Barenschee 
e t  a l . ,  (1992). In this process, extraction o f penicillin was coupled with 
conversion into new penicillin derivatives via penicillin-G-amidase, 
immobilised in the liquid membrane carrier.
Recovery and purification of bioproducts, including antibiotics, from their
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crude sources involve various steps including precipitation, centrifugation, 
extraction, membrane filtration and sorption (Ramos e t  a l . ,  2004). 
Guzeltung and Ulgen, (2001) suggested that incorporation of a 
chromatographic technique early in this sequence o f purification steps will 
lead to higher product yield. Chromatography-mediated recovery 
processes have long been associated with the recovery o f proteins, but 
applications in antibiotic recovery has been the focus of much interest 
(Lee e t  a l . ,  2003, Ribeiro and Ribeiro, 2003), even though solvent- 
mediated recovery strategies were more traditionally employed. Aiba and 
Okabe, (1976) suggested that ion-exchange adsorbents could be 
employed in place o f solvent exchange reactors in their configuration of an 
optimised antibiotic recovery process.
Of particular significance in chromatography-mediated antibiotic recovery 
processes is the use of adsorbent resins. In 1965 Rohm and Haas 
commercialised the first synthetic organic macroporous or macroreticular 
adsorbents, the so called Amberllte XAD resins (Voser, 1982). In a 
document by Voser, (1982) an extensive technical bulletin describing the 
resins was detailed. This document stated that the adsorbent resins were 
characterised by a selection of surface polarities, surface properties, and 
sorption behaviour. The bulletin went on to suggest that it is not possible 
to predict accurately just what materials will be adsorbed well by a given 
adsorbent. This technical bulletin, though focused on the Amberlite series 
of adsorbents, holds true for the majority o f synthetic adsorbents, and 
adsorbent resins in general.
Dutta e t  a l ., (1999) stated that a significant amount o f commercially 
produced cephalosporin is isolated using polymeric adsorbents, and found 
that adsorbent resins could be used for the recovery o f a range of ¡3- 
lactam antibiotics. Adsorbent resins can also be used to recover antibiotics 
from a range of feeds. Robberson e t  a l . ,  (2006) demonstrated that 
adsorbent resins could successfully recover antibiotics from water feeds, 
which is a positive result with regards to the antibiotic recovery from liquid 
fermentations, since the majority o f antibiotics produced must be 
recovered from aqueous-based fermentation broths. Dutta and Dutta,
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(2006) therefore suggested that, in view o f the fact that the high 
concentrating factor of adsorption can satisfy the requirements of high 
recoveries and a large volume reduction, adsorption can be considered as 
an efficient separation method for the recovery o f antibiotics from very 
dilute sources.
Adsorbent resins have a broad application range, can be applied in novel 
reactor configurations (Hicketier and Buchholz, 2002) and modified to 
enhance or confer application (Jung e t  a l . ,  2001, Wang and Sobnosky, 
1985). Modification of adsorbent resins involves engineering the resins to 
comprise o f moieties which will only adhere, adsorb or interact with other 
specific compounds. It is even possible to develop mixed mode 
adsorbents. An example would be adsorbents prepared using chemistries 
containing hydrophobic and ionic groups (Hamilton e t  a l . ,  2000). It is 
therefore important to note, that antibiotic recovery by adsorbent resins 
may not be attributed to a single means o f chemical separation but 
instead, an interrelationship between the possible modes of actions may 
exist. This point was also considered to by Voser, (1982).
In summary, adsorbent resins can be successfully employed for the 
recovery o f antibiotics in a solid-liquid contacting method, as an alternative 
to liquid-liquid recovery of antibiotics, and via the maintenance of 
appropriate contacting conditions, the success and selectivity of the 
adsorption processes can be increased (Barboza e t  a l . ,  2003, Barboza e t  
a l . ,  2001, Chaubal e t a i ,  1995).
Combinational processes for antibiotic recovery also exist. These involve 
novel techniques which combine extraction and permeation and are 
occasionally termed perstraction systems. An example of one such system 
was detailed by Wyss e t  a l . ,  (2005). In their assessments Penicillin G, the 
most common raw material for the production o f /?-lactam antibiotics, and 
the use o f liquid-core capsules for product recovery, was examined. These 
capsules were composed of a dibutyl sebacetate solvent core, 
encapsulated in a crosslinked alginate / polyacrylamide membrane. The 
product permeated through the membrane and was extracted into the
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solvent. A further novelty of this process was that it was possible to 
immobilise the enzyme penicillin acylase onto the surface of the capsule 
and therefore increase the operational stability o f the enzyme during the 
process.
A sim ilarly novel extraction process was described by Lye and Stuckey, 
(2000) and Lye and Stuckey, (2001). The processes detailed involved the 
application of colloidal liquid aphrons (CLAs) in the recovery of 
erythromycin. These CLAs are micron-sized solvent droplets surrounded 
by a thin aqueous film which is stabilised by a mixture of non-ionic and 
ionic surfactants. It was also found that CLA use was an attractive 
alternative to conventional liquid-liquid extraction fo r the recovery of 
erythromycin and that their use allowed an extremely rapid recovery 
process, due to the large interfacial area for mass transfer available.
1.2 .5  I n - S i t u  P ro d u c t R e c o v e ry  o f  A n t ib io t ic s
Previously, it was highlighted that I n - S i t u  Product Recovery techniques are 
applied to increase the production of biotechnological processes by 
removal o f the product from the vicinity o f the biocatalyst as soon as it is 
formed. Employing ISPR helps to overcome toxic effects of the product 
which are noted in antibiotic fermentations, minimise product degradation 
and reduce subsequent Downstream Processing requirements (Stark and 
von Stockar, 2003, Freeman e t  a l . , 1993, Martin e t a ! . ,  2005). Considering 
I n - S i t u  recovery of antibiotics, Schugerl (2000b) suggested that the most 
important I n - S I t u  recovery methods for antibiotics are solvent extraction, 
crystallisation and adsorption.
Schugerl (2000b) suggested that, although solvent extraction is a 
commonly applied method for the recovery o f antibiotics from fermentation 
broths, there are relatively few examples o f its use In - S i t u .  The main 
reason I n - S i t u  solvent extraction application is restricted, is due to many 
organic solvents being toxic to microbes (Stark and von Stockar, 2003), 
which therefore limits the solvents which can be used in extractive
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fermentations (Roffler e t  a l . ,  1984). Inclusion of a solvent, which is 
immiscible with the culture fluid, into the fermentation environment may 
also result in formation of emulsions. Phase separation of, and back- 
extraction from, these emulsions is difficult and constitutes a potential 
source of product loss (Tessier e t  a l . ,  2005, Li e t  a l . ,  2004, Stark and von 
Stockar, 2003).
The organic solvent used in I n - S i t u  separation processes, especially when 
viable cells are participating, has to be biocompatible, have a favourable 
distribution coefficient for the product, have a low price and established 
commercial production, low viscosity emulsion tendency and mutual 
solubility, and have a high chemical stability (Cen and Tsao, 1993). 
Although I n - S i t u  solvent extraction has been detailed fo r product recovery 
from plant cell cultures (Choi e t  a l . ,  2001), not many solvents satisfy these 
requirements, and therefore alternate In - S i t u  extraction strategies for 
recovery o f antibiotics are frequently investigated.
The application of aqueous two-phase systems was previously outlined 
with relation to downstream recovery o f antibiotics. Paquet e t  a l . ,  (1994) 
examined the partitioning of pristinamycins, produced by S t r e p t o m y c e s  
p r i t in a e s p ir a l is ,  in aqueous two-phase systems and found that even in the 
presence of cells, recovery o f the antibiotics from the fermentation broth 
could be achieved. The cells were confined to the bottom phase and the 
pristinamycins partitioned in the top phase. Paquet e t  a l . ,  (1994) believed 
that this represented a first step towards the development of antibiotic 
production by extractive fermentation using aqueous two-phase systems.
Production o f subtillin by B a c i l lu s  s u b t i l lu s  ATTC 6633 has been studied in 
an aqueous two-phase system composed o f 20% polyethylene glycol 
6000 and 5.5% potassium phosphate. Although the amount of subtillin 
produced in the two-phase system was 60% of the single-phase 
fermentation, a maximum of 13.1 U/ml subtillin could be recovered from 
the top phase after 10 h fermentation, compared to 8.2 U/ml produced in 
minimal salts medium. This was because subtillin mainly partitioned in 
favour of the top phase, in contrast to cells which partitioned in favour of
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the bottom phase (Sinha e t  a l . ,  2000, Kuboi e t  a l . ,  1994).
Crystallisation In - S i t u ,  although feasible, is even less commonly applied 
than I n - S i t u  extraction of antibiotics using solvents. I n - S i t u  crystallisation 
usually takes the form of a precipitation event in the fermentation, like that 
of tetracycline production by S. a u r e o f a c ie n s .  In - S i t u  crystallisation of the 
tetracycline results from the accumulation o f product at the bottom of the 
fermenter during the process (Schugerl, 2000b).
One of the most significant methodologies fo r the In - S i t u  recovery of 
antibiotics examined has been the application o f adsorbent resins. Kim e t  
a l . , (1999) described the potential advantages of solid sorbents over 
organic solvents as extractants, and believed that there was a lower risk of 
toxicity when using polymeric materials as sorbents over solvents.
Adsorbents are generally applied in In - S i t u  systems to limit the impact of 
some environmental or physiological conditions, and it is believed the 
primary mechanism by which adsorbents return increased product yield 
and recovery, is through rapid removal o f the product from the 
fermentation environment, and the associated benefits o f such (Wang e t  
a l . ,  1989). Freeman e t  a l . ,  (1993) concurred with this finding and gave 
evidence that increases in both antibiotic yield and productivity could be 
achieved using adsorption-based ISPR techniques.
Examining the production profile of antibiotic fermentations can give an 
indication o f how production may be limited. It is frequently the case that 
identifying the fermentation parameter responsible for limitation of 
production can highlight the benefits o f applying adsorbent resins for In -
S i tu  antibiotic recovery.
Lee e t  a l . ,  (2003) outlined the production o f teicoplanin, an antibiotic 
produced by A c t in o p la n e s  t e ic o m y c e t ic u s .  They found that A c t in o p la n e s  
t e ic o m y c e t ic u s  was sensitive towards its own antibiotic in fermentation. 
They investigated the addition of adsorbent resins into the fermentation as 
an I n - S i t u  product recovery processes and found that the toxic effect on
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growth was eliminated, feedback repression o f teicoplanin was reduced 
and the overall recovery process was shortened. Wang, (1983) noted a 
sim ilar result. They found that final concentrations of cyclohexamide, 
whose production in fermentation had been found to be feedback 
regulated, and its synthesis rate, could be increased by adding adsorbent 
resins directly to the fermentation.
Gastaldo e t  a l . ,  (1996) hypothesised that the two main factors which may 
influence yields of kirromycin fermentations were inhibition of the 
producing organism through antibiotic production and loss of antibiotic 
through degradation, and therefore postulated that the benefits they 
observed from the use o f adsorbent resins in an I n - S i t u  recovery process 
could be attributed to sequestering of the toxic end-product and removal of 
the antibiotic from the potentially degradative fermentation environment. 
These theories were shared by Marshall e t  a l . ,  (1990), who found that 
using adsorbent resins to recover rubradirin I n - S i t u ,  resulted in enhanced 
production.
The benefits of applying these adsorbents in I n - S i t u  antibiotic production 
and recovery processes have been made clear. The adsorbents applied 
are usually solid, porous adsorbents with extremely large surface areas. 
They can be applied in a variety of contexts, they can be added directly 
into the fermenter, placed in a separate vessel with circulation of the 
fermentation broth or incorporated in dialysis membranes (Roffler e t  a l . ,  
1984, Wang, 1983).
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1 .3  S u m m a r y
Biotechnology and Bioprocessing are scientific disciplines which employ 
the combined knowledge of an array o f other disciplines, from biology to 
engineering, to control the mechanisms of selected organisms, to produce 
valuable compounds, or carry out desired operations. The techniques 
associated with these disciplines have their applications far reaching into 
history. One o f the first examples was believed to be the development of 
brewing by the Sumerians, about 6000 BC (Scragg, 1991). Biotechnology 
and Bioprocessing methods have developed with time. Their applications 
have resulted in the production of numerous compounds of significance to 
the modern world, such as interferon and antibiotics. These processes 
employ a variety o f organisms, from microbes to plants, to produce the 
desired compounds, and to facilitate the successful production process, 
considerable effort is expended on development and optimisation of the 
production and recovery process.
The two most important facets of any biotechnology process are the 
production and recovery methods employed. The most commonly 
employed method to produce compounds o f interest is through 
fermentation. The choice of the fermentation process which is employed, 
however, is dictated by the organism to be cultured and the product 
formed. The growth requirement o f the organism must be met, thus 
agitation, nutrients, heat, aeration, etc, must be supplied by the 
fermentation system. The fermentation system employed must be capable 
of addressing any sensitivities of, or problems caused by, the product. If, 
for example, the product is pH sensitive the fermentation must be able to 
maintain pH in a suitable range, or if the product is toxic to the producing 
cell, the fermentation process must provide an ability to remove the 
product. All these issues are addressed by the selection o f the appropriate 
fermentation technique, and the subsequent optim isation of operational 
parameters.
The recovery process is the second major consideration in 
biotechnological processes. Similar to the production method employed,
which must suit the producing organism, the recovery method must suit 
the product generated, in order for maximal amounts of product to be 
recovered. In general, it can be argued that there are two main means by 
which a product can be recovered, and depend on the time at which 
recovery occurs during the production process. These are downstream 
recovery, whereby the product is recovered when the production process 
has been completed, or In - S i t u  product recovery, whereby the product is 
recovered continuously, during the production process, as it is being 
produced.
In general, production processes are characterised by low product yields, 
thus the product frequently requires recovery form a dilute environment. 
As a result, downstream processing techniques are generally aimed at 
concentrating and purifying the product once its production has ceased. 
The general techniques involved include identification of the location of the 
product in the fermentation system, and the subsequent removal o f the 
contaminating stream. Once primary separation of the product feed has 
been achieved, a number o f processing steps are carried out, from 
chromatography and extraction, to evaporation and crystallisation, in order 
to concentrate and purify the product for further use or sale. It is during 
these recovery steps that product yields can be reduced, through 
degradation for example, thus the downstream recovery process 
employed must take into account the susceptibilities of the compound, and 
be developed to minimise product losses during recovery.
In - S i t u  product recovery involves techniques employed to reduce the 
potential losses in product recovery which can be frequently encountered 
during downstream processing o f product feeds, degradation and further 
metabolism of product. In conjunction with limitation of product loss, the 
advantage of In - S i t u  product recovery techniques is that by recovering the 
product of interest as it is formed, the unit operations required for total 
recovery o f product are usually reduced over those required in 
downstream processing applications. In some instances the product can 
negatively impact on the production system. For example the product may 
be toxic to the producing cell, or may negatively impact on the rheological
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properties of the fermentation, through increasing the viscosity, which 
would lower the oxygen mass transfer potential of the system. In such 
instances, the use o f I n - S i t u  product recovery techniques may not only be 
advantageous fo r product recovery, but may be essential for a successful 
production process.
As outlined in this Chapter, the number o f compounds which are produced 
through biotechnological and bioprocess applications is extensive, and 
although antibiotics are not the only products o f these processes, they are 
among the most important. Antibiotics have application in an array of 
fields, from medicine to forestry, industry to the farm. Despite an increase 
in the chemical synthesis of antibiotics, a considerable amount are still 
derived from microbial sources, and it is believed continued research and 
screening procedures will unearth even more compounds of interest 
(Watve e t  a l . ,  2001, Overbye and Barrett, 2005, Thompson e t  a/., 2002). 
As with any bioprocess, the production methodology is of key importance, 
and the vast majority o f antibiotics are produced through fermentation. The 
antibiotic fermentation can be complex, and the production scientist must 
deliberate on the optimal organism, fermentation type, media constituents, 
fermentation parameters, requirements o f the organism and how each of 
these may impact on the product, both in-fermentation, and duing 
recovery.
Leading from optimal production o f antibiotics, the importance of the 
recovery process becomes obvious. Like many bioproducts, antibiotics 
can be recovered post-fermentation, via downstream processing 
techniques. Antibiotics are generally excreted into the culture fluid during 
fermentation, and will be present in the liquid phase. Recovery of the 
compound would require removal o f biomass and fermentation particulate, 
and the subsequent retrieval o f the antibiotic in a purer, more concentrated 
form. Downstream antibiotic recovery therefore frequently employs 
techniques of extraction to achieve this. The two main extraction 
techniques are liquid-liquid and solid-liquid.
In liquid-liquid extractions, the antibiotics are usually recovered into a
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suitable organic solvent, for which the antibiotic has an affinity. These 
solvents are generally immiscible with the culture liquid, and the antibiotic 
partitions preferentially into the solvent. Once present in the solvent 
phase, the stream can be treated further, if necessary, and the antibiotic 
recovered in a more concentrated, purer form, than what it was present in 
in the fermentation culture liquid.
Solid-liquid extractions of antibiotics usually involve some sort of 
chromatographic step. A solid adsorbent, with an affinity for the antibiotic, 
or some chemical structure which is part o f the make up of the antibiotic, is 
brought in contact with the antibiotic and adsorption takes place. The 
antibiotic can then be eluted from the material, yielding a purified product 
stream. The development of polymeric adsorbent resins, with specific 
chemistries, has given rise to a number o f interesting applications. These 
resins can be applied in a batch recovery or arranged in column modes, 
and can be modified to increase the selectivity o f the recovery process. 
Such adsorbents reduce the handling of toxic solvents commonly used in 
liquid-liquid antibiotic recovery processes, and are applicable in a wide 
range o f modes.
The I n - S i t u  product recovery of antibiotics is an interesting area, since it 
allows the issue of product stability, commonly encountered with antibiotic 
production processes, to be addressed. Antibiotics can subjected to 
detrimental influences in fermentation. They may be susceptible to 
fermentation conditions such as temperature and pH, and exposure to 
oxygen and light during processing. Thus, any method which could hasten 
their recovery, minimise the number of steps required to do so, and limit 
their exposure to detrimental elements, would be beneficial to the 
production process. I n - S i t u  antibiotic recovery processes are methods 
employed to achieve these goals.
There are relatively few I n - S i t u  recovery methods which can be applied for 
the recovery o f antibiotics. Solvent mediated liquid-liquid extractions have 
a limited applicability because the solvents used are usually toxic to the 
producing organism. I n - S i t u  crystallisation is limited because there are few
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antibiotics which undergo crystallisation in-fermentation. A  number of 
novel techniques, such as membrane-assisted extractions, aqueous two- 
phase systems and perstraction methods have been developed, which 
show some very interesting application potential for the recovery of 
antibiotics In - S i t u .
The use o f adsorbent resins however, has been shown to possess 
particular potential in these types o f applications. These resins are 
generally less toxic than solvents and can thus be incorporated into the 
fermentation environment. They can also be arranged in different 
configurations, such as in external loops, to aid the recovery process and 
minimise treatment steps. The resins can selectively adsorb the 
compound of interest and allow its subsequent concentration and 
purification, with minimal negative impact on the production system. An 
added benefit o f application o f these resins is that, in some I n - S i t u  
applications, the yield of product has been seen to increase over the 
normal fermentation. This is believed to occur as a result of prevention of 
product degradation and perhaps stimulation o f metabolic paths as a 
result of the adsorption, and therefore regulation, of other fermentation 
media constituents and metabolic intermediates.
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C h a p t e r  2 .  A i m s  a n d  O b j e c t i v e s
2.1 Geldanamycin and its’ significance
Geldanamycin (Figure 2.1), a yellow antibiotic produced by S t r e p t o m y c e s  
h y g r o s c o p ic u s  var. g e ld a n u s  (Sasaki e t  a/., 1970), is a benzoquinone 
ansamycin produced as a secondary metabolite, which exhibits 
sensitivities to temperature, light, oxidation, acid and base (DeBoer e t  a i ,  
1970). Geldanamycin is a broad spectrum antibiotic which exhibits activity 
against Gram positive and Gram negative bacteria, protozoa and fungi 
(DeBoer e t  a i . ,  1970), and in nature geldanamycin is produced to serve 
the organism in situations of competition or protection.
Apart from its antimicrobial applications, geldanamycin gains clinical 
significance due to its anticancer properties. Interest in such 
benzoquinone ansamycins increased greatly upon the discovery o f the 
broad antiviral and antitumour properties of geldanamycin (Rascher e t  a i ,
2003, He e t  a i . ,  2006). Geldanamycin displays an anticancer activity 
through its interaction with the Heat Shock Protein (Hsp) 90 family of 
molecular chaperone proteins, binding them in a stable and 
pharmacologically specific manner (Whitesell e t  a i ,  1994). Although 
geldanamycin is not a clinically employed antibiotic, a number of its 
analogues, in particular 17-allaylamino-17-demethoxygeldanamycin (17- 
AAG), are presently under evaluation (Hwang e t  a l . ,  2006).
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o c o n h 2
Hsp90 is a ubiquitous protein, present in the cytosol o f both eukaryotic and 
prokaryotic cells, and is one o f the most abundant cellular proteins 
(Neckers e t  a l . , 1999). Hsp90 is over expressed in many malignancies, 
possibly as a result o f stress that is induced by the mutation and aberrant 
expression o f oncoproteins (Hwang e t  a l . ,  2006). Therefore, through its 
association with the activation o f proteins involved in cell-cycle regulation, 
signal transduction, and steroid hormone response, it is an attractive 
target for antitumour drug development (Roe e t  a l . ,  1999). Hsps play the 
role o f ‘molecular chaperone’, binding and stabilising proteins, aiding their 
assembly and transport across membranes. It is the N-terminal domain of 
Hsp90 which binds ATP and drives the chaperone activity of the protein, 
and therefore binding of ligands to this site, results in Hsp90 inhibition and 
the development o f therapeutic opportunities (Barril e t  a l . ,  2005). 
Geldanamycin binds with a high affinity to the ATP binding pocket of
Figure 2.1: Structural diagram of the antibiotic geldanamycin
Hsp90 resulting in cancer-causing proteins being left malformed and 
readily degradable by the cells own mechanisms (Roe et a l., 1999).
The significance of S t r e p t o m y c e s  and their role as antibiotic producing 
organism can not be over-stressed. S t r e p t o m y c e s  are the most widely 
studied and well known genus o f the Actinomycete family. They are soil 
dwelling organisms, ubiquitous in nature, play a role as natural 
decomposers and are the largest antibiotic producing genus of 
microorganism known at present (Watve e t  a l . ,  2001). The organism which 
is the focus o f the research outlined in this document is S t r e p t o m y c e s  
h y g r o s c o p ic u s  var. g e ld a n u s ,  which was originally isolated from a 
Kalamazoo soil (DeBoer e t  a l . ,  1970). As with many S t r e p t o m y c e s ,  
S t r e p t o m y c e s  h y g r o s c o p ic u s  exhibits pelleted growth in submerged 
culture (O'Cleirigh e t  a l . ,  2005). The reason this organism has been 
investigated is as a result o f its ability to produce the antibiotic 
geldanamycin (Lee e t  a l . ,  2006, Rascher e t  a l . ,  2003, DeBoer e t  a l . ,  1970, 
DeBoer and Dietz, 1976, Patel e t a ! . ,  2004).
2.1.2 Focus of the Work
There are a number of key objectives which are the focus of the 
experimental work undertaken in this document. The main aim however, is 
to assess the applicability o f adsorbent resins in processes for the 
recovery o f geldanamycin. Adsorbent resins are gaining considerable 
application in bioprocessing fields and antibiotic recovery is no different. It 
is believed that a potential exists for solid phase-mediated recovery of 
geldanamycin, and if so, it could benefit product yield and recovery 
efficiency.
In order to accurately assess the application o f adsorbent resins it will first 
be necessary to develop methods for the detection and quantification of 
compounds, and in particular, geldanamycin in S. h y g r o s c o p ic u s  
fermentations. To that end, there are perhaps two major goals o f the work.
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The first is the development of methods which will allow the determination 
of compound production. S t r e p t o m y c e s  can produce an array of products, 
and like many o f them, geldanamycin is an antibiotic which possesses a 
bioactive effect against certain microorganisms. By developing methods 
which can accurately assess the presence o f bioactive compounds in 
samples, one will be better equipped to establish product levels. It may 
also be advantageous to develop methods for the accurate identification 
and quantification of single compounds. Again, since S t r e p t o m y c e s  can 
produce an array o f products, it may be necessary to be able to determine 
the concentration of geldanamycin alone in order to accurately determine 
product levels. There are a number o f methods which could be employed, 
however the most important factors which should be considered is that the 
techniques employed should be robust, high throughput and accurate.
Once accurate determination of production can be achieved assessment 
of the applicability of adsorbent resins can be suitably accomplished. The 
recovery o f antibiotics traditionally takes place in a single Downstream 
Process, whereby, post-fermentation, the broth is recovered clarified and 
treated to recover product. Therefore, in the investigation of adsorbent 
resins it will be desirable to assess them in such an application. A 
prelim inary investigation will be aimed at answering the question ‘can 
adsorbent resins be used to recover geldanamycin from fermentation 
broth?’. If this question can be answered the applicability o f the resins will 
have been determined. If the answer to this question is yes, then it would 
be beneficial to examine more ways in which these resins can be applied.
In modern bioprocessing strategies, movement is towards novel reactor 
design and recovery methodologies, which facilitate more that one unit 
operation in a single stage or configuration. Such techniques often take 
the form of an integration of fermentation and product recovery, and are 
termed In - S i t u  Product Recovery techniques. These novel approaches cut 
down on processing and time requirements. They constitute a means of 
retaining product levels and may even result in an increased level of 
production or product recovery. It would be desirable to examine the In -  
S i t u  application of these adsorbent resins and determine if hey can lead to
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C h a p t e r  3 .  M i c r o t i t e r  p l a t e - b a s e d  a s s a y  f o r  t h e  
a s s e s s m e n t  o f  b i o a c t i v i t y
3.1 1ntroduction
Many biological assay techniques have been developed to assess the 
bioactivity o f compounds. This entails determining the potency o f chemical 
compounds against microorganisms (Sin and W ong, 2003). When applied 
to antibiotic fermentations, these methods use the bioactivity o f the broth 
as an indication o f antibiotic production. Traditional approaches involved 
the use o f the disk diffusion assay technique, where the susceptibility of 
an organism to a sample would result in a zone o f inhibition, with a 
magnitude related to the amount of bioactive compound present in the 
sample (Selvakumar e t  a l . ,  1999). The disk diffusion assay proves 
unreliable in certain applications (Swenson e t  a l . ,  1989) and can lead to 
interpretational problems, including in-growth in the zone of inhibition, 
whereby sparse growth of organism occurs within the zone o f inhibition 
(Piliouras e t  a l . ,  2002) and subjectivity associated with visual assessment, 
such as interpretation of where inhibition zone boundaries are located 
(Deighton and Balkau, 1990). DeBoer e t  a l . ,  (1970) took steps to 
standardise the assessment of the zone of inhibition and reported results 
in biounits, defined as the amount o f antibiotic necessary to produce a 20 
mm zone o f inhibition under standard conditions.
Using the disk diffusion method is time consuming, material intensive and, 
as a result, movement has been towards more standardised and high- 
throughput methods of bioactivity assessment (Brown, 1988). A number of 
m icrotiter plate-based assays have been developed for screening o f the 
antim icrobial activity of natural products (Devienne and Raddi, 2002), 
determination of the antimicrobial susceptibility patterns o f microorganisms 
(Jones and Dudley, 1997), determination o f microorganism adherence 
(Deighton and Balkau, 1990) and for the quantification of biofilm formation
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inhibition (Stepanovic e t  a l . ,  2000). When assaying bioactivity using 
microtiter plate-based techniques, ambiguities may be encountered in the 
determination of biomass growth trends and in the calculation of the 
bioactive effect itself. These difficulties arise because standardisation of 
the response o f microorganisms in these systems is difficult.
Assays for monitoring biomass growth and death using optical density 
(Archer e t  a l . ,  1996), turbidity (Nayak e t  a l . ,  2002) or absorbance (Lopez- 
Garcia e t  a l . ,  2003), relate bioactivity to a decrease in the measured 
absorbance. Such turbidity based methods often assume a linear 
relationship between test organism growth and absorbance. Antoce e t  a l . ,  
(1997), suggested that direct assessment o f bioactivity based on turbidity 
can be a source of computational error and, as a result, employed 
calorimetric methods instead, in the determination o f the inhibitory effect of 
C1-C4 n-alcohols on yeast growth.
A number o f methods for the examination o f sample bioactivity or for 
assessing microorganism susceptibility, report the ir findings as Minimum 
Inhibitory Concentration (MIC) (Benincasa e t  a l . ,  2003, Kiehn e t  a l . , 1982, 
Stock e t  a l . ,  2003, Waites e t  a l . ,  2003). Often MIC assessments from 
different sources are vaguely defined and thus results may be subject to 
interpretational errors. For example, Lopez-Garcia e t  a l . ,  (2003), defined 
MIC as the lowest compound concentration that resulted in no growth at 
the end o f the experiment, in their examination of antifungal activity of 
compounds, whereas Devienne and Raddi (2002) define MIC as the 
concentration at which there was a sharp decline in the absorbance value, 
in their screening fo r antimicrobial activity.
This Chapter describes a method to calculate bioactivity of samples, which 
is designed to yield a quantitative measure o f efficacy. The main aim of 
the work was to develop a means of examining the production of bioactive 
compounds in S t r e p t o m y c e s  h y g r o s c o p ic u s  fermentation broths. The 
development o f a microtiter plate-based assay method, free from 
mathematical inaccuracies in relation to the calculation o f biomass growth,
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which also provides a strategy to successfully calculate the MIC o f a 
bioactive compound, would be o f significant benefit in this pursuit.
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3 . 2  M a t e r i a l s  a n d  M e t h o d s
3.2.1 S tra in  a n d  m e d ia
S t r e p t o m y c e s  h y g r o s c o p ic u s  v a r .  g e ld a n u s  (strain NRRL 3602 obtained 
from ARS Patent Culture Collection, Peoria, Illinois, USA) was used 
throughout this assessment. Spores were produced on Bennett’s medium 
agar containing: technical agar No.3 (Oxoid, Basingstoke, England), 20 
g/l; yeast extract (Oxoid), 1 g/l; 'Lab-lemco' beef extract (Oxoid), 1 g/l; N- 
Z-amine A (Sigma-Aldrich, Dublin, Ireland), 2 g/l and dextrose 
monohydrate (Riedel-de Haen, Seelze, Germany), 10 g/l. Spores were 
recovered using resuspension solution containing: yeast extract (Oxoid), 3 
g/l; bacteriological peptone (Oxoid), 5 g/l and M gS 04 ' 7 H2O, 1 g/l. The 
fermentation medium was Bennetts liquid medium containing: yeast 
extract (Oxoid), 1 g/l; 'Lab-lemco' beef extract (Oxoid), 1 g/l; N-Z-amine A 
(Sigma-Aldrich), 2 g/l and dextrose monohydrate (Riedel-de Haen), 10 g/l.
3 .2 .2  A n t ib io t ic  fe rm e n ta t io n s  a n d  o rg a n is m  p re p a ra t io n
A spore inoculum of S. h y g r o s c o p ic u s  was used to inoculate fermentations 
and was prepared by culturing the organism on static cultures o f Bennett's 
medium agar, in 5 L Erlenmeyer flasks, for 21 days at 28°C. The spores 
were recovered by washing with resuspension solution at 100 rpm for 1 
hour at 4°C. Bennett’s media was then inoculated at 1% using a spore 
suspension of approximately 107spores/ml and incubated at 28°C at an 
agitation o f 150 rpm for at least seven days.
At later stages in the project some modifications were made to the 
standard production medium, and it was found that higher yields of 
geldanamycin were achieved using modified Bennett’s medium (using 20 
g/l to 50 g/l dextrose monohydrate instead of 10g/I). Methods such as the 
production o f spore stock and the general S t r e p t o m y c e s  h y g r o s c o p ic u s  
var. g e l d a n u s  fermentations are generally conserved throughout this
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document and the above sections should be referred to when considering 
fermentation conditions.
3.2 .3  M ic ro t ite r  a s s a y  m e d iu m  re q u ire m e n ts
YEPD media was used as nutrient source in the bioassay and contained: 
yeast extract (Oxoid, Basingstoke, England), 10 g/l; bacteriological 
peptone (Oxoid), 20 g/l; dextrose monohydrate (Riedel-de Haen, Seelze, 
Germany), 20 g/l. The disk diffusion assays were performed on YEPD 
medium agar containing: technical agar No.3 (Oxoid), 20 g/l; yeast extract 
(Oxoid), 10 g/l; bacteriological peptone (Oxoid), 20 g/l; dextrose 
monohydrate (Riedel-de Haen), 20 g/l.
3 .2 .4  M ic ro t ite r  a s s a y  te s t  o rg a n is m s
Three test organisms were used in the assay, B a c i l lu s  s u b t i l is  strain 1650 
(NCIMB Ltd. - National Collection of Industrial and Marine Bacteria, 
Aberdeen, Scotland), E s c h e r ic h ia  c o l i strain 9485 (NCIMB Ltd.) and 
bakers yeast S a c c h a r o m y c e s  c e r e v is ia e  obtained in Active Dried Yeast 
(ADY) form (DCL Yeast Ltd, Surrey, England). The test organisms were 
grown in YEPD media cultures, for 24 hours, until in a log phase o f growth 
was achieved. The cells were then harvested, resuspended in 40% (w/v) 
glycerol (BDH laboratory supplies, Poole, England), dispensed into 1ml 
aliquots, frozen and stored. A 1 mi-aliquot o f test organism was thawed 
and added to 9 mis of sterile water for use as inoculum in the assay. After 
thawing, a short lag period is observed, however the impact of this is 
minimised by the 24 hour incubation period o f the assay. These test 
organisms were selected in order to examine broad spectrum bioactivity, 
on Gram positive, Gram negative and eukaryotic microorganisms.
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3 .2 .5  M ic ro tite r  b io m a s s  s ta n d a rd  c u rv e  g e n e ra tio n
To develop the standard curves o f biomass concentration versus turbidity, 
a test organism was grown fo r 24 hours in YEPD media. This stock culture 
was then serially diluted in spent media to give a range of samples for 
biomass concentration and turbidity analysis.
Biomass concentrations were determined using dry-weight analysis. 
Clean, labelled, glass universals were dried in an oven (100°C, 24 hours). 
These were placed in a desiccator, weighed and retained for later use. 10 
m l-aliquots of the culture samples were centrifuged at 3500 rpm for 10 
minutes. The supernatants were discarded and the pellets were retained 
and resuspended in ethanol. This biomass slurry was transferred to the 
glass universals, placed in a 100°C water-bath and the ethanol 
evaporated. The universals were dried for 24 hours and again cooled and 
weighed. The dry-weight biomass concentration was determined by 
subtracting the weight o f the glass universal from that of the glass 
universal plus dried biomass. The analysis was performed in duplicate.
The turbidity of the culture samples were recorded using a Tecan, Spectra 
Classic, A-5082 plate reader and associated data retrieval software 
(Tecan, Mannedorff, Switzerland). 300 pi of the test culture was added to 
the wells o f a sterile, polystyrene 96-well m icrotiter plate (Sarstedt, 
Wexford, Ireland) and the turbidity read at 570 nm. The analysis was 
performed in duplicate.
Biomass concentration was plotted against turbidity to generate standard 
curves. This process was performed for each test organism and the 
results are shown in Figure 3.1. The equations o f the curves of best fit 
(obtained from a polynomial regression fit o f the data, using SigmaPlot 
Regression Wizard, from Systat Software UK Limited. London, UK), for 
each standard curve, are given in Table 3.1.
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3 .2 .6  M ic ro t ite r  b io a s s a y
50 ¡j \ of sample was added to the wells o f a m icrotiter plate. This was 
followed by the addition of 200 / j \  o f YEPD medium and 50 //I of test 
organism inoculum. The contents were mixed by drawing the solution up 
and down in a multipipetter a number o f times. The plates were aseptically 
read in the plate reader at 570 nm and the turbidity recorded. The plates 
were incubated at 30°C for 24 hours, and the turbidity read again. These 
turbidity values were converted to biomass concentrations and used in the 
calculation o f bioactive effect. For assaying o f fermentation samples, the 
control was 50 //I of Bennett’s medium containing: yeast extract (Oxoid), 1 
g/l; 'Lab-lemco' beef extract (Oxoid), 1 g/l; N-Z-amine a (Sigma-Aldrich, 
Dublin, Ireland), 2 g/l; dextrose monohydrate (Riedel-de Haen), 10 g/l.; for 
non-fermentation derived samples, the control was 50 ¡ j \ o f sterile 
deionised water.
3 .2 .7  C a lc u la t io n  o f  th e  b io a c t iv e  e ffe c t
Having established the turbidity values prior to and immediately following 
incubation, the bioactive effect o f the sample on test organism growth 
could be calculated. Turbidity values were converted to biomass 
concentrations using the established standard curves. W here bacterial 
growth was completely retarded, no increase in turbidity would result, 
therefore signifying no increase in biomass concentration during 
incubation. On this basis, an equation was developed to describe the level 
of growth retardation for a sample. This equation took the following form:
R  =  (<^24 - Q ) - f e ,  - r o ) j y 1 0 0  ( £ q  3 1 )
where: R  is the Retardation o f biomass growth (%), ( C 2 4 - C 0 )  is the
biomass growth in the control wells (g/l) determined by subtracting initial 
biomass concentration in the control wells from that after incubation for 24 
hours at 30°C and (T24 -  T 0 ) is the biomass growth in the sample wells
(g/l) determined by subtracting initial biomass concentration in the sample 
wells from that after incubation for 24 hours at 30°C.
3 .2 .8  D o s e -re s p o n s e  c u rv e  d e te rm in a tio n
Bioactivity analysis o f a single sample yields a result for the retardation for 
the test organisms’ growth at that concentration only. To establish the 
complete relationship between organism growth and sample bioactivity a 
dose-response curve should be determined. A  dose response curve is 
graphical representation o f the quantitative relationship between the 
amount, or dose, of an administered agent, and the biological response 
resultant in the organism under investigation. To obtain the data for a 
dose-response curve, a series of sample dilutions were assayed in 
accordance with the method applied for single sample analysis. 
Retardation of biomass growth was plotted versus the common log of 
bioactive compound concentration to give the dose-response curve. A 
regression o f the concentration dependent region is incorporated for use in 
the determination o f the MICs.
3 .2 .9  R e v e rs e  P h a se  H ig h  P e rfo rm a n c e  L iq u id  C h ro m a to g ra p h y  
(R P -H P LC )
See Chapter 4 for HPLC methodologies
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3 . 3  R e s u l t s  a n d  d i s c u s s i o n
3.3.1 B io m a s s  c o n c e n tra t io n  d e te rm in a t io n s
When absorbance based assays are used to assess biomass growth, 
results are often presented as absorbance fluctuations (Turcotte e t  a l . ,
2004, Das e t  a l . ,  1998, Pitts e t  a l . ,  2003). If using sim ilar methods to 
establish the bioactive effect o f a sample on test organisms, it is important 
to note that accurate prediction o f the bioactive effect will only be 
accomplished if biomass growth trends share a linear relationship with 
absorbance / turbidity fluctuations, or if efforts are made to linearise the 
relationship, or work within a linear region of response. Figure 3.1 clearly 
demonstrates the non-linearity o f absorbance with respect to biomass 
concentration. Welkos e t  a l . ,  (2004) also noted discrepancies in their 
results when using absorbance as an analytical means, and as a result, 
altered their analysis processes to use a fluorescence based approach in 
their examination of B . a n t h r a c ls  germination.
In order to accurately determine the bioactive effect o f a sample, from 
turbidity data, it was necessary to develop a method which would allow the 
conversion of turbidity values from microtiter plate wells to biomass 
concentration. This was achieved using biomass conversion standard 
curves established for all test organisms and shown in Figure 3.1. The 
equations o f the line of best fit for each standard curve (Table 3.1) allow 
the calculation of biomass concentration directly from recorded turbidity. 
Using these standard curves removes the limitations associated with the 
previous turbidity based methods.
The assay is limited to the model organisms B . s u b t i l is ,  E .  c o l i  and S. 
c e r e v is ia e ,  since standard curves have been generated for these 
organisms only. Extending the array of test organisms fo r which bioactivity 
can be assessed simply involves the construction o f biomass standard 
curves fo r all new test organisms and using this to determine the bioactive 
effect.
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B io m a s s  c o n c e n tra t io n  (g /l)
B io m a s s  c o n c e n tra t io n  (g /l)
B io m a s s  c o n c e n tra t io n  (g /l)
F igure  3.1: Microtiter standard curve fo r the estimation o f (A) 6. subtilis, 
(B) E .  c o l i  and (C) S. c e r e v i s i a e  biomass concentrations from turbidity
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Table 3.1: Equations for the determination of biomass concentration from 
turbidity for three test organisms, where X is the biomass concentration 
(g/l) and OD is the turbidity at 570 nm
Test C onvers ion V a lid  B iom ass
O rgan ism Equation C oncen tra tion  Range
B . s u b t i l is X = 0 .9949(O D f + 0.4841 (OD) 0 - 2.4 (g/l)
E . c o l i X = 0.8768(OD)2 + 0.8714(OD) 0 - 1 . 5  (g/l)
S . c e r e v i s i a e X = 0.9261 (OD)4 -  1.6011 (OD)J 
+ 1.5843(OD)2 + 0.5645(OD)
0 - 5.0 (g/l)
3 .3 .2  D o s e -re s p o n s e  c u rv e  g e n e ra tio n  a n d  M IC  c a lc u la t io n
The effective concentration range o f a bioactive compound on an 
organism can be represented by a dose-response curve. In this method, a 
log-linear plot of bioactive compound concentration versus retardation of 
biomass growth, returns a sigmoidal dose-response curve, comprised of a 
concentration range of no response, a concentration dependent region 
and a region of saturated response. It is from the concentration dependent 
region that MIC values and effective concentration ranges can be 
determined. Dose-response curves have been explained previously by 
Sarangapani e t  a l . ,  (2002), and are comparable to the exposure time- 
response curves determined by Welkos e t  a l . ,  (2004) in their examination 
of inhibition of B . a n t h r a c is  germination and the drug potency curves 
derived by Antoce e t  a l . , (1997), for the determination o f MIC from specific 
growth activity and specific growth retardation.
As indicated previously, there is significant ambiguity in relation to the 
definition o f Minimum Inhibitory Concentration. The phrase “Minimum 
Inhibitory Concentration” for a bioactive compound can be argued to 
indicate the minimum compound concentration at which there is any 
inhibition of growth or the minimum compound concentration at which 
there is total inhibition of growth. For reasons o f clarity it is proposed that
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the following terminology be applied in relation to MICs. Three distinct 
evaluations of MIC are necessary to avoid ambiguity. MICo, (highest 
bioactive compound concentration which results in no retardation of 
biomass growth), MIC50 (the actual bioactive compound concentration 
which results in 50% retardation of biomass growth) and MIC100 (the 
lowest bioactive compound concentration which results in 100% 
retardation o f biomass growth). Such values afford an understanding of 
the impact a given sample has on biomass growth.
Determination o f MICo, MIC50 and MIC100, results in the following benefits 
to bioactivity assessment. MIC50 is a classically measured value in the 
assessment o f bioactivity and allows the comparison of activity o f samples 
based on a 50% retardation of test organism growth. Evaluating MIC0 and 
MIC100 values allows the complete characterisation of the dose-response 
of an organism. These MIC evaluations not only supply the compound 
concentrations below which no bioactivity is detectable and above which 
complete retardation of biomass can be achieved, but connecting these 
two points allows the determination of the concentration dependent range 
of a sample, i.e. the range over which bioactivity changes with respect to 
compound concentration.
A regression of the concentration dependent, region o f the sigmoidal 
dose-response curve is used to determine the three indicated MIC values. 
Figure 3.2 shows the analysis o f the dose-response curves o f B . s u b t il is ,  
E . c o l i and S. c e r e v is ia e  using a commercially available detergent, 
Parazone™, with active ingredient Sodium Hypochlorite. The basis of the 
assessment was the Sodium Hypochlorite concentration as estimated as 
5% from the formulation of Parazone™. The data resultant from each 
analysis is summarised in Table 3.2.
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Sodium Hypochlorite concentration (g/l)




















Sodium Hypochlorite concentration (g/l)
F igure  3.2: The dose-response curve o f B . s u b t i l is  (A), E .  coli (B) and S. 
c e r e v i s i a e  (C) to Parazone™
MICo, MIC50 and MIC100 are determined from the intercept of 0 , 50 and 
100% retardation of biomass growth reference lines, with a regression of 
the concentration dependent region of the dose-response curve.
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Table 3.2: Data acquired from the dose-response curves, indicating the 
bioactivity o f sodium hypochlorite (as the active ingredient in Parazone™) 
against B . s u b t i l is ,  E . c o l i and S. c e r e v is ia e
T est O rgan ism MICo (g/l) MICso (g/l) MIC-ioo (g/l)
B . s u b t i l is 0.61 1.02 1.70
E . c o l i 1.03 1.63 2.58
S . c e r e v is ia e 3.11 3.74 4.67
3.3 .3  M e th o d  v a lid a t io n
Since the method was primarily developed fo r the examination of bioactive 
compound production in fermentations and the assessment of 
fermentation broth samples, it was decided to validate the method using a 
fermentation broth sample. A Day 7 sample o f S. h y g r o s c o p ic u s  
fermentation broth was examined. The regression o f the concentration 
dependent region of the dose-response curves for the fermentation 
sample is given in Figure 3.3, and the predicted MIC values summarised 
in Table 3.3.
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107  1 0 «  1 0 - 5 1 0 4  1 0 - 3 1 0 - 2 1 0 - 1 
Geldanamycin* concentration (g/L)
F igure  3.3: Effect of day seven Bennett’s media fermentation sample on 
biomass growth. (*)S . s u b t il is , (□) E . c o li, (A )  S. c e r e v is ia e ,  (— ) 
regression of the dose-response region for each test organism
Table 3.3: Data acquired from the dose-response curves, indicating the 
bioactivity o f geldanamycin* against B . s u b t i l is ,  E .  c o l i and S. c e r e v is ia e
T est O rgan ism MICo (g/l) MICso (g/l) MIC100 (g/l)
B . s u b t i l is 0.00001 0.0003 0.0080
E . c o l i 0.00074 0.0038 0.0200
S . c e r e v is ia e 0.00012 0.0010 0.0092
The above analysis was performed on a fermentation broth sample thus 
the assessed bioactivity may incorporate the bioactive effects of 
geldanamycin and any other bioactive compounds present. DeBoer e t  a i ,  
(1970) examined purified geldanamycin and determined that the MIC of
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the compound, against a range o f test organisms, ranged from 0.1 g/l to 
0.002 g/l, with some species of B a c i l lu s  having MIC values in the order of 
0.025 g/l. These values are higher than the MIC values obtained fo r the 
crude geldanamycin fermentation broth samples assessed in this study. 
This indicates that apart from geldanamycin, there may be other bioactive 
compounds present in the fermentation broth.
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3 . 4  C o n c l u s i o n
In any antibiotic production process it is important to be able to establish 
how the production is progressing and the yields o f the product of interest 
attained. The most frequently employed technique has been the disc 
diffusion assay. These types of assays em ploy solid culture, diffusion- 
based methodologies, to assess the potential o f a sample to limit test 
organisms growth. A zone of growth inhibition o f a suitable test organism, 
proportional to the bioactive efficacy o f the sample, is returned. This is 
essentially a qualitative assessment, allowing the determination o f the 
presence o f a bioactive effect, and as a result, the accurate quantification 
of this effect is difficult, and open to subjective error. As a result, 
movement has been towards more robust, high throughput methods for 
bioactivity assessment, which frequently involve the use of turbidiometric 
readings.
Previous methods o f direct assessment o f bioactivity based on turbidity 
had been found to be a source o f computational errors, and with this in 
mind, it was decided to develop a method that utilised a more 
mathematically stringent assessment o f bioactivity. The conversion of 
turbidity readings to biomass concentrations using biomass standard 
curves removed the errors associated with the non-linearity of the 
relationship between turbidity and test organism biomass growth, thereby 
allowing the more accurate assessment o f bioactive ranges. The methods 
employed for the development o f turbidity to biomass concentration 
standard curves had to be readily adaptable and standardised to facilitate 
a later increase in the number and type o f m icroorganisms against which 
bioactivity could be examined.
Although numerous methods exist for the reporting o f bioactivity, the 
calculation of Minimum Inhibitory Concentrations has been the standard 
for antibiotic susceptibility testing (Ceri e t  a/., 1999). Such methods 
provide a limited amount of information regarding the activities with 
respect to test compound concentrations (Lowdin e t  a l . ,  1998). The 
method described in this work allows the determination of the dose-
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response curve of test organism growth with respect to bioactive 
compound concentration. From analysis o f the dose-response curve, data 
can be gathered on MICs and used to compare the susceptibilities of 
different test organisms to the same sample. The evaluation MICo, MIC50 
and MIC100 yield a greater understanding of dose-response behaviour for 
a bioactive compound. Calculation o f MICs, using the intersection o f fixed 
reference lines with the concentration dependent region, of the dose- 
response curve, ensure the results obtained are more mathematically 
stringent than previous MIC determinations, which may be arbitrary by 
definition.
The developed method delivers quantitative results for the determination 
of the bioactive range o f a sample, against a variety o f test 
microorganisms. Such a technique is important in this body of work, since 
it facilitates the monitoring of production of bioactive compounds by S. 
h y g r o s c o p ic u s  in fermentation samples, and returns clear and well defined 
data in relation to MICs. The method may also have application in the 
examination of medical antibiotic dosing. Accurate establishment of the 
effect o f a variety of drug concentrations on microbial growth, as achieved 
by this method, may provide more meaningful information about optimal 
dosing strategies than determinations obtained with a single concentration 
(Lowdin e t  a l . ,  1998). The method is high throughput, simple and robust, 
applies greater mathematical rigour to the establishment o f bioactive 
ranges and MICs, than previously employed methods and can be 
extended to increase the spectrum of test organism subjects.
It was assumed in the bioactivity analysis o f fermentation samples; that 
geldanamycin was the sole contributor to the bioactive effect. However, 
although the fermentation process was optimised for the production of 
geldanamycin, it is important to note other bioactive compounds may be 
produced by the organism, and impact on the retardation o f biomass 
growth. S t r e p t o m y c e s  are the largest antibiotic-producing genus in the 
microbial world and the natural products, including antibiotics, produced by 
the genus include, geldanamycin, streptomycin, elaiophylin and 
erythromycin to name but a few (DeBoer e t  a l . ,  1970, Watve e t  a l . ,  2001,
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Fazeli e t  a i ,  1995). This belief was verified by the assessment of 
geldanamycin fermentation broth samples, which returned lower MIC 
results than those values cited by DeBoer e t  a ! . ,  (1970) fo r purified 
geldanamycin. As a result o f this, the bioactive effect determined and 
quantified by the bioassay, may incorporate the effects o f other bioactive 
compounds present in the sample. It would therefore be necessary to 
employ an alternate, compound specific, method in order to analyse 
samples fo r geldanamycin concentration only.
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C h a p t e r  4 .  S t r a t e g y  d e v e l o p m e n t  f o r  t h e  a n a l y s i s  o f  
g e l d a n a m y c i n  i n  f e r m e n t a t i o n  b r o t h  s a m p l e s
4 .11ntroduction
In the previous Chapter, a method to assess bioactivity in fermentation 
samples was developed. This method comprised a high throughput 
bioassay which allowed the determination o f the relative potential of 
samples to inhibit growth o f target organisms. Although this method was 
considerably more robust and quantitative than previously employed disk 
diffusion assays, it was still not a specific assay fo r geldanamycin. The 
nature of the assay was to determine the minimum inhibitory concentration 
of samples. Since S t r e p t o m y c e s  by their very nature are prevalent 
producers of an array o f bioactive compounds (Crueger and Crueger, 
1982), it was not possible to elucidate whether all o f the bioactive effect 
noted was attributable to geldanamycin. To resolve this issue, it was 
decided to examine the applicability of High Performance Liquid 
Chromatography (HPLC) for the analysis of fermentation samples, and the 
determination o f geldanamycin concentration.
HPLC techniques employ highly sensitive detectors in conjunction with 
small bore HPLC columns, with small diameter column-packing particles, 
and high pressures, to obtain the flowrate necessary for short analytical 
times (Aszalos e t  a l . ,  1982). HPLC has been used for both the purification 
and separation of a number o f different antibiotics (Cantwell e t  a l . , 1984, 
Joshi, 2002, Loadman and Calabrese, 2001) but of importance to the work 
carried out in this chapter, is the application o f HPLC techniques for 
identification and quantification o f the antibiotic geldanamycin. Agnew e t  
a l . ,  (2001) had previously published a method which employed HPLC to 
examine the levels of geldanamycin and its derivative, 17-(allylamino)-17- 
demethoxygeldanamycin in human plasma samples. Although the source 
material in their work was not fermentation broth, this method still provided
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a good basis fo r the development o f a suitable HPLC procedure to 
determine the geldanamycin concentration of samples from  S t r e p t o m y c e s  
fermentation broths.
HPLC analysis methods are an expedient means o f efficiently identifying 
and resolving single compounds in multi-component systems. Up until this 
point, fermentation broth samples were analysed using the bioassay 
detailed in Chapter 3. It was therefore envisaged, that the development of 
a suitable HPLC process would reduce the time constraints and analytical 
lim itations associated with this assay. For this reason, it was decided to 
pursue HPLC as the primary method fo r sample analysis.
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4 .2 .  M a t e r i a l  a n d  M e t h o d s
4.2.1 S t r e p t o m y c e s  h y g r o s c o p i c u s  v a r. g e l d a n u s  a n t ib io t ic  
fe rm e n ta t io n s
The general methodologies applied to generate antibiotic containing 
fermentation broth are outlined in Chapter 3.
4 .2 .2  H ig h  P e rfo rm a n c e  L iq u id  C h ro m a to g ra p h y  (H P LC ) M e th o d  
D e v e lo p m e n t
Agnew e t  a l . ,  (2001) described a HPLC method for the identification of 
geldanamycin in plasma samples. A Hewlett-Packard 1050 HPLC system 
(Wilmington, DE, USA) was employed and utilised a Kingsorb C-18 
Reverse Phase HPLC column (Phenomenex, Cheshire, U.K.) with 
dimensions o f 150 mm x4 .6  mm, and used a stationary phase pore size of 
3 pm and associated Phenomenex Security Guard system as the pre­
column. Geldanamycin U.V. detection was achieved at 308 nm using a 
HP1050 diode-array detector (Wilmington, DE, USA). The mobile phase 
used by Agnew e t  a l . ,  (2001) contained 50% (v/v) acetonitrile-25 mM 
sodium phosphate buffer (pH 3.00), containing 10 mM triethylamine, and 
was delivered at a flow-rate of 1 ml/min, for a run time of 25 minutes. 
Although the method was applied to plasma samples, it was a good basis 
for the development of a HPLC procedure for the analysis of 
geldanamycin in fermentation broth samples.
The preparation o f the mobile phase employed by Agnew e t  a l . , (2001) 
was more difficult than was desired and contained constituents which may 
not have been necessary in a HPLC method for the assessment of 
geldanamycin in fermentation broth samples. It was desirable to employ a 
less complex mobile phase, which was easier to prepare, and whose 
application would not negatively impact on sample resolution and 
identification.
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It was therefore decided to take measures to remove the sodium 
phosphate and triethylamine portions o f the mobile phase and replace 
them with ultra-filtered H20 . These constituents essentially serve to 
improve retention time and separation in mixtures containing acids and 
bases, and address issues of compound peak tailing. It was believed that, 
since the sample material for analysis o f geldanamycin in fermentation 
broths was different to the plasma samples under analysis by Agnew e t  
a l . ,  (2001), these additives may not be as required for the analysis of 
fermentation broth samples.
The proposed new mobile phase comprised o f 50:50 (v/v) ultra filtered 
H20  : acetonitrile (Lennox Chemicals Ltd., Dublin, Ireland). In order to 
preserve the column longevity, a Security Guard HPLC guard cartridge 
system (Phenomenex, Cheshire, U.K.) was also used. The HPLC system 
employed fo r sample assessment was a Merck-Hitachi LACHROM 7000- 
series HPLC system, comprising o f a D-7000 interface device, L-7200 
auto-sampler, L -7400 U.V. detector and a L -7100 isocratic pump system 
(Hitachi Ltd., Tokyo, Japan). Figure 4.1 outlines the effect o f mobile phase 
alteration on the geldanamycin chromatographic results.
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F igure  4,1: Comparison o f mobile phase on analysis o f a geldanamycin 
standard. A) mobile phase employed by Agnew et a/., (2001), B) 
substituted mobile phase of 50% H20  : 50% acetonitrile
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The main aim of altering the mobile phase was to reduce the complexity of 
the preparation procedure and thus limit the potential for variation between 
HPLC analyses.
It was therefore necessary to determine if by altering the mobile phase, 
compound retention or analysis time was adversely effected. Figure 4.1 
shows that the geldanamycin peak could be effectively eluted, and was 
done so in a timely fashion using the new mobile phase. From this result, it 
is clear that using the new mobile phase would reduce the preparation 
time and cost involved in employing the HPLC process. Having 
established that geldanamycin could be eluted via the HPLC process it 
was necessary to employ this technique fo r the identification and 
quantification of geldanamycin in fermentation samples.
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4 . 3  R e s u l t s  a n d  D i s c u s s i o n
4.3.1 A n a ly s is  o f  G e ld a n a m y c in
Geldanamycin is produced as part o f the metabolic processes of 
S t r e p t o m y c e s  h y g r o s c o p ic u s ,  and is excreted into the fermentation broth. 
Nonetheless, it was necessary to verify its presence in the fermentation 
broth samples being generated. In order to achieve this, it was necessary 
to assess the adsorption spectrum of a fermentation broth sample.
A 3 ml sample of fermentation broth was aliquoted into a quartz cuvette 
(Hellma, Hellma U.K. Ltd., Essex, U.K.) and analysed using a Shimadzu 
U.V.-160 A, U.V. to Visible (U.V.-Vis) recording spectrophotometer 
(Shimadzu Europa GmbH, Duisberg, Germany) over a wavelength range 
of 200 to 500nm (Figure 4.2).
F igure  4.2: Adsorption spectrum of S. h y g r o s c o p ic u s  fermentation broth
Analysing the absorption spectrum printout, an absorption maximum was 
noted around 300 nm. This could be related to the geldanamycin
adsorption maximum of 308 nm or 305 nm described by DeBoer e t  a l . ,  
(1970) and Alvi e t  a l . ,  (1995), however a more definitive assessment of 
geldanamycin was desirable.
Since a simple HPLC method for examination o f samples containing 
geldanamycin had been established, it was decided to employ this method 
for the analysis o f fermentation broth samples, with the primary aim of 
identification and quantification o f geldanamycin.
Since the sample source was fermentation broth, there would also be a 
number of ‘contaminating’ compounds inherently present in the 
fermentation medium. These contaminating compounds would include 
fermentation by-products, proteins, minerals, vitam ins and carbohydrate. 
Throughout this Chapter, contaminating compounds will be considered as 
being compounds other than geldanamycin, the compound o f interest. 
Definitive identification of geldanamycin was therefore important.
A fermentation sample was analysed via HPLC at 308 nm, and upon 
examination of the chromatograms, two major peaks were noted. The first 
was believed to be attributable to poorly retained, less hydrophobic 
fermentation compounds and mobile phase constituents and were 
considered contaminating compounds. The second was believed to be 
that of geldanamycin.
Since this was still not conclusive evidence o f the presence of 
geldanamycin, the accurate determination of the presence of 
geldanamycin in the fermentation broth was still required. It was believed 
that this would be best achieved using a combination of chromatogram 
and adsorption spectrum comparison. HPLC employing a Photo Diode 
Array (PDA) detector (Varian ProStar 330, Varian Inc., California, U.S.A.) 
was the apparatus employed to achieve this goal.
Photo Diode Array detection is employed to analyse samples over the 
entire U.V.-Vis spectrum. Unlike with conventional U.V.-Vis detectors, 
where only one datum point can be acquired at a time, PDA detectors are
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generally comprised of several hundred or thousand detectors and can 
therefore acquire data for many wavelengths simultaneously (Choi, 2004). 
This essentially acts to form a 3D-landscape o f a resolved compound 
based on retention time and adsorption wavelength. A  single peak, 
representing a resolved compound can be selected and its adsorption 
spectrum delivered at the retention time at which it was resolved. PDA 
detection is frequently used to monitor and identify bioproducts.
Vandana e t  a l . ,  (1996) detailed the use o f PDA detection for monitoring 
taxol extraction from bark and Mierzwa e t  a l . ,  (1988) described the 
utilisation of PDA apparatus for detection of, and discrim inating between, 
analogues o f the antibiotic blasticidin. PDA detection can also be used to 
monitor reaction products, den Brok e t  a l . ,  (2005) described the use of 
PDA detection for the monitoring o f the formation o f degradation products 
of the compound C1311, a lead compound in a novel group of anticancer 
agents. In order to accurately identify geldanamycin in fermentation broth 
samples three samples were analysed via HPLC with PDA detection. The 
samples were a geldanamycin standard (0.01 g/l), a fermentation broth 
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F igure  4.3: Chromatographic identification o f geidanamycin. A) 
geldanamycin standard, B) fermentation broth sample and C) fermentation 
broth sample spiked with geldanamycin
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Figure 4.3 shows the HPLC chromatographic results at a detection 
wavelength o f 308 nm. It was found that the major peak present in a 
fermentation broth sample was consistent with that o f geldanamycin 
through comparison with the chromatogram o f geldanamycin standards. 
Examination o f the chromatogram of the spiked fermentation broth sample 
showed integration o f the geldanamycin standard peak and the major 
peak present in the fermentation broth sample. This gave further indication 
that the peak resolved at approximately 20 minutes was that of 
geldanamycin. Further proof o f this was gained from comparison o f the 
adsorption spectra o f the 20 minute peak obtained using PDA detection.
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F igure  4.4: Adsorption spectrum comparison and identification of 
geldanamycin. A) geldanamycin standard, B) fermentation broth sample 
and C) fermentation broth sample spiked with geldanamycin
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Figure 4.4 shows the comparison of the adsorption spectra of the major 
peak in the fermentation broth sample with that o f a geldanamycin 
standard. A combination of the results shown in Figures 4.2 to 4.4, gives 
evidence that the major peak in the fermentation broth chromatogram is 
that o f geldanamycin. Examining Figures 4.3 and 4.4 it can be seen that 
the HPLC peaks and adsorption spectra o f broth samples and 
geldanamycin standard share equivalent retention times and adsorption 
spectra.
Trejo-Estrada e t  a l . ,  (1998) verified the production o f geldanamycin in a 
similar way, comparing the U.V. spectrum of a standard to that of the 
compound produced by their test strain of S t r e p t o m y c e s .  Since 
geldanamycin has a broad U.V. adsorption peak from 300 to 320 nm, and 
in literature, geldanamycin has been assessed at a number of 
wavelengths in this range (Alvi e t  a l . ,  1995, DeBoer e t  a l . ,  1970, Rascher 
e t  a l . ,  2003, Trejo-Estrada e t  a l . ,  1998, Agnew e t  a l . ,  2001).
91
4 .3 .2  A n a ly s is  o f  G e ld a n a m y c in  in fe rm e n ta tio n  b ro th
Geldanamycin is excreted by S t r e p t o m y c e s  h y g r o s c o p ic u s , during 
submerged culture, into the fermentation broth. The antibiotic can 
therefore be in the presence of a variety o f fermentation compounds, from 
unfermented carbohydrates and precursors to proteins. Analysis of 
geldanamycin in fermentation samples was initially performed via HPLC 
analysis using filtered fermentation broth. Analysing samples in this 
manner was however, found to be problematic. A fter a number of samples 
had been analysed, the system would show signs o f column fouling, 
including reduced analytical performance, increased pressure and 
reduced column life-span. In order to circumvent these problems, it would 
be necessary to gain a better understanding o f how these problems 
occurred. It would also be necessary to determ ine if alterations to the 
HPLC method could address these issues and ultimately facilitate the 
development of a successful analytical process for fermentation broth 
samples.
In a technical report released by Mac-Mod Analytical Incorporated (2006), 
entitled 'protecting reversed phase HPLC columns’, column fouling was 
highlighted as a major problem in HPLC analytical processes. They stated 
that most damage to reverse phase columns is caused by either 
particulate material plugging the inlet o f the column or non-eluted 
compounds ‘fouling’ the column. They suggested that column fouling leads 
to an increase in process costs, associated with failure of the column and 
its subsequent replacement, and an increase in process time, due to the 
downtime caused by an increased need for column regeneration and 
equilibration. They also suggested that fouling may be attributed to 
inadequate elution of compounds from the column.
The compounds or materials responsible for column fouling are usually 
derived from the sample and eventually build up on the column to the point 
where it adversely affects chromatographic performance. There are a 
number o f compounds and materials which can lead to column fouling, 
and can be comprised of particulate matter (Lindemann e t  a l . ,  2000) to
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proteins (Waterborg, 2000, Hagestam and Pinkerton, 1985). The 
fermentation broth in which geldanamycin is produced can be complex, 
containing carbohydrates, minerals, proteinaceous material and other 
compounds, and it should therefore come as no surprise that fouling could 
occur. It was found that the major impact o f fouling on the HPLC analysis 
of geldanamycin from fermentations broth samples mirrored those 
highlighted in the Mac-Mod technical report. They included prevention of 
sample analysis due to pressure constraints (the column optimal working 
pressures were below 3500 psi and the pump maximum discharge 
pressure was just over 5000 psi), column down time and the increased 
requirement fo r column replacement.
HPLC is based on similar principles to those o f gas chromatography (GC) 
with the major difference being the use of liquids in place of the gas 
phase. Since liquids are more viscous and exhibit lower diffusion rates 
than gases, the separation process must be conducted at higher 
pressures. These higher pressures also facilitate fast sample analysis 
times. The pressures encountered in the system can be affected by two 
main sources, the mobile phase flowrate and column fouling. If one 
increases the flowrate to reduce sample analysis time, the pressure in the 
system will also increase. This is due to the fact that a greater pressure is 
required to move the liquid through the narrow column, and small packing 
material pore size, at the more rapid rate. If there is a build up of material 
in the column as a result of fouling, this will act as a barrier to liquid flow, 
and therefore increase the pressure in the system.
Increased pressures are problematic because many columns and HPLC 
systems do not have satisfactory life-times above 5000 psi (Hancock and 
Sparrow, 1984), or the complete HPLC system, including tubing and 
fittings, may have pressure limits below this. The technical data of the 
column used for geldanamycin assessment stated that, in order to prolong 
column life, pressure should be maintained below 3500 psi, which dictated 
that the typical flowrate employed was 0.5 ml/min.
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After relatively few broth samples were analysed a considerable increase 
in the pressure in the system would be noted, which indicated it was 
necessary to clean the column. If cleaning did not take place the pressure 
would continue to increase until column or system thresholds would be 
reached, or poor resolution of samples would result.
The cleaning o f columns was carried out to facilitate the removal o f 
strongly retained compounds, and thus reverse column fouling and reduce 
system pressure. The standard cleaning procedure was rinsing the 
columns with 10 column volumes of the following solutions in sequence: 
95% H20  : 5% acetonitrile, 100% tetrahydrafuran, 95% acetonitrile : 5% 
H20 , and then the mobile phase (which was 50% H20  : 50% acetonitrile). 
If, after cleaning the column, the pressure was still high upon equilibration 
of the column, the cleaning was repeated. This time, however, it would be 
carried out with the column in the reverse orientation, and having been 
heated to 50°C. The heating served to aid solublisation of compounds and 
washing in reverse helped to flush the compounds back out of the column 
inlet rather than encouraging their progression further down the column.
If the cleaning o f columns was insufficient to reverse the column fouling, 
as indicated by an insufficient reduction in system pressure, the column 
could no longer be employed in the analysis process and had to be 
replaced with a new column. This occurred on a frequent basis, and 
columns were being irreparably fouled at an excessive rate. It was 
therefore decided that a pre-treatment step was required to limit fouling 
and the associated damage to the columns.
4.3.2.1 B u ta n o l e x tra c t io n  to  a id  a n a ly s is  o f  g e ld a n a m y c in  in  
fe rm e n ta t io n  b ro th  s a m p le s
It was decided to examine the application o f solvent extraction of 
geldanamycin from the fermentation broth samples as a means to reduce 
the potential of column fouling, and to therefore increase the speed of the 
overall analytical process. Solvent extraction is a method frequently
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employed to recover selected compounds from a stream containing many 
compounds. It was decided that extraction o f geldanamycin prior to 
analysis would serve to reduce the amount o f contaminating material 
which could pass onto the column and therefore limit subsequent fouling 
o f the column. The extraction o f geldanamycin from fermentation broth 
was achieved via liquid-liquid extraction o f the samples using butanol as 
the extracting solvent, since it had been identified, in literature, as a 
suitable solvent (DeBoer e t  a ! . , 1970).
The liquid-liquid extraction process involved contacting fermentation broth 
with butanol in a 1 : 1 ratio in a universal. This was then agitated by hand, 
and then sonicated, in a sonicating water bath, fo r 10 minutes. The sample 
was then centrifuged, at 3500 rpm for 10 minutes to promote partitioning 
of the two phases. The butanol was recovered and ready for analysis.
Although extracting the samples with butanol reduced the amount of 
contaminating compounds in samples to be analysed (a reduction of the 
order o f 20% depending on the samples being analysed) whilst 
maintaining an extraction efficiency o f geldanamycin of the order of 95%, 
there were some major difficulties encountered with using this butanol 
extraction technique. Butanol was found to be incompatible with the HPLC 
analysis protocol. Butanol samples returned very poor analytical resolution 
and frequently resulted in fronting of samples, whereby the front part of a 
resolved peak (before the apex) tapers in advance o f the remainder of the 
peak.
When butanol alone was analysed via HPLC, it would traverse the column 
expediently and be eluted early. However analysis o f a butanol extracted 
sample resulted in a phenomenon of ‘poorly resolved peaks’ being noted. 
Although the majority o f geldanamycin in the sample was eluted at the 
appropriate retention time, it was believed that some geldanamycin was 
‘retained’ with the butanol and, was continuously transferred to the mobile 
phase, with elution occurring sooner than the majority of the 
geldanamycin. The resulting chromatograms showed these poorly 
resolved peaks, eluted prior to the primary geldanamycin peak. Figure 4.5
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highlights the negative impacts of the presence o f butanol on HPLC 
analysis o f fermentation broth samples.
F igure  4.5: Effect of butanol on sample analysis and resolution
As a result o f these problems it became clear that analysis o f butanol 
extracted samples was not viable. In order to address these issues, the 
butanol would have to be removed from the samples and replaced with a 
suitable solvent, which was inert with relation to the HPLC system. The 
most suitable means of removing the butanol was deemed to be through 
evaporation techniques.
The first method o f butanol removal attempted was flash evaporation, 
which involved rapid removal o f solvent through the use o f high 
temperatures. Butanol evaporates at a temperature o f approximately 
117°C. Since geldanamycin is a thermolabile compound, elevating a 
sample to this temperature would be detrimental. However, it was 
theorised that if the butanol could be evaporated quickly then the time the 
sample would spend at elevated temperatures would be minimised.
96
The flash evaporation process involved the following. 1 ml o f a butanol 
extracted fermentation broth sample (i.e. the butanol phase) was aliquoted 
in 20 ml glass test tubes. The test tubes were then lowered into a silicone 
oil bath, heated to 170°C. After approximately 10 to 20 seconds the 
butanol would evaporate. In initial applications of this technique, a rapid 
recondensing o f the butanol was encountered. This was overcome by 
using smaller glass test tubes (8 ml), which could also be immersed 
deeper into the bath. This alteration also reduced the evaporation time.
Although the technique resulted in the evaporation of the butanol, it was 
not a successful method, since the heat required for butanol evaporation 
resulted in geldanamycin degradation. Also, the evaporation was 
frequently violent, resulting in eruption of sample from the evaporation 
vessel (see Figure 4.8 for comparison of the effect of butanol removal 
methods on geldanamycin signal).
The poor performance o f the flash evaporation method was attributed to 
the high temperatures required to evaporate butanol. It was therefore 
decided that removal of butanol should take place at lower temperatures. 
This was achieved using a rotary vacuum evaporation method.
The rotary evaporation method involved placing a butanol extracted 
sample into a round bottom flask and coupling it to the evaporation and 
condensing apparatus (the unit and apparatus are displayed in Figure 
4.6). The flask was then lowered into a water bath maintained at 40°C, and 
rotated. At this point a vacuum pump connected to the unit, capable of 
exerting a vacuum of - 0.98 bar, was switched on and the unit slowly 
sealed to create a vacuum. The sealing processes took on average 5 
minutes, this slow sealing process was required to prevent suction of the 
sample out o f the flask. The evaporation o f the butanol took approximately 
10 minutes, with the evaporated butanol vapour being recovered using a 
condenser, with circulation o f a polyethylene glycol-water mixture, 
maintained at approximately - 4°C, using a Frigomix S-1, recirculating, 
cooling, waterbath (B. Braun, Melsungen, Germany). An in-line cold trap,
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immersed in liquid nitrogen, prevented any butanol vapour which may 
have escaped from the condensing apparatus, from  entering the pump.
F igure  4.6: Schematic of the rotary evaporation unit employed for the 
removal of butanol from samples
The rotary evaporation process was successful at removing the butanol 
without signal loss, however, the main problem encountered with this 
method was sample throughput. Using the rotary evaporation method for 
large sample numbers was both time and labour intensive and required a 
large working volume. It was decided to examine other methods for 
butanol removal.
The final method for butanol removal examined was low pressure 
evaporation. This method was analogous to rotary vacuum evaporation, 
but involved the construction of a stainless steel evaporation chamber, 
and a schematic of the apparatus is provided in Figure 4.7.
The low pressure evaporation method involved evaporation of 1 ml 
samples o f butanol extracted samples, however, it was possible to treat a 
greater number o f samples in a single batch. The samples were added to
8 ml glass test tubes. The test tube openings were covered with tin foil and 
a small perforation placed in each one to allow solvent vapour removal. 
The test tubes were then placed into a test tube rack (with space for 72 
samples) and lowered into the evaporating vessel. The vessel comprised 
of a stainless steel, fully sealable unit, w ith an internal volume of 
approximately 0.1 m3, and which was evacuated using a vacuum pump. A 
layer o f silicone oil (approximately 1 inch deep) covered the bottom of the 
chamber, and aided heat transfer. The cham ber was heated to 40°C, via 
an integrated heating mantle, whilst the vacuum was applied. Once at 
40°C, the heating was ceased and the evaporation continued for a further 
thirty minutes, after which the samples were removed, completely dry.
F igure  4.7: Schematic of the low pressure evaporation unit employed for 
the removal of butanol from samples
This method proved to be the best of the alternate methods examined. 
The temperatures and process times involved were not excessive and the
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method allowed the evaporation of a large number of samples at once. 




















Figure 4.8: Effect of Butanol removal method on geldanamycin signal. FE) 
Flash Evaporation, RE) Rotary Evaporation, LPE) Low Pressure 
Evaporation
From these results it was now possible to carry out a butanol-mediated 
liquid-liquid extraction of the fermentation broth samples. Doing so would 
reduce the level of contaminating compounds present in the samples to be 
analysed, and would therefore reduce the potential for fouling of the 
columns, and would in turn, reduce column downtime and damage. The 
extracting solvent could then be removed and substituted with a solvent 
which was more suitable to the HPLC analytical method. The solvent 
employed was a 50% : 50% (v/v) mixture of H20  : acetonitrile. This was 
also the HPLC mobile phase, and therefore its application would be inert 
in the analysis process.
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4.3.2.2 Optimisation of analysis of geldanamycin from  
fermentation broth samples
The HPLC method was developed to be the primary means of assessing 
the presence and concentration of geldanamycin in fermentation samples. 
It was therefore apparent that the HPLC analysis of samples was the most 
likely ‘bottleneck’ of the project work and in order to address this, high 
throughput analysis of samples would be required. Although low pressure 
evaporation could successfully treat a large number of samples in a single 
run, each sample had to undergo solvent extraction, solvent removal and 
resuspension prior to analysis. This represented a drain on time and 
resources, and although the method addressed the issues of column 
fouling, it did not increase sample throughput.
Column fouling and low sample throughput can be considered as 
interlinked problems. Fouling results from interactions between the 
compounds in samples with the column stationary phase. Low sample 
throughput is essentially dictated by the analysis time required for a 
sample, which in turn is associated with the flowrate of the mobile phase. 
The maximum flowrate which can be employed is dictated by the pore size 
of the stationary phase, which, if small, may have a greater potential to 
clog and become fouled. As a result of this interrelationship, it was 
decided to examine modifying the HPLC apparatus as a means of tackling 
both the column fouling and sample throughput issues.
The packing phase pore size of the HPLC column employed for sample 
assessment was 3 pm. The technical specifications of the column and 
pressures resultant, meant that the maximum flowrate utilisable was 0.5 
ml/min. Using this method the runtime of each sample was 60 minutes, 
with the geldanamycin peak identified at approximately 20 minutes. In 
HPLC, short analytical times and high speeds are achieved by high 
solvent / mobile phase flow velocities, and because of the fast flowrate a 
high pressure exists at the column inlet (Aszalos et ai, 1982). Essentially, 
in HPLC analyses, the pore size of the stationary material plays an 
inherent role in the pressure limitations and therefore the flowrate
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achieved. The HPLC column employed could also be supplied by 
Phenomenex in a 5 pm pore size. Using the 5 pm pore size column 
reduced the pressure in the system, and allowed the HPLC process to be 
run at a flowrate of 1ml/min. This facilitated a reduction in the runtime, 
allowing samples to be run in 2 0  minutes, with the geldanamycin peak 
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Figure 4.9: The effect of column alteration on analytical success. A) 3 |jm 
pore size column, B) 5 pm pore size column
A further benefit of employing the column with a larger stationary phase 
pore size was that there was an inherent reduction in the risk of clogging 
and therefore fouling of the column. If the pore size is larger, the 
compounds being applied to the column will not be associated or retarded 
to the same degree as with a smaller pore size stationary phase. This
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reduces the residence time of compounds and reduces liquid flow 
pressure and fouling events.
Since HPLC analysis of samples was one of the most central aspects of 
any particular experiment carried out, it was decided to put in place further 
measures to optimise the process. Using the security guard cartridge unit 
supplied by Phenomenex, it was possible to stack guard columns. It was 
decided to use two guard columns to reduce the risk of contaminating 
compounds passing through from the sample to the analytical column. 
When the first guard column becomes saturated with fouling material it 
can be changed, and one can be sure that the second guard column has 
acted a ‘safety net’, limiting access of any fouling compounds which may 
have traversed the first guard column, from gaining access onto the 
analytical column.
F e m ¿ l i e  L J m i t  ( /V )
<__a . r t r i d g e  ( B )
: M a l e :  I  J n  i l ( C ",)
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Flow -+•
Figure 4.10: Schematic of the Phenomenex Security Guard guard column 
system, and diagrammatical representation of guard column stacking
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4 .3 . 2 . 3  T h e  e f f e c t  o f  f e r m e n t a t i o n  b r o t h  d i l u t i o n  o n  a n a l y s i s
Since employing a HPLC column with a larger stationary phase pore size 
in conjunction with stacking of guard columns reduced column fouling and 
downtime, it was believed that it may again be possible to attempt to 
reduce sample preparation requirements and revert back to analysis of 
broth samples which have not been extracted. In order to limit the potential 
of column fouling it was decided to dilute the fermentation broth samples 
prior to analysis. By diluting the fermentation broth, the amount of 
contaminating materials, or compounds capable of causing fouling, could 
be reduced. Dilution of samples would also provide a means of reducing 
the number of process steps required for analysis of each sample, 
therefore reducing the total processing times associated with sample 
analysis.
In order to determine if dilution was a viable means of assessing 
geldanamycin concentration in fermentation broth samples, it was decided 
to examine what effect dilution of fermentation broth in H2O had on the 
chromatographic results returned. Fermentation broth was diluted in H2 0, 
to give a range of samples and the linearity of dilution examined. This 
would indicate the robustness of the dilution process, and help determine 





Figure 4.11: The effect of serial dilution of fermentation broth in H20  on 
geldanamycin signal
From Figure 4.11 it can be seen that dilution of fermentation broth in H20  
returns a non-linear geldanamycin signal with respect to concentration. 
This result suggested that the soluble saturation levels of geldanamycin in 
H20  were low, and that in neat broth, the geldanamycin signal will be 
underestimated. This theory is corroborated by the fact that no technical 
data could be found for the solubility of geldanamycin in H20. Instead, 
solvents such as DMSO (dimethylsulphoxide) are more commonly 
employed. Also, InvivoGen (San Diego, C.A. USA) noted issues with 
aqueous solubility, identifying a derivative of geldanamycin, 17-DMAG (17- 
(Dimethylaminoethylamino)-17-demethoxygeldanamycin), as the first 
water soluble derivative. Further corroboration of the limited solubility of 
geldanamycin is gained from the work of Barril et a!., (2005) and Hwang et 
al, (2006). Both groups detail how one of its analogues, 17-AAG exhibits 
poor solubility.
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In order to address this issue, it was decided to attempt to increase the 
solubility of geldanamycin in the aqueous phase by addition of a polar 
solvent. Kandori et a!., (2002) found that addition of a polar solvent such 
as acetonitrile could bring about conformational changes in the target 
molecule which could lead to an increase in its adsorption, in their studies 
of adsorption behaviour of bovine serum albumin onto synthetic 
adsorbents. Grezegorczyk and Carta, (1996) also suggested that the 
solubility of compounds in aqueous solutions could be altered by the 
addition of solvents.
It was believed that by addition of acetonitrile to the sample, the issue of 
reduced solubility could be addressed, and may lead to an increase in the 
geldanamycin signal. In order to achieve this, samples were serially 
diluted in 50% H2O : 50% acetonitrile (v/v) and 100% acetonitrile. 
Acetonitrile was chosen as the diluent since it was the solvent component 
of the mobile phase and was miscible with the fermentation broth. The 
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Figure 4.12: Effect of diluent on geldanamycin signal
From Figure 4.12 it was found that addition of acetonitrile to fermentation 
broth samples increases the linearity of the dilution curve. It is also evident 
that addition of acetonitrile increases the magnitude of the geldanamycin 
signal and thus calculation of the concentration of geldanamycin in 
undiluted fermentation broth samples.
Examining the samples diluted in acetonitrile, it can be seen that when a 
sample, diluted 1 in 2 , and a sample, diluted 1 in 8 , are back calculated to 
give a result for an undiluted sample the results would be comparable. 
This indicates that the benefits of acetonitrile addition, to the determination 
of geldanamycin in fermentation broth samples, can be gained even at low 
levels of acetonitrile addition. This trend is confirmed by the fact that even 
dilution in 50% H2 0: 50% acetonitrile shows a linear dilution pattern and 
high geldanamycin signal.
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In the analysis of fermentation broth samples, the geldanamycin signal 
results were occasionally lower than would have been expected, or 
fluctuated between analyses. In order to attribute low signal results and 
poor reproducibility to poor solubility of geldanamycin in aqueous phases, 
it was decided to compare treatments of ‘stabilised’ versus ‘unstabilised’ 
samples. The general analysis of fermentation samples involved filtering of 
the sample prior to HPLC analysis in order to limit fouling. It was theorised 
that this could be a source of error. If the geldanamycin in broth samples 
was of low solubility, then potential existed for some of the poorly 
solublised geldanamycin to be to be retained by the filter. If this occurred it 
may be possible, by extension, that ‘removal’ of geldanamycin could also 
occur during sample preparation or analysis.
To establish if this was possible, a comparison of treatments was set up. 
The first sample was filtered (0.22 pm pore size nylon filters, PALL 
Scientific) and then diluted in acetonitrile prior to HPLC analysis. The filter 
paper was then washed in one sample volume of acetonitrile and the 
filtrate examined. The second sample was diluted in acetonitrile prior to 
filtration and analysed. Again the filter paper used was washed in one 
sample volume of acetonitrile and the filtrate analysed. Performing this 
analysis would determine if the geldanamycin was poorly soluble, if there 
was potential for it to be ‘lost’ during HPLC sample filtration and if 
acetonitrile could stabilise the geldanamycin in the sample so as to limit 
these negative effects on sample analysis and analytical reproducibility. 
Table 4.1 summaries the results.
Table 4.1: Comparison of the effect of dilution of acetonitrile pre and post 
filtration on the stability of geldanamycin signal
Sample Filter then Dilute % of Dilute then Filter % of
(Geldanamycin Total (Geldanamycin Total
Area Counts) Signal Area Counts) Signal
Broth 4694130 53.73 10993645 94.35
Filter Wash 4100790 46.27 658325 5.65
Total Signal 8794920 100 11651970 100
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From Table 4.1 it can be seen that the difference in the total geldanamycin 
signals returned from the two treatments indicates that even though the 
filter was washed, residual geldanamycin may be retained on the filter. 
The quantities retained on the filter used to filter the pre-diluted samples 
are low, thus any remaining geldanamycin would be even less. The results 
indicate that addition of acetonitrile increases the solubility of 
geldanamycin in aqueous broth samples. Those samples which are 
filtered prior to acetonitrile addition have considerable quantities of 
geldanamycin retained on the filter. This again indicates that poorly 
solublised geldanamycin may be removed through filtration and that 
addition of acetonitrile increases the level of geldanamycin solublisation in 
the fermentation broth samples and therefore benefits accurate sample 
analysis.
The work performed in this section involved determining if it was possible 
to reduce the potential of column fouling, increase the ease of sample 
treatment, and facilitate a high sample throughput, via dilution of 
fermentation broth samples. The results of this assessment indicate that it 
is possible to dilute fermentation broth samples for these purposes, 
however, it was noted that that the diluent employed could influence the 
results returned. During the assessment an issue regarding the solubility 
of geldanamycin in fermentation broth samples was encountered. It was 
believed that due to the potentially limited solubility of geldanamycin in 
aqueous systems, analysis of broth samples directly would require 
treatment, in the form of suitable dilution, in order to return accurate and 
reproducible results. It was therefore decided to examine the effect of 
different diluents on the chromatographic assessment of geldanamycin in 
fermentation broth samples.
It was decided to carry out assessments aimed at gaining a greater 
understanding of the implications of dilution of fermentation broth samples. 
By carrying out such an assessment, it was believed that the dilution 
process could be standardised, and could therefore be used for the 
analysis of all subsequent fermentation broth samples.
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Firstly, the impact of the diluent on the reproducibility of analysis of a 
sample was assessed. Obtaining reproducible results confers a degree of 
consistency and accuracy to the assessment of geldanamycin in 
fermentation broth samples. The assessment involved dilution of 
fermentation broth samples in 100% H20, 50% H20  : 50% acetonitrile and 
100% acetonitrile. These diluents were used because they were 
compatible with the mobile phase and had been involved in the previous 
assessment of the impact of fermentation broth dilution on analysis.
Each set of sample dilutions were run in triplicate, denoted Run 1, Run 2 
and Run 3 over a period of 45 hours. The samples were analysed in the 
order; 100% H20  diluted samples, 50% H20  : 50% acetonitrile diluted 
samples and 100% acetonitrile diluted samples. In order to determine the 
fluctuations in repeated analysis over time, the average geldanamycin 
area counts for each sample were calculated and the deviation from that 
for each sample determined. This process serves the combined purpose 
of assessing the reproducibility of analysis, in conjunction with determining 









Figure 4.13: Effect of diluent, dilution and sample Incubation time on 
reproducibility. A) 100% H20  B) 50% H20  : 50% Acetonltrile, C) 100% 
Acetonitrile. •  = Run 1 (1st injection of samples), o = Run 2 (2nd injection of 
samples) and ▼ = Run 3 (3rd injection of samples)
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From Figure 4.13 it can be seen that the diluent used to dilute 
fermentation broth can impact on the reproducibility of sample analysis. It 
is seen that those samples diluted in 1 0 0 % acetonitrile return the best 
signal stability over the 45 hour analysis period. Dilution in 100% H20  
returned considerable deviation in signal from the average signal result for 
the three sample injections.
The second assessment, of the impact of the diluent on analysis of 
geldanamycin in fermentation broth, was focused on determining how the 
diluent impacted on geldanamycin calculations. It was desirable for dilution 
of samples to be used to prepare all subsequent fermentation broth 
samples for HPLC analysis. From the initial assessment of dilution, it was 
noted that addition of solvent increased solubility of geldanamycin in 
samples and therefore returned higher results. It was therefore decided to 
examine this further and ultimately, establish which diluent should be used 
in future sample analysis protocols.
The assessment involved diluting samples in 100% H20, 50% H20  : 50% 
acetonitrile and 100% acetonitrile. These samples were analysed using 
HPLC and the geldanamycin signal determined. These results were then 
multiplied by the dilution factor, to return a result for geldanamycin 
concentration in an undiluted sample. The average of these results, for 
each diluent used, was calculated and the deviation of samples from the 
average was determined. This would give an indication of the effect of 
diluent on calculation of geldanamycin signal as well as providing an 
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Figure 4.14: Dilution linearity check and the effect of diluent utilised. A) 
100% H2O B) 50% H2O :50% Acetonitrile, C) 100% Acetonitrile, with error 
bars indicating the deviation from the average geldanamycin area count 
for each dilution
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It can be seen from Figure 4.14 that 100% acetonitrile and 50% H20  :50% 
acetonitrile return similar evaluations for geldanamycin in the fermentation 
broth. There is significant loss however in those samples diluted in 100% 
H20. When 100% acetonitrile and 50% H20  : 50% acetonitrile are used as 
diluents the deviation form the average is minimised compared to that 
returned when 100% H20  is used as a diluent
Combining the results of the assessment of the effect of diluent on 
analysis of geldanamycin in fermentation broth, it is clear to see that 
dilution in 1 0 0 % acetonitrile is the best means of diluting fermentation 
broth samples prior to analysis using HPLC. This diluent continually 
returns the highest signals for geldanamycin, and also the best analytical 
reproducibility and consistency. It was therefore decided that subsequent 
analysis of fermentation broth samples, for the determination of 
geldanamycin, would all be conducted through dilution of the samples in 
1 0 0 % acetonitrile.
4.3.3 Stability of geldanamycin during analysis
As outlined a number of times in this Chapter, the primary concerns, 
relating to development of a successful analytical process, were efficient 
and expedient analysis of fermentation broth samples and minimisation of 
analytical column damage. This chapter has described the processes 
undertaken to achieve these goals, and a point has been reached, 
whereby a suitable column and operating conditions, in conjunction with a 
suitable sample preparation method, have been identified, and can be 
successfully employed for the analysis of geldanamycin in fermentation 
broth.
There is however, another consideration remaining. The analysis of large 
sample numbers was now possible, however, it was important to establish 
if the time between sample preparation and sample analysis could impact 
on the results returned. It was frequently the case that analysis of a series
115
of samples would require preparation of all samples and their analysis, via 
HPLC, in a single batch. This could involve an analysis period of 20 hours, 
during which time, the samples would be maintained at room temperature. 
It was therefore decided to examine the stability of geldanamycin samples 
over time, and determine if the idle time between when a sample is 
prepared for analysis, and when it is actually analysed, could impact on 
the results returned.
The assessment involved periodic injection of a geldanamycin standard 
over a 20 hour period and again after 72 hours. The sample was 
maintained in the HPLC autosampling unit at a temperature of 
approximately 22°C (room temperature). The effect of incubation time on 
signal was determined and is displayed in Figure 4.15.
Time (h)
F i g u r e  4 .1 5 :  Effect of 2 2 °C  in cu b a t io n  on  g e ld a n a m y c in  s igna l
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From Figure 4.15 it is clear to see that there should be no detrimental 
effect to signal and sample analysis up to 2 0  hours after preparation for 
analysis. This is an important result since it indicates that analysis of 
samples, as soon as they are prepared, is not required. Samples injected 
after a 20 hour period do however, risk loss of geldanamycin signal. This 
was evident when a sample, injected 72 hours after preparation, returned 
a 30% loss in signal.
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4.4. Conclusion
The main aim of the work carried out in this chapter was the development 
of a suitable HPLC method to accurately assess geldanamycin in 
Streptomyces hygroscopicus fermentation broth samples. It was desirable 
to have a method which increased upon the qualitative, and broadly 
quantitative, attributes of the bioassay detailed in Chapter 3, and which 
could deal with an increased analysis sample load.
The basis for the HPLC method was derived from Agnew et al., (2001). 
Initially, filtered fermentation broth samples were injected without further 
pre-treatment, onto the HPLC column. This approach to geldanamycin 
analysis was found to be problematic. The two main problems 
encountered were that the presence of a variety of fermentation 
compounds in the broth samples resulted in fouling of the column. This 
occurred due to strong association of compounds with the stationary 
phase, and resulted in an increased need for column cleaning and 
ultimately, caused irreparable damage to the column. It was also noted 
that samples did not always return consistent results.
It was decided to address these issues by employing solvent extraction. 
Solvent extraction could be used to recover the antibiotic into the solvent 
phase and therefore reduce the contaminant loading of the samples and 
by extension, the potential for column fouling. The solvent employed was 
butanol. Although it was found that butanol could be used to efficiently 
extract geldanamycin, the analysis of butanol extracted sample was 
inaccurate, and poor sample resolution was frequently encountered. As a 
result, efforts had to be made to develop a method for its removal, and 
subsequent resuspension of the extract, in a more suitable solvent.
A number of methods were employed to remove the butanol. These 
included rotary vacuum evaporation, flash evaporation and low pressure 
evaporation. Of the methods examined, low pressure evaporation was 
found to be favourable, since it could not only be used to remove the 
butanol with minimal loss of product, but could also be used to treat a
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large number of samples in a single run. The samples would then be 
resuspended, prior to HPLC analysis, in 50% H20  : 50% acetonitrile, 
which was a suitable resuspension liquid since this was also the mobile 
phase applied in the HPLC process.
Although the above method could be successfully employed to reduce the 
potential for column fouling, the time taken to prepare samples was still a 
limitation with regard to high throughput of samples. In HPLC processes, 
analysis can be influenced by a number of factors. For example, sample 
throughput is influenced by sample runtime, which is dependent on the 
mobile phase flowrate, which is a function of the pressure in the system, 
which is dictated by the pore size of the HPLC stationary phase. As a 
result of these somewhat complex interactions, it was believed that 
increasing sample throughput may be achieved through increasing the 
pore size of the stationary phase of the HPLC column.
Fortunately, the column employed could also be supplied with a stationary 
phase pore size of 5 pm. The column was commissioned and it was found 
that there were no negative effects to sample analysis as a result of its 
application. Application of this column reduced the pressure in the system, 
and allowed a flowrate of 1 ml/min to be achieved. This reduced the 
runtime by more than half, and thus increased the sample throughput. An 
added advantage of using the new column was that, having a stationary 
phase with larger pore size, meant that material was less likely to clog the 
pores and therefore foul the column.
Since the new column would be more robust to column fouling, it was 
decided to re-examine, the analysis of broth samples without solvent 
extraction. As highlighted previously, the solvent extraction process was 
successful, but it still leads to sample preparation times in excess of 40 
minutes. Reverting back to analysing broth samples, with minimal pre­
treatment, would significantly reduce this time expenditure. Nonetheless, 
some pre-treatment was required. It was decided to dilute the samples 
prior to analysis, this step requires minimum of time input, but serves to 
reduce the risks of column fouling. The dilution of the samples was
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examined and it was found that dilution in water was not a successful 
means of attaining reproducible results.
Samples diluted in water did not return a linear dilution relationship, and 
further investigation indicated that geldanamycin had a limited solubility in 
aqueous systems. In order to accurately examine geldanamycin in 
fermentation broth samples, it was necessary to add solvent to the 
sample. An investigation of possible diluents took place, and it was found 
that diluting in acetonitrile helped to increase the detectable geldanamycin 
in fermentation broth samples and facilitated a more robust analysis. It 
was decided, from the results of these assessments, that all subsequent 
analysis of geldanamycin broth samples should be diluted prior to analysis 
in acetonitrile, to prevent poorly soluble geldanamycin from being omitted 
for the analysis and to facilitate a more accurate assessment.
The final examination of the HPLC analysis of geldanamycin took place 
with respect to the stability of the compound over an analytical period. It 
was commonplace, due to the generation of large numbers of samples, 
that a batch of samples for HPLC analysis would be required to run 
overnight, thus the samples would experience an ‘idle time’ between 
preparation and analysis of in excess of 12 hours. Examining the effect of 
room temperature storage (22°C) of geldanamycin, it was found that there 
was no significant loss in geldanamycin signal over an analysis period of 
20 hours. It was also found, that after this time, loss of signal may begin.
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Chapter 5. Applicability and characterisation of 
adsorbent resins for geldanamycin recovery from 
fermentation broth
5 .1 1ntroduction
The antibiotic geldanamycin is produced by Streptomyces hygroscopicus 
var. geldanus in submerged culture, and is excreted into the culture fluid. 
The recovery of geldanamycin therefore involves its isolation from a 
number of other compounds, including proteins and sugars, which are also 
present in the fermentation broth. In the previous Chapters, methods were 
developed to allow the determination of the presence of geldanamycin in 
fermentation broth and its quantification. As a result of developing these 
methods, it was possible to pursue the primary goals of the project. In this 
Chapter, the applicability of adsorbent resins, for use in a Solid Phase 
Extraction (SPE) method for removal of geldanamycin from fermentation 
broth, is addressed.
Solvents have traditionally been used to obtain primary separations in 
processes aimed at the recovery of antibiotics. Previously, butanol and 
chloroform have been shown to be suitable solvents for the recovery of 
geldanamycin from fermentation broths (DeBoer et al., 1970). There are 
however, a number of concerns when using solvents for antibiotic 
recoveries. Solvent-based liquid-liquid extractions can result in the 
generation of solvent waste and increase the expense of sample recovery 
and analysis. In solvent extractions, product-containing solvent may be 
partially miscible with the aqueous phase (Ghosh et al., 1997) forming an 
emulsion, which may result in the loss of product and difficulty in 
accurately determining product concentrations in samples.
Arias et al., (1979) found solvent and resin-based extractions were both 
applicable when examining the extraction of antibiotics produced by
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Myxcoccus coralloides. As a result, it was decided to examine the 
application of adsorbent resins for the recovery of geldanamycin from 
fermentation broths. Pyrzynska and Wierzbicki, (2005) believed that use of 
sorption procedures for pre-concentration or separation could be 
considered superior to liquid-liquid extraction due to their simplicity and 
ability to obtain high enrichment factors.
Adsorption chromatography is often used for the isolation and purification 
of fermentation products, and the correctly selected resin and optimal 
working conditions can lead to such excellent results that resin-based 
adsorption chromatography can be superior to any of the alternative 
methods presently available (Voser, 1982). Guzeltung and Ulgen, (2001) 
found incorporating a chromatographic technique, in the form of adsorbent 
resins, early in the sequence of purification steps lead to higher product 
recovery yields. Adsorbent resin use in bioprocessing is widespread and 
not confined to product recovery applications. They are also used to 
eliminate toxic effects on growth, reduce feedback repression of 
production (Lee et al., 2003) and ultimately extend fermentation time and 
increase product yield (Tolonen etal., 2004).
As a result of these factors, it was deemed that an examination and 
characterisation of the applicability of adsorbent resins for the removal of 
geldanamycin from fermentation broth could provide a novel means for the 
antibiotics’ recovery. It would also be beneficial to determine which resin, if 
any, warrant further examination and application in a SPE method for 
geldanamycin recovery.
123
5.2 Materials and Methods
5.2.1 Streptomyces hygroscopicus var. geldanus antibiotic 
fermentations
Chapter 3, section 3.2.2
5.2.2 Adsorbent Resins
Seven resins were utilised in this assessment, all chosen for their 
application in adsorption studies of antibiotics. Five Amberlite non-ionic 
polymeric adsorbent resins; XAD-4 and XAD-7 (examined by Cen and 
Tsao, (1993), for cyclohexamide recovery) XAD-16 (examined by Lee et 
al., (2003), to improve teicoplanin fermentations), XAD-1600 (examined by 
Xie et al., (2001) for the purification of cephalosporin precursors from 
fermentations) and XAD-1180 (examined by Ghosh et al., (1997) for the 
extraction and purification of cephalosporin antibiotics) supplied by Rohm 
and Haas Company (Philadelphia, PA, USA). There were also two ion 
exchange resins; Sepabeads SP-850 (examined by Adachi and Isobe,
(2004) for application in industrial separations) and Diaion HP-20 
(examined by Okada et al., (1998) for the isolation of antifungal antibiotics 
from culture broth) supplied by Mitsubishi (Mitsubishi Chemical Industries 
Ltd., Tokyo, Japan).
5.2.3 Geldanamycin analytical methods
In geldanamycin fermentations, the product may be excreted by the 
Streptomyces, into the fermentation broth, from which it must be 
recovered. To assess the applicability of adsorbents to recover 
geldanamycin solid-liquid extractions of the fermentation broth must be 
carried out. In order to assess the performance of the resin the 
geldanamycin present in two streams were routinely examined. These 
streams were a liquid stream, the fermentation broth, and a solid stream,
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the post-adsorption resin beads. The broth levels of geldanamycin were 
determined via the broth dilution method outlined in Chapter 3, using 
acetonitrile as the diluent and analysing samples via HPLC.
The geldanamycin adsorbed by the resins was determined by washing 
them once with one broth volume (the volume of broth which was 
contacted with the resins) of distilled water to remove loosely adsorbed 
compounds, but not to desorb geldanamycin. This was followed by one 
broth volume wash with acetonitrile, which was recycled twice more to 
facilitate desorption of geldanamycin. This was then analysed for 
geldanamycin concentration via HPLC.
5.2.4 Adsorbent Resin Preparation
Prior to their application for the recovery of geldanamycin from 
fermentation broths, each resin underwent a pre-treatment step. The 
resins were washed with water to remove compounds such as sodium 
chloride and sodium carbonate salts, which were used to retard bacterial 
growth during shipping. They were then rinsed and soaked in acetonitrile 
(a suitable resin regenerant) until required. Prior to application with the 
fermentation broth, the resins where rinsed, approximately five times, in 
ultra pure water.
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Table 5.1: Adsorbent resin properties
1 Porosity (ml/ml) data not available, instead the data provided is for the 
pore volume (ml/g). H Predominant mode of action of resins is hydrophobic 
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5.3 Experimental
5.3.1 Examination of the geidanamycin adsorption capabilities 
of adsorbent resins
5.3.1.1 Introduction
Frequently, the first step in developing an adsorption-based purification 
strategy is screening of adsorbents. Grezegorczyk and Carta, (1996) 
examined a range of adsorbents for application in the recovery of amino 
acids, and suggested that unlike other adsorbents such as activated 
carbon, the use of polymeric adsorbents allows a greater degree of control 
over the adsorption process, especially with reference to control of their 
chemistries and pore structures. The aim of this assessment was to 
determine the effect of variation of resin concentration on recovery of 
geidanamycin, and to gain an understanding of the adsorption efficiency, 
based on the decrease in geidanamycin remaining in the broth. This 
assessment was comparable to that performed by Gokmen and Serpen
(2 0 0 2 ), who examined the adsorption of dark coloured compounds from 
apple juice.
5.3.1.2 Materials and Methods
A batch contacting assessment was set up for 24 hours at 4°C in 25 ml 
plastic universals, agitated at 150 rpm. Various concentrations of resins [0 
(control), 2, 5, 10, 12.5 and 15 g/l] were added to filtered fermentation 
broth and the concentration of geidanamycin remaining in the broth was 
monitored via HPLC analysis. Figure 5.1. outlines the effect of resin 
concentration on recovery of geidanamycin from fermentation broth.
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5 .3 .1 .3  R e s u l t s
From Figure 5.1 it can be seen that Amberlite XAD-1600, XAD-16, XAD- 
1180 and Diaion HP-20 all showed good absorptive capabilities for 
geldanamycin from fermentation broth. When present at a concentration of 
10 g/l, the resins could adsorb in excess of 90% of geldanamycin present 
in the fermentation broth within 24 hours. Gokmen and Serpen (2002), 
noted that adsorption increased with increasing resin concentration and 
attributed this to an increase in the available adsorption sites. This is also 
true for the resins under examination, and indicates an equilibrium 
favouring adsorption onto the resins.
/  ....... O Diaion HP-20
/  -------▼------XAD-16
/  -------v -----  XAD-1180
, -------*  —  Sepbeads SP-850
♦  -------O------  XAD-7
-------♦ ------XAD-4
0 H---------- 1--------- 1----------1------------ r--------- 1---------- 1----------1---------- 1
0 2 4 6 8 10 12 14 16
Resin concentration (g/l)
Figure 5.1: Absorbent resin performance in fermentation broth containing 
47mg/l geldanamycin
Although Sepabeads SP-850, XAD-4 and XAD-7 showed an ability to 
adsorb geldanamycin, in this assessment, they did not display the same 
adsorptive performance or capabilities of the other resins under 
investigation. Examining seven different resins throughout the entire
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assessment was deemed to be excessive. Therefore, in order to reduce 
the examination overheads, it was decided to remove the resins XAD-4 
and XAD-7 from further examination at this point, and focus on the five 
remaining resins for the rest of the study. Although the performance of 
Sepabeads SP-850 was similar to that of XAD-7, Sepabeads SP-850 was 
not omitted from the study at this point because it was desirable to 
maintain more than one ion-exchange resin in the study.
5.3.2 Adsorption model fitting
5.3.2.1 Introduction
The use of adsorption isotherms is a favoured approach to investigate 
adsorption mechanisms (Ribeiro and Ribeiro, 2003). Isotherms can be 
used to describe how solutes interact with adsorbents and are important 
when examining the application of resins (Juang and Shiau, 1999). 
Muhammad et al., (1998) assessed adsorption of heavy metals and found 
that adsorption isotherms could be used to describe the equilibrium 
relationships between adsorbent and adsórbate, and that the two main 
types of adsorption isotherms are the Langmuir and Freundlich isotherms. 
Adsorption isotherms can provide information on the adsorption 
capabilities, capacities and affinities of adsorbents for the compound of 
interest, and may be used to determine the impact of chemical, physical or 
environmental conditions on adsorption (Dutta et al., 1999, Kyriakopoulos 
et al., 2005, Adachi and Isobe, 2004, Jung et al., 2001).
5.3.2.2 Materials and Methods
The geldanamycin adsorption isotherms for each resin were determined 
using similar methods as those described numerous times in literature 
(Veit et al., 2002, Adachi and Isobe, 2004, Güzeltung and Ülgen, 2001). 
Fermentation broth was serially diluted in Bennett’s medium, to produce a 
range of samples of varying geldanamycin concentration. 5 g/l of each
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resin was added to 10 mis of each dilution, in 25 ml plastic universals, and 
extracted. The extractions took place for 24 hours to allow equilibrium to 
be achieved. After contacting, the aqueous and solid phases were 
separated, via filtration, and recovered for geldanamycin analysis. The 
equilibrium concentration in the fluid ( C * a )  was determined via HPLC. The 
equilibrium loading concentration (C* as )  was determined by washing the 
resins with 1 0 mls of acetonitrile and recycling it twice to maximise 
desorption. This was then analysed for geldanamycin concentration via 
HPLC.
The constants for each model were calculated using the experimental 
data. Using these constants it was then possible to generate a data set of 
the theoretical equilibrium concentration in the fluid, and apply this to each 
model. This allowed the generation of Langmuir and Freundlich isotherms 
which were compared with the raw data isotherm to determine which 
model best fit the experimental data. The models applied in this 
examination are based on those described in Doran, (1995).
The Langmuir isotherm model was expressed as:
C*as = Cas”,KaC/  (Eq. 5.1)
1+ KAC A
where: C* as is the equilibrium loading concentration (g/g), C*a is the 
equilibrium concentration in the fluid (g/l), CASm is the maximum loading 
concentration (g/g) and K A is an adsorption or equilibrium constant (l/g), 
experimentally determined and indicates the affinity of the binding sites for 
the compound of interest.
C* 1A plot of C* a versus ■ / will yield a straight line with slope = ------ and
C AS CASm
intercept = — -—c* i<r^ASm A
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The theories of the model are based on three principles:
1) The adsorbed molecules form a monolayer on the adsorbent surface
2) Each site for adsorption is equivalent in terms of adsorption energy
3) There are no interactions between adjacent adsorbed molecules
The Freundlich isotherm model was expressed as:
C*M = K FC*Al"  (Eq. 5.2)
where: K F is an experimentally determined equilibrium constant which 
increases with total adsorption capacity of the adsorbent to adsorb the 
compound of interest, i.e. an indicator of adsorption capacity and n is an 
experimentally determined, dimensionless constant which is an indication 
of the efficiency and energy of adsorption and which may vary along the 
adsorption process, i.e. an empirical constant related to the adsorption 
driving the value of n . If adsorption is favourable n is > 1; if adsorption is 
not favourable, n < 1 .
The equation is linearised to give a slope of — and intercept of Log(KF).
n
5.3.2.2 Results
Having fitted both the Langmuir and Freundlich adsorption models to the 
experimental data and having examined the regression co-efficients, it 
was found that the Langmuir model proved to be the most accurate fit 
(Figure 5.2 gives an example of the results for one of the resins examined, 
XAD-1600). It was found that all resins had a good affinity for 
geldanamycin with XAD-1600 displaying the largest maximum loading 
capacity according to the Langmuir model (Table 5.2). Ribeiro and Ribeiro,
(2003), also examined the fit of the Freundlich and Langmuir models to 
experimental data and found that both adsorption models returned a good 
fit to the experimental data in the examination of XAD-7 and IRA-410 
resin-mediated adsorption of erythromycin. Ramos et al., (2004), detailed
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phenomena in their examination of cephalosporin-C (CPC) adsorption 
onto Amberlite XAD-16 whereby, up to a concentration of 1 g/l CPC, the 
Langmuir model best fit the data, however above this concentration the 
Freundlich isotherm was the better fit. This indicates that the adsorption 
mechanisms at work are often complex and experimental examination is 
important when assessing the performance of a particular resin.
Table 5.2: Summary of the maximum loading concentration, CASm, using













The maximum loading concentrations derived from fitting the Langmuir 
model to the experimental data are comparable to the results of the 
assessment of the adsorption capabilities. In that assessment it was found 
that a favourable equilibrium existed for adsorption of geldanamycin onto 
adsorbent resins from fermentation broth which contained 47 mg/l of 
geldanamycin.
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Figure 5.2: Adsorption model fitting to the experimental geldanamycin 
adsorption data for XAD-1600
It was also found during the assessment of the adsorption models, that 
dilution of the fermentation samples in Bennett’s medium returned 
experimental results which possessed a higher regression co-efficient for 
the adsorption models, than if H2 O was used as the diluent. It was 
believed that this occurred because by diluting in Bennett’s medium, a 
level of contaminants was maintained in the adsorption system, i.e., only 
the geldanamycin concentration was diluted. Dilution in H2O however, 
serves to dilute all compounds present in the broth, contaminants and 
geldanamycin, and therefore does not maintain an environment of 
competition which would exist in normal fermentation broths.
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5.3.3 Specificity assessment of geldanamycin adsorption by 
adsorbent resins
5.3.3.1 Introduction
The aim of this study was to assess the application of adsorbent resins for 
the recovery of geldanamycin from fermentation broth, however it was also 
important, to examine to what extent other compounds were adsorbed. 
Traditionally solvent extraction and adsorption have been of low selectivity 
(Payne et al., 1989). As with Xie et al., (2001), using crude fermentation 
broth posed a number of problems, primarily that there are several 
contaminant compounds present in the broth which can be adsorbed by 
the resins, as well as the compound of interest. The adsorption of 
contaminants may reduce the adsorptive abilities of a resin and thus limit 
performance in crude samples.
Also, as with most extraction systems, the ultimate goal is to increase the 
purity of the recovered compound of interest. The selectivity of adsorption 
may be limited by the non-specific nature of adsorptive interactions (Payne 
etal., 1989), and as a result, any impurities adsorbed have the potential to 
be desorbed and can contaminate the product stream. Chaubal et al., 
(1995) and Dutta and Dutta, (2006) both suggested that there is a limited 
knowledge of how solutes bind to sorbents, and that greater empirical 
knowledge is required inorder to reduce the non-specific adsorption (i.e. 
fouling) by components of the complex fermentation broth. It was therefore 
decided to assess the specificity of the resins for adsorption of 
geldanamycin, and determine if any resin out-performed the others.
5.3.3.2 Materials and Methods
The specificity of the resins for geldanamycin over contaminating 
compounds, was based on the determination of the ratio of geldanamycin 
adsorption to adsorption of contaminating material. The analysis utilised
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HPLC to determine the ratio of compounds present in fermentation broths 
pre and post adsorption. Batch adsorptions were set up whereby 10 g/l of 
the resins were added to 100 ml of fermentation broth in 250 ml 
Erlenmeyer flasks and incubated at 150 rpm and 4°C. The experiment ran 
for 24 hours and samples were taken periodically.
The relative selectivity of the resins for geldanamycin was assessed by 
determining the ratio of adsorption of geldanamycin to contaminants. 
Contaminants were those compounds other than geldanamycin, and the 
adsorption was based the area counts retuned from the HPLC 
chromatograms. The assessment was based on the following equation:
R =
f Gc-G „'
\  Gç J
( Cc - C ^
Cc
(Eq. 5.3)
Where: Gc is the amount of geldanamycin in the broth sample before 
adsorption, GB the amount of geldanamycin in the broth sample after 
adsorption. Cc is the amount of contaminants in the broth sample before 
adsorption and CB the amount of contaminants in the broth sample after 
adsorption. The results are displayed in Figure 5.3. When R > 1, 
geldanamycin is preferentially adsorbed over contaminants, when R < 1 
contaminant adsorption is favoured.
5.3.3.3 Results
In the assessment of the adsorption specificity, it can be seen that 
selectivity increased until approximately five hours. After this time period, 
selectivity of adsorption was maintained at a relatively constant level.
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Figure 5.3: Adsorption selectivities - A ratio of adsorption of geldanamycin 
to contaminating compounds
All adsorbents showed preferential adsorption geldanamycin, in each case 
adsorbing a greater proportion of the geldanamycin present in the broth 
than contaminants. It is important to note that these resins had undergone 
no modification to increase their selectivity for geldanamycin, and such 
techniques may prove valuable in further recovery processes.
5.3.4 Impact of environmental conditions on adsorption
The adsorption of compounds from solutions is a complex and relatively 
poorly understood process. Robberson et al., (2006) suggested that the 
adsorption of compounds could be achieved by a number of phenomena,
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including electrostatic attraction between the solute and sorbent or 
hydrophobic repulsion of the solute from the aqueous carrier to the 
sorbent. These phenomena are most frequently effected by alteration in 
the environmental conditions of the adsorption system and among the 
most commonly examined environmental influencing factors are 
temperature and pH (Aksu, 2001, Otero et al., 2004, Netpradit etai, 2004, 
Rodda et al., 1993).
Temperature, for example, is an important parameter which can influence 
the equilbria and kinetic rates of sorption process (ten Hulscher and 
Cornelissen, 1996). Srivastava et al., (2006) suggested that pH can effect 
the adsorptive process through disassociation of functional groups on the 
adsorbents surface active sites, which can impact on kinetic and 
equilibrium characteristics. As a result, it was decided to examine how 
temperature and pH affect the adsorption process. It was also decided to 
examine the impact of modifying the pre-adsorption broth polarity, since 
incorporation of a polar solvent into adsorption systems had been shown 
to impact on such processes (Hodgkinson and Lowry, 1981, Eltekova et 
al., 2 0 0 0 ).
5.3.4.1 Effect of temperature on adsorption
5.3.4.1.1 Introduction
Barboza et al., (2003) described, in their assessment of the recovery of 
clavulanic acid, that temperature sensitivities were exhibited in their 
processes and thus decided to assess the impact of temperature on the 
kinetics of adsorption. It has been reported that adsorption efficiencies and 
rates can be affected by altering the adsorption temperature. Gokmen and 
Serpen, (2002) showed that increasing the adsorption temperature 
resulted in increased maximum adsorption capacity of the resins. In fixed 
bed studies of the adsorption of phenol and salicylic acid by XAD-16 and 
Duolite S-861, Otero et al., (2005) found that an increase in adsorption
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resulted from and decrease in temperature, and Kyriakopoulos et al.,
(2005) showed that increasing the temperature resulted in a decrease in 
adsorption of trifluralin and protmetryn byXAD-4 and XAD-7.
This indicates that the impact of temperature on adsorptive performance 
may be complex and warrant empirical assessment. As result, it was 
decided to examine the effect temperature had on adsorption of 
geldanamycin from fermentation broth, and determine if there was any 
benefit in performing adsorptive processes at higher temperatures.
5.3.4.1.2 Materials and Methods
The assessment included an examination of how different temperatures 
affected adsorption and stability of geldanamycin. Four different 
temperatures were assessed; 4°C, 22°C, 28°C and 37°C. A 10 ml working 
volume of fermentation broth in 25 ml plastic universals was used, with a 
resin concentration of 1 0  g/l and agitated at 150 rpm.
5.3.4.1.3 Results
Figure 5.4 shows the effect of temperature on adsorption by two of the 
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Figure 5.4: Effect of temperature on the adsorption of geldanamycin. A) 
XAD-1600 B) Sepabeads SP-850
Examining Figure 5.4 it was found that the rate of adsorption is most rapid 
over an initial one hour period, at which point there is a gradual decrease. 
Dutta et al., (1999), observed similar phenomena in their examination of 
beta-lactam adsorption and suggested that the fast initial adsorption may
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be correlated with adsorption in the easily accessible mesopore of the 
particle and the slow step to adsorption in the micropore of the 
microsphere typical of the resin used.
The fast initial binding and capacity displayed in Figure 5.4 concurs with 
the findings of the assessment of the adsorption model, whereby these 
resins showed a high affinity for geldanamycin adsorption according to 
Langmuir kinetics. In general, it was found that adsorptive performance 
varied over the 1 2  hour assessment period, however, by the completion of 
the assessment, adsorptive performance was found to be relatively 
independent of temperature. XAD-1600 and Diaion HP-20 were found to 
be the optimally performing resins, routinely adsorbing 95% of product, at 
all temperatures, and adsorbing comparable amounts of contaminants
5.3.4.2 Effect of pH alteration on adsorption
5.3.4.2.1 Introduction
In adsorption studies, the pH of the adsorption environment has been 
frequently found to impact on the success of the adsorption. The pH can 
influence the adsorption of compounds by altering charge which may 
impact on adsorption or even result in altering solubility (Grezegorczyk 
and Carta, 1996, Chaubal et al., 1995). Young and Kuen-Chyr, (2000) 
found that removal of phenols by XAD-4 varied significantly with variation 
in the target solution pH. Goyne et al., (2005) showed that adsorption of 
the antibiotic ofloxacin onto different forms of the mineral Si0 2  varied with 
pH, and did so most dramatically around the pKa2 of the antibiotic. It was 
therefore decided to investigate if alteration of the fermentation broth pH 
prior to adsorption affected the recovery of geldanamycin.
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5 . 3 . 4 . 2 . 2  M a t e r i a l s  a n d  M e t h o d s
Assessment of the effect of pH on adsorption was carried out at 4°C and 
took place in 25 ml universals with a 10 ml working volume and a resin 
concentration of 10 g/l, agitated at 150 rpm for a period of 24 hours. The 
pH of the unaltered fermentation broth was 7.7 and was altered to 6.7 and 
5.7 using 0.5 Molar HCL and 8.7 and 9.7 using 0.5 Molar NaOH.
5.3.4.2.3 Results
The pH of geldanamycin fermentation broth normally ranges between pH
6.5 to pH 8.0. It was noted that altering the pH to 9.7 resulted in a very 
significant colour change, the broth assuming a purple colouration and 
resulted in a degradation of approximately 40% of the geldanamycin 
present in control broth (pH 7.7).
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Figure 5.5: Effect of pre-adsorption pH adjustment of fermentation broth 
on the adsorption of contaminants over 24 hours
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The assessment of resin performance was based on the percentage of 
geldanamycin present in pH-adjusted broth which was adsorbed. On this 
basis it was found that there was no significant increase in performance as 
a result of adjusting the pH of the broth prior to adsorption. There was 
some slight variation in the adsorptive performances of the resins, but in 
general the affect of pH alteration was minimal. Similarly, Silva et a!.,
(2004) found that monilate adsorption onto XAD-4 was independent of the 
solution pH over the range examined, in their remediation studies.
Examining the effect of pH alteration on the adsorption of contaminants 
however (Figure 5.5), showed that pH adjustment can affect the amount of 
contaminants adsorbed by each resin. Perhaps the most significant finding 
is that, except for XAD-16, at pH 7.7 (the control broth pH) adsorption of 
contaminants was at its minimum.
5.3.4.3 Effect of solvent addition on adsorption
5.3.4.3.1 Introduction
In Chapter 4 the importance of acetonitrile as an agent for the accurate 
analysis and quantification of geldanamycin in solution was highlighted. 
Hodgkinson and Lowry, (1981) found that incorporation of acetonitrile, 
which acted as a depolarising agent, aided the purification of human 
prolactin in their adsorption chromatography studies. Eltekova et al., 
(2 0 0 0 ) believed that acetonitrile molecules could effectively screen the 
active adsorption sites on the surface of carbon sorbents and cause a 
decrease in the adsorption of the solutes in their studies of adsorption of 
organic compounds on porous carbon sorbents.
As a result it was decided to examine the impact of modifying the 
adsorption environment using acetonitrile. Acetonitrile is miscible with
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fermentation broth, is the preferred desorption solvent and is a constituent 
of the mobile phase used in the HPLC analysis of samples.
5.3.4.3.2 Materials and Methods
A working volume of 5 ml in 25 ml plastic universals and a resin 
concentration of 10 g/l was used. A range of samples were generated by 
increasing the percentage of acetonitrile added to fermentation broth from 
0% to 40%. The overall adsorptive performance of the resins was 
assessed based on the percentage of geldanamycin adsorbed from 
comparable controls. The samples were incubated at 4°C for 24 hours and 
agitated at 150 rpm.
5.3.4.3.3 Results
From Figure 5.6 it can be seen that addition of acetonitrile at higher 
concentrations had a detrimental impact on the adsorption of 
geldanamycin. It was found that Sepabeads SP-850 showed the least loss 
of adsorptive performance in the presence of acetonitrile. At higher 
concentrations addition of acetonitrile essentially limited the uptake of 
geldanamycin from the liquid phase by the resins.
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Acetoni t r i l e  concen t r a t i on  (% )
Aceton i t r i l e  concen t r a t i on  (% )
Figure 5.6: Effect of acetonitrile addition on A): geldanamycin adsorption 
and B): contaminating material adsorption
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Assessing the effect of acetonitrile on the adsorption of contaminants 
showed that, similarly to geldanamycin adsorption, increasing the 
concentration of acetonitrile reduced the adsorption of contaminants. The 
effect however was markedly more pronounced, resulting in a large drop 
in contaminant adsorption even at low concentrations of acetonitrile. 
Kandori et a!., (2002) suggested a reason for this. They found that 
incorporation of acetonitrile into an adsorption system could affect the 
structure of certain molecules therefore impacting on adsorption, in their 
studies of the adsorption of bovine serum albumin. It can thus be 
understood why a reduction in the adsorption of, for example, protein 
molecules, could be brought about via conformational alterations, as a 
result of acetonitrile addition.
From a combination of the results, it is apparent that by using low 
concentrations of acetonitrile it may be possible to optimise the adsorption 
process to reduce the adsorption of contaminants while maintaining a high 
level of geldanamycin adsorption. If one considers Diaion HP-20. It can be 
seen that with the addition of 20% (v/v) of acetonitrile, approximately 90% 
of the geldanamycin could be adsorbed. At the same time, less than 10% 
of contaminating material is adsorbed. This indicates great potential to 
preferentially adsorb the compound of interest, over contaminants, and 
thus facilitate the production of a purer product stream.
5.3.5 Product recovery assessment
5.3.5.1 Introduction
Up until this point, the examinations performed were aimed at determining 
if adsorbent resins could be used for the recovery of geldanamycin from 
fermentation broth. In such assessments it is important to consider not 
only the adsorption of the product of interest from the broth, but also its 
recovery from the resins into a suitable liquid phase ready for analysis and 
or further treatment. Therefore, in order to complete the assessment of the
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applicability of adsorbent resins for the recovery of geldanamycin it was 
decided to examine the desorption of compounds from the resins, and 
determine if there was any benefit of using resins to generate a product 
stream of greater purity than the original fermentation broth. In this way it 
would be possible to determine, not only if the compound of interest could 
be removed from the broth by resins, but also to what extent 
geldanamycin and contaminant compounds were desorbed.
5.3.5.2 Materials and methods
Five resins were examined; 10 ml of fermentation broth was contacted 
with 10 g/l of resin for 20 hours at 4°C and agitated at 150 rpm in 25 ml 
plastic universals. The post-adsorption broth was separated from the 
resins via filtration and the two streams examined for geldanamycin 
concentration. The recovered resins were desorbed using three 10 ml 
volumes of acetonitrile, and the purity determined via HPLC analysis.
5.3.5.3 Results
It was found that 10 g/l of resin adsorbed in excess of 97% of all 
geldanamycin present in the broth. Desorption from the resins showed 
some interesting results. It was found that all resins allowed desorption of 
considerable quantities of the adsorbed geldanamycin. Of particular note 
however, was the desorption of contaminating compounds. Table 5.3 
details the desorption of contaminants which were present in the control.
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XAD-16 98.47 72.40 97.39 27.49
XAD-1600 99.10 96.67 98.32 22.31
XAD-1180 98.69 75.97 96.36 18.24
Sepabeads
SP-850
97.69 89.53 96.35 25.58
Diaion HP- 
20
98.03 95.61 96.83 24.63
From Table 5.3 it can be seen that less than 30% of the adsorbed 
contaminants were returned in the washes. Thus the recovered stream, 
while containing in excess of 70% of adsorbed geldanamycin, is devoid of 
in excess of 70% of the adsorbed contaminants. This has obvious benefits 
for the pursuit of a purer product stream. Again it was found that XAD- 
1600 and Diaion HP-20 were the best performing resins. These were 
among the resins which adsorbed most geldanamycin, but also allowed 
the most desorption of geldanamycin, whilst retaining among the most 
contaminating compounds.
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5.4 Discussion and Conclusion
Adsorbent resins are chromatographic solids which are finding increased 
application for the recovery and purification of a range of bioproducts. As a 
result of this, it was decided to examine their application for the recovery 
of geldanamycin from fermentation broth. Establishing the applicability of 
these resins would highlight if a solid phase extraction process would be 
viable for the recovery of geldanamycin from fermentation broth. A series 
of examinations were performed, the culmination of which, indicated that 
adsorbent resins were capable of geldanamycin recovery and purification.
In such solid-liquid adsorption process, the separation of compounds from 
one phase onto another, depends somewhat on the equilibrium 
relationships between the two phases. Adsorption continues to take place 
until the distribution of the compounds remains constant. This ‘transport’ of 
compounds occurs as a result of the adsorbent having a higher affinity for 
the adsórbate than that of the fermentation fluid. It is therefore important to 
note that when assessing the performance of the resins, the results 
returned are indicative of how favourable is the adsorption of 
geldanamycin, from the broth, onto the resins. Establishing this is 
important for the purposes of antibiotic adsorption, since the fermentation 
broths generated in antibiotic fermentations often varies form batch to 
batch. The concentration of the antibiotic present in the broth may 
increase or decrease between batches and therefore impact on the 
amounts of antibiotic which can be adsorbed by a set concentration of 
resins. Examining the adsorptive performance of the resins, it was found 
that all resins displayed an ability to adsorb geldanamycin. It was found 
that 1 0  g/l of resins was sufficient for recovery of geldanamycin from a 
fermentation broth at a geldanamycin concentration of 47 mg/l, for the 
adsorbent resins XAD-16, XAD-1600, XAD-1180 and Diaion HP-20.
It is commonplace when assessing the applicability of adsorbents, to 
assess the relevance of adsorption models. An adsorption isotherm 
describes the relationship between the liquid phase and solid phase 
concentration of a solute. For the assessment of the applicability of
adsorbent resins, for the recovery of a particular antibiotic, an adsorption 
isotherm can be used to provide insight into adsorptive performance of the 
adsorbent under examination, including the affinity of the adsorbent for the 
antibiotic and its capacity to adsorb it. Two frequently applied adsorption 
models are the Langmuir and Freundlich models. It was found that both 
models could be applied to assess the performance of the resins, however 
the Langmuir model was generally the best fit. According to the Langmuir 
model, XAD-1600 and Diaion HP-20 possessed the greatest maximum 
loading capacity for geldanamycin.
The five resins examined in most detail all showed applicability for 
geldanamycin recovery. During the evaluation of the performance of these 
resins phenomena such as a fast initial adsorption followed by a slower 
adsorption period were observed. It is possible that such adsorption 
anomalies can be attributed to the physical form of the resins (pore size, 
volume and number) and the interactions between adsorbent and 
adsorbed compounds. Thus it becomes clear, that the general behaviour 
of the resins cannot be determined solely from their measurable physical 
properties (Voser, 1982) and therefore, experimental assessments are 
vital, in order to select the optimal resin for a particular application.
Having established that the adsorbent resins had capacity to adsorb 
geldanamycin from fermentation broths, it was decided to examine to what 
extent other compounds present in the fermentation broth were adsorbed. 
The success of an adsorption process can be considered to be related to 
the capacity and affinity of an adsorbent for the compound of interest. It 
was found that all resins showed some preference for the adsorption of 
geldanamycin over contaminants present in the fermentation broth. It was 
interesting to find that, in general, the selectivity of the adsorption process 
increased with contacting time. Reduction in the adsorption of 
contaminants is beneficial as it reduces the contaminants present for 
desorption, and may facilitate the recovery of a purer product stream.
It has been established that adsorbent resins could successfully recover 
geldanamycin from fermentation broth, and a number of resin had
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displayed strong capacities and affinities for geldanamycin. In the 
assessment of adsorption or extraction processes, it is routine to examine 
the effect modification of the adsorption environment has on the recovery 
system. Two of the most commonly altered environmental parameters are 
temperature and pH.
Altering the temperature at which an adsorption is carried out can affect 
the rate of adsorption of the compound of interest. It was decided to 
examine the adsorption of geldanamycin at various temperatures and 
determine the impact on adsorption, and stability, of geldanamycin. It was 
found that the rate of adsorption was most rapid over an initial one hour 
period. At higher temperatures, adsorption of geldanamycin was more 
rapid and equilibrium would be established earlier. At higher temperatures, 
however, it was found that geldanamycin was less stable. Geldanamycin 
is a thermolabile compound, thus incubation of samples at increased 
temperatures leads to degradation. Adsorption at 22°C resulted in a rapid 
adsorption with minimal geldanamycin loss or degradation.
Biocompounds frequently exhibit sensitivities in environments outside their 
optimal pH ranges. Altering pH can therefore increase compound stability, 
but it has also been seen to influence adsorption of specific compounds. 
Assessing the impact of pH alteration, on adsorption of geldanamycin from 
fermentation broth, it was found that there was no significant impact on 
adsorption. It was noted however that at pH values of the order of pH 9.5, 
the stability of geldanamycin, and hence the level of recovery, would be 
reduced. It was also found that, for most resins, the adsorption of 
contaminants was lowest at pH 7.5, the pH of the unaltered fermentation 
broth.
In Chapter 4 it was found that addition of acetonitrile increased the liquid- 
phase solubility of geldanamycin in fermentation broth samples, and 
allowed a more accurate analysis of samples using HPLC. In literature it 
had also been found that incorporation of acetonitrile into the adsorption 
environment could impact on the adsorption of compounds, of particular 
note, was how inclusion of acetonitrile could interact with the adsorbent or
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compounds in the fermentation system, and alter the adsorptive 
performance.
Examining the addition of acetonitrile into the pre-adsorption fermentation 
broth, it was found that, at higher concentrations, addition of acetonitrile 
reduced the adsorption of geldanamycin. When the effect of acetonitrile 
addition on adsorption of contaminants was examined, a very interesting 
finding was made. As the concentration of acetonitrile increased, the 
adsorption of contaminants decreased. This decrease occurred at a more 
substantial rate than the adsorption of geldanamycin. This result 
suggested that it would be possible to engineer an optimised adsorption 
system. The results indicated that at a low addition of acetonitrile, 
contaminant adsorption could be reduced, without a loss in adsorption of 
the compound of interest. This finding was of particular note for Diaion HP- 
20. Examining the effect of acetonitrile addition on adsorption of 
compounds by Diaion HP-20 it was found that as acetonitrile concentration 
increased, up to values of 2 0 %, no major decline in geldanamycin 
adsorption, was observed, however significantly less contaminants were 
adsorbed. As a result of this finding, it would be desirable to examine this 
further, and assess acetonitrile addition, over smaller addition ranges, to 
determine the optimal system which would promote a more specific 
adsorption of geldanamycin than when no acetonitrile is added to the 
fermentation broth.
Since it is not only desirable to adsorb maximal amounts of geldanamycin 
from fermentation broth, but also, to subsequently recover the product, it 
was decided to assess the desorption of compounds from the resins. The 
assessment of the desorption of compounds showed that XAD-1600 and 
Diaion HP-20 allowed desorption of the greatest amount geldanamycin. It 
was also found that using acetonitrile to desorb compounds from the 
adsorbent resins resulted in desorption of between 72 and 96% of the 
geldanamycin and between 18 and 27% of the contaminants present in 
the pre-adsorption fermentation broth, for the different resins assessed. 
The levels of contaminant desorption are important because selectively
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desorbing the compound of interest, while retaining contaminants on the 
resins, allows the production of a product stream of higher purity.
The benefits, with respect to product stream purity, come at the cost of 
resin reusability. In order to prepare the resins for reuse the strongly 
retained compounds must be removed using harsher methods such as 
acid and base washes. It would be desirable to further assess this issue of 
reusability. One of the benefits of using adsorbent resins over solvents in 
extraction processes is a reduction in costs. For an optimised process, it 
would be advantageous to effectively regenerate the adsorbents, and 
apply them in repeated extractions, without loss in adsorptive 
performance.
Examining the application of these adsorbent resins for the recovery and 
purification of geldanamycin from fermentation broth, it can be seen that 
there is considerable potential to optimise the process. The investigations 
undertaken in this Chapter were focused on a preliminary examination of 
resin application, however the results indicate that there are a number of 
facets, of the application of these resins, which could be optimised for 
geldanamycin recovery. Assessing the modification of adsorption in 
conjunction with the desorption profile of the resins, it would theoretically 
be possible to generate a geldanamycin product stream approximately 25- 
fold purer than the initial fermentation broth. This is a very significant 
result, however it would be necessary to verify this theory by performing 
sequential optimised adsorption and desorption processes, on a 
fermentation broth sample.
The resins employed in this study were not specifically developed for 
geldanamycin adsorption, nor modified to increase their selectively for 
geldanamycin. Modification of resins to make them more selective for a 
target compound is a viable means to improve the adsorption process. 
Pyrzynska and Wierzbicki, (2005) detailed the functionalisation of 
Amberlite resins with porphyrin ligands for application in vanadium species 
recoveries and found that a greater affinity for the loaded sorbent could be 
gained. Other modifications can also be made to adsorbents to confer
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increased capacities or to address some other processing concerns. Jung 
et al., (2 0 0 1 ) examined modification of commercially available adsorbents. 
They modified Amberlite XAD-2 ad XAD-4 through the introduction of a 
porphyrin molecule and found it resulted in an increased capacity for 
phenol adsorption. Wang and Sobnosky, (1985) showed, that by modifying 
the adsorbents physically, via incorporation into a hydrogel matrix, it was 
possible to increase selectivity for compound of interest, to increase the 
stability and structure strength of the adsorbents, and facilitate application 
in environments of shear.
There is great potential for the use of adsorbent resins for the recovery of 
geldanamycin from fermentation broth. The advantages of such an 
extraction process are a reduction in solvent consumption, less product 
loss and a more controllable and standardised extraction process, and it 
would be desirable compare the entire pros and cons of solid-liquid 
mediated recovery of geldanamycin versus those of liquid-liquid mediated 
geldanamycin recovery. Although each resin assessed is capable of 
application in a solid phase extraction method for geldanamycin recovery, 
the two most suitable resins for further application would be XAD-1600 
and Diaion HP-20. Prior to commencing this study, it was predicted that 
the hydrophobic interaction-based resins may perform best, since 
geldanamycin displays a hydrophobic nature. However, the culmination of 
the results of all assessments performed showed that the adsorption of 
compounds from their production environments is a complex procedure. 
Even though XAD-1600 and Diaion HP-20 exhibit two different modes of 
action, both have been found to be suitable adsorbent resins for further 
examination. This result could be rationalised based on the fact that the 
mode of action of adsorbents is usually complex an poorly understood, 
and also geldanamycin is an amphiphilic compound, thus displays a 
complex chemical nature.
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Chapter 6. I n - S i t u  Product Recovery of 
Geldanamycin
6 .1 1ntroduction
Recovery of the compound of interest is a key consideration for the 
successful bioprocess. In bioprocessing operations, the yield of the 
compound of interest can be affected by exposure to detrimental 
conditions and processes during production, but can also be affected by 
the presence of the product in the production environment. The problems 
encountered are somewhat product specific, but commonly include end 
product inhibition, feedback repression and degradation. The direct or 
rapid removal of the product when it is formed, limits the potential for these 
phenomena to occur, and as a result integrated bioprocessing strategies, 
such as In-Situ Product Recovery (ISPR), have been developed to 
address such issues.
ISPR methodologies may be expected to improve productivity and yield 
via three effects: (a) minimisation of product inhibition: (b) minimisation of 
product loss due to cross-interaction with the producing cell (degradation, 
further modification) or uncontrolled loss (e.g. by evaporation); and (c) 
reduction of the number of subsequent downstream processing steps 
(Mattiasson and Holst, 1991, Freeman et al., 1993). For this reason, ISPR 
techniques find application for the recovery of an array of products 
including flavour and fragrance compounds (Bluemke and Schrade, 2001) 
and even application in bio-catalytic reactions (Ahmed et al., 2001).
If the production of the compound of interest is regulated by its own 
presence, increasing product yields will be problematic, since this feed­
back regulation will reduce or cease metabolic processes towards 
production. If the organism can further metabolise the product of interest 
into new metabolites, its continued presence in the fermentation
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environment may lead to its consumption by the producing organism. It is 
clear from such phenomena that the production, and therefore recovery, of 
the product of interest must be tightly monitored to prevent reduction in 
product yields. If the compound of interest is susceptible to environmental 
conditions such as temperature, pH or oxygen, its exposure to the 
production environment may result in reduced product yields. If the 
product is toxic to the producing organism, it may inhibit its own 
production. These events are commonly seen in antibiotic fermentations 
and the importance of application of ISPR techniques are highlighted by 
the belief that productivity of fermentations could be increased if product 
separation took place directly in the fermenter or in an external loop (van 
Erkel et a!., 2004).
It may be the case that a single methodology may not be the only method 
by which the compound can be recovered in such processes. The work of 
Choi et al., (2001) focused on the integrated bioprocessing of plant cell 
cultures and they suggested that there are a number of ISPR techniques 
which can be employed for a particular application. Their findings also 
serve to stress that no single methodology is universally applicable.
With that in mind, it was decided to examine the ISPR of geldanamycin. 
Geldanamycin can be recovered from fermentation broth through solvent- 
mediated liquid-liquid extraction, however, in Chapter 5, the applicability of 
adsorbent resins for the recovery of geldanamycin form fermentation broth 
was assessed. It was found, in a downstream processing context, that 
these resins were suitable for the recovery of geldanamycin from 
fermentation broth, and it was therefore decided to examine their 
application in an ISPR context. It was desirable to determine if application 
of these resins in an ISPR process could facilitate direct removal of the 
product during fermentation, and determine if their application could 
increase overall yield of geldanamycin. Two resins in particular, Amberlite 
XAD-1600 and Diaion HP-20, were found to have significant potential for 
application in the recovery of geldanamycin in downstream processes and 
it was therefore decided that these resins would be the focus of the
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assessment of the In-Situ Product Recovery of geldanamycin from 
fermentation broth.
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6.2 Materials and Methods
6.2.1 Streptomyces hygroscopicus var. geldanus antibiotic 
fermentations
Chapter 3
6.2.2 Analysis of broth levels of Geldanamycin
Chapter 4
6.2.3 Analysis of solid phase levels of Geldanamycin
In order to determine total production one must consider the presence of 
two streams in the fermentation: the liquid stream, the amount of product 
secreted into the medium by the organism and remaining in 
solution/suspension, and the solid stream, the amount of product 
associated with cell matter, either entrapped/immobilised or retained 
intracellularly. When an additional solid phase is included in the 
fermentation system, e.g. adsorbent resins, these must be incorporated 
into the assessment of the solid phase-associated product levels.
Applying adsorbent resins in an ISPR process for geldanamycin recovery 
meant that in order to determine the amount of geldanamycin associated 
with the solid phase the biomass and resins were to be treated as a 
combined solid phase stream. Samples were centrifuged for 10 minutes at 
3500 rpm. The recovered solids (biomass and resins) were then washed 
in one quarter fermentation volume of acetonitrile. The washing process 
involved resuspension of the solids with vigorous agitation followed by 1 0  
minutes sonication to maximise mass transfer and disassociate product 
which is strongly associated with biomass. Lindemann et a/., (2 0 0 0 ) also 
used sonication to increase the extraction of compounds from solids. The 
material was centrifuged again and the acetonitrile phase recovered. The
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process was repeated once more to facilitate recovery of product and the 
two acetonitrile washes were pooled to form one sample for analysis via 
HPLC.
6.2.4 Resin preparation for ISPR applications
Addition of resins into a fermentation increases the potential for 
contamination of the system. When resins were added at the initiation of 
the fermentation, they were weighed out into the Erlenmeyer culture flask, 
5 ml of sterile H20  was added, and autoclaved (121°C for 30 minutes). 
The media was then added into the flasks and the fermentations 
inoculated, at 1%, with spore stock of approximately 107spores/ml. When 
resins were to be added during fermentation, the resins were autoclaved, 
in 5 ml of H20  in glass universals, and stored until required. When it was 
time to incorporate them into the fermentation, the resins were added 
rapidly, with minimal exposure to the open environment. The resins were 
not autoclaved in the presence of media because it was believed this 
could affect the adsorption process. Marshall et al., (1990) had found 
evidence that autoclaving resins in the presence of media components 
may alter the resins, reducing their ablity to bind their target molecule, 




6.3.1 Effect of resin addition on broth levels of geldanamycin
6.3.1.1 Introduction
In Chapter 5, it had been found that the resins were suitable for application 
in a Downstream Processing capacity, thus the major difference with 
respect to their application in an ISPR context was the adsorption would 
take place under fermentation conditions (agitation and temperature) and 
in the presence of biomass. A decrease in the broth levels of product upon 
the addition of resins indicates the resins are adsorbing product, and 
application in an ISPR capacity does not hinder their activity. It was 
decided to examine if this was the case with the two resins; Amberlite 
XAD-1600 and Diaion HP-20, which had previously been identified as 
warranting further examination.
6.3.1.2 Materials and methods
It would be necessary for appreciable levels of product to be present in the 
fermentation system in order for a noticeable effect to be elicited upon 
resin addition. It was decided that on Day 7, the resins would be added 
and the effect of resin inclusion on broth levels of geldanamycin would be 
assessed and compared to control levels. Two different resin 
concentrations, 1 g/l and 5 g/l, were employed to assess the impact of 
concentration. The resins were added to the fermentations and broth 
samples were taken daily, with the broth levels of geldanamycin being 
assessed by HPLC.
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6 .3 .1 .3 .  R e s u l t s
It can be seen from both Figures 6.1 and 6.2 that the addition of adsorbent 
resins into the fermentation system resulted in a drop in geldanamycin 
concentration in the fermentation broth. This indicates that the resins were 
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Figure 6.1: Effect of addition of 1 g/l of adsorbent resin at Day 7 of
fermentation on broth levels of geldanamycin
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Fermentation Time Elapsed (Days)
Figure 6.2: Effect of addition of 5 g/l of adsorbent resin at Day 7 of
fermentation on broth levels of geldanamycin
In both Figures, after the drop in signal, resultant from the introduction of 
the resins, the broth levels gradually begin to increase again. This 
indicates that, added at low concentrations, the resins adsorb 
geldanamycin until saturated. Production continues, and after a period of 
fermentation time, achieves levels comparable to control fermentations. 
This suggests that there may be no detrimental effect of low level addition 
of resins on the metabolic and biological processes of the organism.
From Figure 6.2 however, it can be seen that although the drop is greater, 
since a greater concentration of resins is added, control levels of 
production are not re-established in the broth after the same fermentation 
time. This indicates that in order for broth levels of geldanamycin to be re­
established in fermentations containing higher concentrations of adsorbent 
resins, a longer fermentation period may be required.
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The above results highlight the potential application of these adsorbent 
resins in ISPR processes and in particular the potential for ISPR to 
increase geldanamycin production yields. The continual removal of 
product as it is formed benefits the production process with relation to 
limiting inhibition and degradation, and it would thus be beneficial to 
determine the effect of resin inclusion on total geldanamycin yields.
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6 .3 .2  E f f e c t  o f  r e s i n  i n c l u s i o n  o n  t o t a l  g e l d a n a m y c i n  y i e l d s
6.3.2.1 Introduction
In production fermentations, it is common to deal with a single product 
stream. Prior to assessment of the applicability of adsorbent resins for the 
recovery of geldanamycin, only the liquid stream of the fermentation was 
assessed. Aiba and Okabe (1976) suggested that in actinomycete 
fermentations, the solid phase mycelia may contain quantities of the 
entrapped antibiotic. Assessing the applicability of adsorbent resins 
incorporates an additional stream into the process, a solid stream. These 
resins adsorb product from the liquid stream and it is recovered via 
desorption. The solid phase therefore comprises biomass for control 
fermentations and biomass plus resins for test fermentations.
6.3.2.2. Materials and Methods
Since it had been determined that the adsorbent resins could function in 
an ISPR system (i.e. adsorb product), it was decided to expand the 
assessment and determine if an increased amount of geldanamycin could 
be produced in an ISPR application of the resins. The process involved 
addition of resins (at 1, 5, 10 and 20 g/l) on the initiation of fermentation, 
and examination of geldanamycin yields on Day 7 and Day 16. Total 
production was assessed as a summation of the geldanamycin recovered 
from the fermentation broth and the solid phase of the fermentation.
6.3.2.3. Results
Examining the effect of inclusion of resins from the initiation of the 
fermentation, it was found that, even at as low a concentration as 1 g/l, an 
increase in production was achieved over those fermentations devoid of 
resins (Figure 6.3). It was therefore decided to examine the effect of resin 
addition on broth levels of production. Assessing the broth levels alone
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would highlight the benefits of including a solid phase treatment with 
respect to the total amount of geldanamycin which could be recovered.
It can be seen from Figure 6.4 that control levels of production were 
achieved at lower resin concentrations. Likewise it was found that the 
broth levels of geldanamycin in fermentations containing higher resin 
concentrations were lower than control fermentations. This again 
demonstrates that there is residual potential for the resins to adsorb 
product and that there may be further benefits to product yield if the 
fermentation is allowed progress for longer.
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6 .3 .3  I S P R  o f  g e l d a n a m y c i n  f o r  i n c r e a s e d  p r o d u c t  y ie ld
6.3.3.1 Introduction
The preliminary results of the effect of resin inclusion on total 
geldanamycin production indicated that inclusion of resins results in 
increased productivity over control fermentations. It was decided to 
perform a more in-depth examination by increasing the number of time 
points at which the fermentation environment was assessed. This would 
allow a more accurate assessment of how resins affect the fermentation 
and the determination of how they could be used to benefit production in 
an ISPR process.
6.3.3.2 Materials and Methods
It was decided to omit resin concentrations of 1 g/l and instead focus on 
the impact of addition of higher concentrations of resins. The results 
obtained to-date had indicated that there was potential for higher 
geldanamycin yields if higher resin concentrations were employed in the 
ISPR process.
Fermentations containing 5, 10 and 20 g/l of resin from initiation of 
fermentation were established, and were sampled at important times 
during fermentation. The time points selected were Day 7 (suitable product 
levels would be starting to accumulate), Day 11 (a mid fermentation 
sample) Day 16 (a suitable end of fermentation sample) and Day 21 (an 
extended time point to assess the implications of fermentation time on the 
success of ISPR and production trends with time).
6.3.3.3 Results
From Figure 6.5 it can again be seen that the inclusion of resins in 
fermentations has significant benefits for the production of geldanamycin.
The higher the concentration of resins incorporated, the greater the 
amount of geldanamycin produced, and all resin concentrations showed 
an increase in the production of geldanamycin over control levels. It was 
found that the increase in production tailed-off with respect to fermentation 
time and was most apparent for Diaion HP-20, which approached its 
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Figure 6.5: Effect of resin addition and concentration on geldanamycin 
recovery with time
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6.3.4 Effect of resin inclusion on growth and substrate  
utilisation
6.3.4.1. Introduction
In the previous section the effect of addition of resins from the start of 
fermentation on geldanamycin production was examined and it was found 
that this resulted in a considerable increase in geldanamycin yield. It was 
decided to examine the effect of resin addition on the growth of the 
organism, in particular the generation of biomass. It was also decided to 
correlate this with the consumption of nutrients, in particular glucose, the 
primary carbohydrate source in the medium. Caution had to be taken 
during this assessment for two reasons. The resins are non-selective for 
the product, and use of non-specific adsorption has the draw-back of 
extracting other compounds, besides the desired product, from the 
fermentation broth (Wang and Schultz, 1981). The resins could adsorb 10 
g/l of glucose from Bennett’s medium, containing 50 g/l of glucose, in 
approximately 48 hours, under fermentation conditions of 28°C incubation, 
agitated at 150 rpm. This may bias the pattern of glucose 'consumption', 
thus one must be aware that the 'consumption' of glucose, may be partly 
attributable to adsorption onto the resins.
With respect to the determination of biomass growth, it was necessary to 
factor into account the amount of resins incorporated into a homogenous 
sample. Irrespective of these difficulties, it was envisaged that it would be 
possible to gain some understanding of the overall impact on a 
fermentation system resultant from the inclusion of adsorbent resins form 
the initiation of the fermentation. It had previously been seen that even if 
glucose is adsorbed by the resins, it had no major inhibitory impacts on 
production, thus it was important to examine just what trends were 
occurring in the In -S itu  Product Recovery fermentation.
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6.3 .4 .2 . M a te r ia ls  a n d  M e th o d s
To determine the dry weight of biomass an homogenous 10ml sample of 
the fermentation was taken and aliquoted into a plastic centrifuge tube 
(Sarstedt, Wexford, Ireland) and centrifuged at 3500 rpm for 10 minutes. 
The pellet was resuspended in approximately 5 ml of ethanol and 
transferred to pre-weighed, labelled glass universals. The glass universals 
had been prepared cleaned, labelled and dried in a 100°C oven for 24 
hours. The universals were then removed cooled, in a desiccator (to 
ensure they were free from additional moisture-derived weight), weighed 
on a three decimal place balance (Chyo Balance Corps., Japan) and 
retained for use. Once the resuspended pellet was recovered into the 
glass universals they were placed in a water bath and heated to 100°C to 
evaporate the ethanol. Once devoid of ethanol, the universals were 
returned to the 100°C oven overnight and cooled in the desiccator prior to 
re-weighing. The biomass concentration was determined using the 
following equation:
BiomassConcentration  = (A — B )x  100, where; (Eq. 6.1)
A  is the weight (g/l) of the dried glass universal containing sample, B  is 
the weight (g/l) of the dried glass universal prior to sample addition and 
( A - B )  is the difference in weight of the universals after addition and 
drying of 10ml of sample (g). This is multiplied by 100 in order to scale-up 
the assessment to a g/l amount.
When this method is applied to a sample which contains resins the 
presence of the resins must be incorporated into the dry weight 
assessment otherwise a false high result would be returned. In order to 
factor in the presence of the resins, once a dry weight concentration (g/l) 
had been determined, the concentration of the resins which was added 
(g/l) is subtracted from this value. This gives the dry weight of biomass 
only (g/l).
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The glucose concentration in samples was determined using the GOD- 
PAP assay. This assay allows the quantitative determination of glucose 
concentration in samples via the combined action of the enzymes glucose 
oxidase and peroxidase. The method employed is a modification of that 
described in the Randox Laboratory’s Ltd. assay kit (Crumlin, Co. Antrim, 
Northern Ireland). The method has been adapted for microtiter plate use 
and thus allows a higher throughput of samples in a shorter processing 
time. The kit comprised of a glucose standard, which is used to establish a 
standard curve, and reagents, which are comprised of the necessary 
reactants including the enzymes, in a suitable buffer. Samples of the 
fermentation broth were taken following centrifugation at 3500 rpm for 10 
minute.
The modified assay involved addition of 20 |jl of sample (diluted in distilled 
water, into the range of the standard curve) to a well of a 96-well plastic 
microtiter plate (Sarstedt, Wexford, Ireland). To this 200 pi of reagent was 
added. The solutions were mixed and incubated at room temperature (15 - 
25°C) for 25 minutes (alternatively, the plates could be incubated at 37°C 
for 10 minutes to increase the speed of the analysis). The samples were 
then read using a Tecan, Sunrise, A-5082 plate reader and associated 
data retrieval software (Tecan, Mannedorff, Switzerland) at a wavelength 
of 492 nm. The absorbance of the glucose containing samples (standards 
and test samples) were measured and compared to a blank sample 
(distilled water). The glucose concentration was then determined using a 
glucose standard curve. (See Appendix for standard curves).
6.3.4.3. Results
Williams e t  al., (1992) found that adsorbent resins, used for the recovery 
of the antimicrobial compound sanguinarine, could adsorb growth 
regulators and vitamins from the culture environment and inhibit cell 
growth. Examining the effect of addition of resins on S. h y g r o sc o p ic u s  
growth it seemed that this may also be the case, since the growth rate 
showed signs of reduction (Figure 6.6). With respect to final biomass 
yields it was found that it was possible for the fermentations containing
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resins to achieve approximately the same levels of biomass generation as 
those without resins, however it took a longer period of fermentation time. 
These results indicated that when the resins were present in the 
fermentation environment from the initiation of the fermentation, they may 
have adsorbed compounds required for growth and thus slowed down the 
growth rate. This may be seen from the fact that the biomass 
concentration is low with relation to higher resin concentrations, at early 
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Figure 6.6: Effect of resin addition on biomass growth
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Examining the effect of resin inclusion on glucose consumption, it was 
found that as the fermentation progressed, the concentration of glucose in 
the fermentation decreased. This was expected, since glucose would be 
consumed by the organism for growth and production, and could also be 
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6 .3 .5  E f f e c t  o f  r e s i n  a d d i t i o n  t i m e  o n  t o t a l  p r o d u c t i o n :
6.3.5.1 Introduction
Since it had previously been shown that higher concentrations of resins 
resulted in greater yields of geldanamycin, it was decided to determine the 
effect of resin addition time on the fermentation system. Previously 
addition times of Day 0 and Day 7 were examined, however it was decided 
to extend this assessment and examine the addition of resins at a number 
of important fermentation times. In this manner it would be possible to 
determine if addition time effected production and recovery of 
geldanamycin.
6.3.5.2 Materials and Methods
The experimental involved the addition of 20 g/l of resins to fermentations 
at the initiation of fermentation and subsequently on Day 0, 7, 11 and 16. 
The fermentations were allowed run until Day 21 at which point they were 
harvested and analysed. Resin concentrations greater than 20 g/l were not 
used because volumetrically, they would occupy a large amount of the 
fermentation environment. Increased resin concentrations may also lead 
to increased non-specific adsorption of nutrients, which in turn, may either 
deplete the environment of nutrients resulting in limitation of growth, or 
deplete it to levels which may favour the growth of contaminating 
organisms.
6.3.5.3. Results
Again it was found that the incorporation of adsorbent resins into the 
fermentation system increased geldanamycin yields (Figure 6.8).
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Resin Addition Time (Day)
Figure 6.8: Effect of resin addition time on geldanamycin production and 
recovery for a Day 21 harvested fermentation. 20 g/l of each resin was 
employed, and —  represents the yield of geldanamycin from resin free 
fermentations
It was also found that the time at which resins were added could impact on 
the total amount of geldanamycin recovered. Adding the resins after a 
period of fermentation time had elapsed aided the recovery of greater 
quantities of geldanamycin. The greatest benefit to production and 
recovery is achieved when the resins are added at approximately Day 7. 
Adding the resins later had minimal additional benefit to production levels 
over the fermentation time examined. It is also important to highlight that 
even if the resins are added at the initiation of fermentation, the positive 
effects on production levels over that obtained in control fermentations 
was still clear.
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6 .4 . D i s c u s s i o n  a n d  C o n c lu s io n
Microbes can produce and accumulate certain substances which are toxic 
to the microbial cells themselves. These substances can limit and regulate 
their own production and negatively impact on the success of 
fermentations. Removal of these products from the vicinity of the 
producing organism as soon as they are formed would clearly be 
beneficial.
Having applied adsorbent resins in a Downstream Processing (DSP) 
application for the recovery of geldanamycin, and identifying the two 
optimally performing resins, it was decided that utilisation of these resins 
may be a viable means to achieve the goal of increased productivity. The 
resins could be applied in an In -S itu  Product Recovery (ISPR) method and 
the effect of doing so on the levels of production and product recovery 
could be assessed. An initial assessment of the performance of the resins 
under fermentation conditions showed that their action was not hindered, 
and they adsorbed product, resulting in a drop in the broth levels of 
product.
A more in-depth assessment of the impact of resin inclusion on 
geldanamycin yields indicated that incorporation of the resins into the 
fermentation allowed the recovery of increased amounts of product over 
that produced in control fermentations. As the resin concentration 
increased so too did the amount of geldanamycin recovered. It is believed 
that the addition of resins may have allowed an enhanced maintenance 
and control of the levels of different compounds present in the 
fermentation system. The resins could remove geldanamycin from the 
production system as it was formed, preventing its further metabolism or 
degradation as a result of exposure to the fermentation environmental 
conditions.
Since the resins were not selective for geldanamycin, they may facilitate 
increased production by adsorption of contaminating compounds or 
compounds which have negative effects on production, such as precursor
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or regulatory compounds. Removing compounds like these from the 
fermentation system would diminish their impact on production regulation. 
Addition of the adsorbents into the fermentation system can also result in 
the adsorption of nutrients (Tone et al., 1968). If adsorption and slow 
release of nutrient compounds occur, this too may have a beneficial 
impact on production. A more encompassing examination of the effect of 
resin inclusion demonstrated definitively that an increase in the 
geldanamycin was possible by addition of these resins in an ISPR mode.
It was also found that if the fermentation was allowed to progress for a 
number of days prior to addition of the resins, a further increase in 
production could be achieved. The primary reason for this was believed to 
be that by allowing the fermentation to progress similar to control 
fermentations, biomass levels build up more rapidly than they would if the 
resins were present from the beginning of fermentation. On addition of the 
resins, there is a combined benefit of the fermentation being in a more 
advanced state and the benefits previously attributed to addition of the 
resins.
Another reason for the difference in yields could be that inclusion of the 
resins from an early stage may result in biomass growth in the pores of the 
resins. This would limit the positive effects of resin inclusion through 
clogging of the resin pores and thus reduce the potential for geldanamycin 
adsorption by the resins. Adding the resins later, means that the biomass 
would be in a larger size and less likely to colonise the pore structures. 
Senthuran e t  al., (2004) took measures to reduce the impact of microbial 
growth on the adsorptive performance by shielding the adsorbent in a thin 
layer of non-ionic polymer in their studies of integrated lactate production.
Bader, (1986) suggested that during fermentation production of antibiotics, 
the primary objectives during the early phase of the fermentation are to 
grow a large concentration of cells, develop the enzymatic pathways for 
antibiotic production and deplete the medium of metabolite which may be 
inhibitory to the production of the antibiotic. With this in mind, it is clear to 
see some reasoning behind the increased levels of geldanamycin
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production resultant from the addition of adsorbent resins. The resins are 
not only capable of adsorbing and stabilising the product, thus removing it 
from environmental and metabolic hazards, but may also remove some 
product in the environment which may contribute to the inhibition of 
geldanamycin production.
Likewise the addition of resins at a later stage in the fermentation allows 
the maximum amount of biomass growth to be achieved sooner, and when 
the resins are added the combined effect of increased biomass 
concentration, removal of inhibitory compounds and recovery of product is 
elicited. Similarly, Marshall e t  al., (1990) elucidated to the fact that addition 
of resins may benefit production in two ways, namely sequestering of 
product away from its sensitive producing organism and also serve to 
promote stabilisation of the product, and in particular, prevent its 
conversion to different products.
In summary, it is clear to see that the work undertaken has proven that the 
selected adsorbent resins display a potential for application in an ISPR 
methodology for the recovery of geldanamycin. The use of the resins not 
only facilitated recovery of the product but also resulted in an increase in 
the total amount of geldanamycin which could be recovered. The use of 
these resins in an ISPR context was a success and has considerable 
application possibilities for further work. There has been significant work 
performed in developing novel techniques using adsorbents or other 
methods, and also combinations of techniques, to achieve increased 
productivities or to address or prevent some process or metabolism- 
associated product loss (Zelic e t  al., 2004, Wang, 1983, Cen and Tsao, 
1993), and are of great value to the bioprocessing world.
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C h a p t e r  7 .  C o n c l u s i o n s  a n d  R e c o m m e n d a t i o n s
7.1 Conclusions
The aim of this project was to examine the applicability of adsorbent resins 
in processes for the recovery of the antibiotic geldanamycin, produced by 
the Actinomycete S tr e p to m y c e s  h y g r o s c o p ic u s  var. g e ld a n u s . Adsorbent 
resins are gaining increased application for the recovery of antibiotics 
generated in a similar manner to geldanamycin and it was therefore 
desirable to determine if their application could lead to the successful 
recovery of geldanamycin. In order to achieve this however, it was 
necessary to have in place, methods by which geldanamycin could be 
assessed and monitored. It was envisaged that successful completion of 
these goals would complement any work performed in future assessments 
of geldanamycin.
Previously, work had been performed in the laboratory to establish the 
growth patterns of the organism, and tie this to productivity. During this 
period the lack of Standard Operating Procedures (SOPs), to allow the 
fast and accurate assessment of the progression of fermentations, and in 
particular the production profile of fermentations, hindered the progress of 
the work. Up until that point the bioactivity of samples, which served as an 
indication of fermentation production levels, was assessed using Disk 
Diffusion assays. These assays were labour intensive, consumed large 
quantities of materials and returned primarily qualitative results. In order to 
rectify this, a high throughput microtiter plated-based bioassay was 
developed. This assay allowed the determination of the efficacy of 
bioactive compounds produced in the fermentation broth, based on 
retardation of biomass growth. This was determined by turbidity 
assessment, and applying the developed technique, it was possible to 
correlate retardation of biomass growth with inhibition potential of 
fermentation samples.
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The development of this assay increased the reliability and standardisation 
of the assessment of production over the traditional disk diffusion method, 
allowed higher throughput of samples and allowed a quantitative 
assessment to be achieved. However, it soon became clear that in order 
determine and asses the presence of a single compound in fermentations, 
namely the target antibiotic geldanamycin, it would be necessary to 
develop a more selective method. Since the very nature of S tr e p to m y c e s  
is the production of an array of bioproducts (Glazer and Nikaido, 1995), 
using the developed bioassay, it could not be definitively determined that 
the bioactive effect assessed, was wholly attributable to geldanamycin.
In order to address this problem, an accurate, reliable, high throughput 
method for analysis and quantification of geldanamycin was required. High 
Performance Liquid Chromatography (HPLC) is frequently used for the 
definitive identification and quantification of compounds, and it was 
therefore decided to develop a suitable HPLC method for geldanamycin 
assessment. HPLC is often used for the quantification of bioproducts 
including antibiotics (Joshi, 2002, Loadman and Calabrese, 2001). 
However, optimisation of the process for a particular application can 
require considerable experimentation. The HPLC method was optimised 
and standardised for identification and quantification using an adaptation 
of the process employed by Agnew e t  a i ,  (2001). However difficulties 
arose with the preparation and analysis of samples, and considerable 
effort was required to optimise sample preparation and treatment.
The direct analysis of geldanamycin-containing fermentation broth 
samples resulted in fouling of the analytical HPLC columns, and resulted 
in significant costs incurred, with relation to irreparable column damage 
and process down-time. As a result, alterations to the analytical process 
had to be examined, with primary focus on reducing the level of potentially 
contaminating compounds, whilst maintaining the high sample throughput, 
inherent of HPLC processes. As with the recovery of many antibiotics, 
solvent-mediated liquid-liquid extraction was the first method attempted to 
resolve these issues. The extracting solvent, butanol, was however, 
incompatible with the HPLC process, and caused resolution problems.
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Although the extraction process performed well, the resolution difficulties 
meant it was necessary to remove the butanol prior to sample analysis. A 
number of methods were examined and it was found that a low pressure 
evaporation method was best, allowing treatment of a number of samples 
simultaneously. This method removed the difficulties with the butanol 
being present in a sample, however, the time required to treat samples in 
such a process was excessive, a single sample taking 40 minutes to 
prepare.
Increasing the pore size of the stationary phase of the HPLC column was 
identified as the most appropriate means of resolving this issue. 
Increasing the pore size returns benefits on two levels, the increased pore 
size is less likely to become clogged and fouled and would also reduce the 
pressure in the system allowing faster mobile phase flowrates and 
therefore sample throughput. Employing a HPLC analytical column with 
larger pore size meant that it was possible to re-address direct injection of 
samples. It was decided that a minimal pre-treatment, dilution of the broth 
samples, would further reduce the risk of contamination, but would have 
minimal bearing on sample throughput.
It was during the dilution of broth samples that an interesting phenomenon 
was encountered. It was found that dilution of broth samples in H20  lead 
to a non-linear dilution pattern. Further investigation of this indicated that 
geldanamycin had a limited solubility in water, and that in order for dilution 
to be applied for the analysis of all subsequent samples, dilution in the 
solvent acetonitrile was required. This proved to be a very important 
finding, and as a result, the analysis procedure for fermentation broth 
samples simply involved dilution of the broth in acetonitrile, filtration and 
HPLC analysis for geldanamycin concentration. This process was 
accurate, and facilitated the high throughput assessment of geldanamycin 
in fermentation broth samples.
Having developed suitable standard procedures to assess geldanamycin 
in S tr e p to m y c e s  fermentation samples, it was then possible to continue 
efforts into assessing the recovery of the product from fermentation broth
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samples. Frequently in production processes, product yields can be 
diminished as a result of the recovery processes employed. Geldanamycin 
has been reported to be recovered using solvent extraction, however in 
pursuit of processes to aid in the recovery of geldanamycin, it was decided 
to examine the application of adsorbent resins. It was believed that an 
appropriate assessment would involve examining their application in two 
major bioprocessing modes, Downstream Processing (DSP) and In -S itu  
Product Recovery (ISPR).
A preliminary investigation was performed to determine the applicability of 
resins for the recovery of geldanamycin from fermentation broth at the end 
of the fermentation. Resins were added to cell-free fermentation broth and 
the adsorption of product assessed. A series of resins were examined, all 
of which had application for the recovery of antibiotics. The examination 
incorporated assessment of the adsorption profiles, capacities and 
affinities of the resins for the product. It was found that the use of resins 
was suitable for the recovery of geldanamycin from fermentation broth and 
that they displayed good affinities, loading capacities and adsorption rates, 
according to empirical experimentation and adsorption model fitting. The 
influence of temperature, pH and solvent addition was also examined, 
since such parameters have been found to frequently impact on the 
adsorption of compounds in complex systems.
Temperature is frequently seen to have an impact on the amount and rate 
of compound adsorption by various adsorbents (ten Hulscher and 
Cornelissen, 1996, Aksu, 2001, Otero e t  al., 2004), however the effect can 
be somewhat specific for particular applications or compounds of interest 
as was seen by Gokrnen and Serpen, (2002) and Otero e t  al., (2005). In 
these cases, increased adsorption was brought about by opposite 
changes in adsorption temperature. By examining adsorption at different 
temperatures it was found that although all temperatures allowed the 
resins to recover comparable proportions of product, the rate of adsorption 
was generally higher at higher temperatures. Examining the impact of pre­
adsorption pH adjustment, it was found that the proportion of 
geldanamycin adsorbed was robust to pH change, as may have been
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expected, since all resins have a broad pH application range. The 
adsorption of contaminants however, showed the least proportion of 
contaminants was adsorbed at pH 7.5, a pH value typical of normal end of 
fermentation broth.
The discovery that acetonitrile could aid the solubility of geldanamycin in 
fermentation broths during sample analysis, lead to the examination of 
what effect inclusion of acetonitrile into the fermentation broth, had on the 
adsorptive performance of the resins. It was found that adsorption of 
geldanamycin was reduced with increasing addition of acetonitrile. The 
acetonitrile may have acted as a competitive force, shifting the affinity from 
adsorption onto the resins to remaining in the liquid phase. Of more 
significance was the discovery that increasing the amount of acetonitrile in 
the pre-adsorption broth reduced the adsorption of contaminants in a more 
significant manner. As a result, it would seem possible to engineer the 
adsorption process, based on a low level addition of acetonitrile, to favour 
the adsorption of geldanamycin over contaminants. This was a very 
interesting discovery and could have significant implications on further 
product purification procedures.
Finally the desorption profile of the resins post-adsorption was examined. 
It was found that the resins selectively desorbed geldanamycin more 
readily than the contaminating compounds which were more stringently 
retained. This would imply that a simple bind and elute process could 
facilitate the generation of a product stream containing large amounts of 
geldanamycin, and at higher purity, than that which existed in the initial 
fermentation broth. It would also seem likely, that purity could be further 
increased by combining treatments, such as modifying the adsorption 
environment prior to elution. The net result of the assessment of the DSP 
application of adsorbent resins was that it was established that resins 
could be applied for geldanamycin recovery, and that two resins in 
particular, Amberlite XAD-1600 and Diaion HP-20 performed optimally.
The final examination undertaken was an assessment of the ISPR 
application of the adsorbent resins XAD-1600 and Diaion HP-20. These
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resins had displayed impressive activities during DSP applications and 
were therefore selected for further assessment on that basis. ISPR 
techniques have been employed for the recovery of an array of 
compounds and are applied for various reasons. The assessment of the 
ISPR application of adsorbent resins was not only focused on whether the 
resins could be applied in such processes and how they, or the production 
environment were effected, but was also concerned with determining if 
product yield could be increased. It was believed that ISPR application of 
resins may allow increased productivity through means of precursor 
regulation or removal of inhibitory compounds or by limiting the 
degradation of product during fermentation.
In order to determine if the resins were suitable for ISPR application it was 
necessary to validate their performance under fermentation conditions. 
This involved determining if they could adsorb product in the presence of 
biomass, at fermentation temperatures and under conditions of agitation. 
In order to assess this, adsorbent resins were added into the 
fermentations after a period of fermentation time had elapsed and the 
effect on broth levels of geldanamycin was assessed. It was found that the 
resins were capable of adsorbing geldanamycin under conditions of 
fermentation, including in the presence of biomass, and incubated at 28°C, 
and agitated at 150 rpm. This was indicated by a drop in geldanamycin 
concentration. Since the resins could adsorb product under fermentation 
conditions it, was decided to continue the assessment of their application 
in ISPR processes.
Adding resins at the initiation of the fermentation and assessing product 
yield showed an increase on control levels of production of approximately 
3-fold, depending on resin type, concentration and the time of harvest. It 
was also noted that as the concentration of resin increased, the broth 
levels of geldanamycin decreased. This was indicative of the adsorption of 
product from the production environment by the resins. It was also found 
that inclusion of the resins from the initiation of fermentation resulted in 
adsorption of glucose and reduced the rate of biomass generation, but still
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consistently returned geldanamycin yields greater than fermentations into 
which no resins were added.
Assessing the time at which the resins were added to the fermentation 
returned an important result. It was found that if the fermentation was 
allowed to progress for a number of days prior to resin addition, a further 
increase in the product yields was achieved. This was believed to be 
attributed, in part, to the fact that there would be an increased rate of 
biomass generation resultant from the resins being absent from the 
fermentation initially, and thus when the resins are added, there would be 
a combined benefit elicited.
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7 . 2  R e c o m m e n d a t i o n s
This project centred on developing strategies for the successful recovery 
of geldanamycin from fermentation broth, using adsorbent resins, and as a 
result required establishing standard procedures for the treatment and 
analysis of fermentation samples to facilitate this. Some interesting 
findings were made during this time, which resulted in the development of 
analytical techniques for the determination of geldanamycin and novel 
methodologies for its recovery. Although the assessment of the application 
of adsorbent resins has been made, and techniques to monitor and 
assess geldanamycin have been developed, there are still some areas of 
interest which remain, and which may warrant further examination.
7.2.1 Correlation of geldanamycin production with bioactivity
Initially, production in fermentations was qualitatively assessed using the 
disk diffusion assay. This technique was laborious and led to the 
development of a microtiter plated-based assay which allowed the 
quantitative assessment of large numbers of samples in a relatively simple 
manner. Although this technique was put to limited use when it became 
apparent that a more accurate evaluation of the specific compounds 
present in fermentation samples was required, there remains some 
comparative work for which it could be utilised. It would be beneficial to be 
able to correlate geldanamycin concentration as determined by HPLC with 
bioactivity. In this manner the assessment of samples would be two fold, 
and the relationship between geldanamycin concentration and bioactive 
effect against test organisms, could be established.
7.2.2 Partitioning potential of geldanamycin in liquid culture
Having determined that geldanamycin has a limited solubility in aqueous 
solutions, and that addition of acetonitrile addresses this limitation, it would 
be desirable to further examine the possibility of product partitioning or
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precipitation in fermentation. If this occurred in fermentation it may involve 
the formation of a two-phase system which in turn could have ramifications 
for product recovery processes. To establish if this were the case would 
require the production of fermentation broths of very high geldanamycin 
concentration and may involve treatment of the broth in a similar manner 
to crystallisation procedures, in an attempt to force product precipitation.
7.2.3 Column-based adsorption of geldanamycin
The assessment of the application of adsorbent resins for the recovery of 
geldanamycin in a DSP context was essentially a preliminary study, 
carried out to investigate application of the resins, and took place In batch 
mode. It would be desirable to explore the application of the resins in 
column mode, which has been cited previously in literature (Giizeltung and 
Ulgen, 2001, Tolonen e t  al., 2004, Xie e t  al., 2001). Determination of the 
adsorption profiles would include the assessment and development of 
breakthrough curves, which in turn would indicate the saturation capacities 
of the resins in a similar manner to those techniques employed in the DSP 
application of resins. Examination of the desorption profiles, would indicate 
potential for further work on optimisation of product recovery, and 
moreover, recovery of purer product streams. Optimising a column-based 
adsorption system would provide information, which would be useful for 
the development of an external extraction loop, fitted to a fermentation 
vessel, and perhaps facilitate continuous removal and recovery of product.
It would also be desirable to combine some of the results discovered so 
far, such as the use of acetonitrile in the pre-adsorption fermentation 
broth, in experiments to increase selectivity of product adsorption and 
desorption. Again the aim of such assessments would be to produce purer 
product streams of high geldanamycin concentration for further study and 
application.
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7 .2 .4  O p t i m i s a t i o n  o f  I S P R - b a s e d  r e c o v e r y  o f  g e l d a n a m y c i n
The ISPR application of adsorbent resins has been shown to possess 
significant benefits for the production of increased yields of geldanamycin 
per-fermentation. Of particular interest remaining in this section would be 
the optimisation of the process parameters to increase the selectivity of 
the adsorption of geldanamycin whilst retaining the benefits to overall 
yield. It would also be interesting to assess all of the resins which were 
examined for Downstream Processing application, or alternatively some 
new resins. XAD-1600 and Diaion HP-20 were selected for examination 
based on their high capacities and affinities and all-round performance in 
DSP applications, however it may be interesting to assess the application 
of other resins which may be more suited to ISPR application, or more 
selective for geldanamycin.
Membrane fermentations and membrane recovery processes are gaining 
significance in bioprocessing industries, and can be used to selectively 
remove biochemicals directly from fermentation broths (Agrawal and 
Burns, 1997). A simple means by which their application in geldanamycin 
fermentations could be assessed would be by inclusion of adsorbent 
resins in dialysis tubing. In this manner, molecular weight cut-off values 
could be established, which would allow the transport, across the 
membrane, of geldanamycin and similarly sized compounds, but prevent 
that of larger contaminating compounds. This would limit the adsorption of 
contaminants and facilitate the generation of a product stream. Although 
this is a simple method It has the potential to be effective in delivering the 
desired goals, Wang, (1983) have detailed a similar idea.
There are however, a number of other means by which membranes could 
be utilised in such a recovery process. One could use a more specific 
membrane than dialysis tubing, and set more appropriate means of cut­
offs than size exclusion. It is also possible to employ non-porous 
membranes which would allow establishment of a system analogous to 
membrane fermentations and facilitate direct extraction of geldanamycin 
into a suitable solvent, which would be retained on the other side of the
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membrane without cross contamination and the associated ill-effects on 
biomass vitality and survival.
Another method by which the recovery of geldanamycin could be 
examined is through the use of encapsulation, in particular encapsulation 
of resins in alginate or some other polymer, or encapsulation of a suitable 
extracting solvent in liquid-core micro-capsules. Encapsulation of the 
adsorbent resins may serve to retard the diffusion of larger compounds 
and thus hinder their adsorption onto the resins contained within the 
alginate. Encapsulation of a suitable extracting solvent in a liquid-core 
capsule would allow the recovery of the compound of interest in a similar 
manner to that achieved using solvents in a liquid-liquid extraction method, 
but would prevent the contamination of the system resultant from direct 
contact with the extracting solvent.
It is also believed that modification of the adsorbents themselves may 
allow further development of the recovery process. The resins applied in 
the study are commonly available materials, and have undergone no 
chemical or physical modification to increase performance or selectivity. It 
may be possible to modify the resins through techniques such as size 
modification, similar to that described by Nigam and Wang, (1986) to 
increase mass transfer, which may in turn impact on the success of the 
recovery process. Alternatively, it may be possible to employ a more 
selective resin, conferred with specific functional groups or physical 
chemistries, which may increase selectivity or affinity for the product, 
similar to those discussed by Wang and Sobnosky, (1985) and Barboza e t  
al., (2001). It may also be possible to use a combination of techniques to 
elicit a more successful recovery process. Roja e t  al., (2005) detailed the a 
combination of elicitation and In -S itu  adsorption for the enhanced 
production and recovery of the polysaccharide arabinogalactan. The net 
result of these modifications would be a more focused extraction or 
recovery process, and perhaps lead to more adsorption of the compound 
of interest and less contaminants. This in turn would lead to generation of 
a more concentrated and purer product stream for further application or 
study.
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7 .2 .5  P r o c e s s  e c o n o m i c s  a n d  f e a s i b i l i t y  s t u d y
It has clearly been demonstrated from the work in this document that 
adsorbent resins can be used for geldanamycin recovery and have 
potential for further applications for the recovery, and increased yield, of 
geldanamycin. It would however be interesting to examine their use from 
an economic feasibility standpoint. It order to achieve this, a comparison of 
the costs associated with stream treatment, product recovery and material 
usage would have to be compiled, and the benefits or lack thereof, to the 
use of adsorbent resins assessed. Performing such an assessment would 
provide information of the potential for application of these resins in an 
industrial context, or in a scaled-up process.
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7 .3  S u m m a r y
The work carried out in this document details application of adsorbent 
resins in novel geldanamycin extraction and recovery methodologies. It 
also highlights factors which may influence their application and the 
product yields resultant. The development of analytical methodologies to 
facilitate, rapid and accurate quantification of geldanamycin from 
fermentation broths was also detailed. It is clear that considerable 
potential exists for the application of adsorbent resin-based processes for 
geldanamycin recovery and it would be of benefit to examine, some of the 
areas of interest, which have been identified and highlighted in this 
document. The potential applications of these resins are not limited to 
geldanamycin, and it is believed their application could be extended to 
other antibiotics and bioproducts.
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A p p e n d ix  A -  S ta n d a r d  C u r v e s
Geldanamycin Concentration (g/l)
Figure A.1 : Standard Curve for Geldanamycin
Glucose Concentration (g/l) 
Figure A.2: Standard Curve for Glucose
a
